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ABSTRACT
Part 1
Screening of Thirty One Medicinal Plant Species Against Herpes Simplex Virus: Acetone and
Methanol Extracts from the Root Tissue of Kalanchoe pinnata Interferes with HSV
Types 1 and 2 DNA Replication and Early and Late Gene Expression Preventing
the Spread of HSV in vitro
Part 2
Professional Development Curriculum: Integrating
Molecular Biology and Microbiology into the
Existing Secondary Biology Curricula

Mary Ruth Jaeger Greer
Department of Microbiology and Molecular Biology
Doctor of Philosophy
PART 1: Thirty-one medicinal plant species from Hawaii, Morocco, and the Sonoran Desert,
USA have been shown in past studies to be highly inhibitory to pathogenic bacteria, fungi, and
certain cancer cell lines. However, none were tested for antiviral activity. Acetone and methanol
extracts from these species were bio-assayed for antiviral activity against herpes simplex virus
types 1 and 2 (HSV 1 and HSV 2) and for cytotoxicity to the Vero C1008 cell line. Extracts from
these species were tested in vitro for antiviral activity using an immunoperoxidase mini-plaque

reduction assay to detect viral structural protein synthesis. Sulforhodamine B and neutral red
assays were used to qualitatively and quantitatively assess the cytotoxicity of extracts to C1008
cells, and to compute a 50% cytotoxic concentration (CC50) using a dose response curve. Eight
of the 31 plant species assayed showed significant antiviral activity against herpes simplex virus
types 1 and 2. The acetone extract of Kalanchoe pinnata Pers. (Crassulaceae) produced the most
promising results with an IC50 of 0.025 mg/ml and a CC50 of 1.25 mg/ml yielding a therapeutic
index of 50. Additionally, this extract reduced plaque numbers to zero or near zero at a
concentration of 0.1 mg/ml when added 30 min before and up to 8 h post infection. Further tests
were performed on the K. pinnata extract in pursuit of the mechanisms of observed antiviral
properties. Quantitative PCR was used to determine HSV susceptibility to the acetone extract.
Antiviral mechanisms were investigated by measuring the reduction of viral DNA at different
time points post infection and by measuring the reduction of viral RNA transcripts for five
specific genes: alpha gene UL54, beta genes UL23 and UL30, and gamma genes US4 and UL17.
Examination of transcript number found a significant decrease in viral DNA replication and early
and late gene transcription when infected cells were exposed to K. pinnata suggesting post entry
events were blocked by extract.
PART 2: The professional development curriculum was written for the Alpine School
District and will offer teachers the opportunity to develop and enhance skills for effective science
teaching emphasizing molecular biology and microbiology disciplines. The course begins with
four assumptions about the nature of secondary science in-service. First, the understandings and
abilities required to be a masterful teacher of science are not static. Second, science content
increases and changes, and a teacher's understanding in science must keep pace. Third,
knowledge about the process of learning is continually developing, requiring teachers to stay

informed. And fourth, we live in a changing society that deeply influences events in schools;
social changes affect students as they come to school and affect what they need to carry away
with them. While the main intent of this course is to improve the knowledge base for secondary
life science teachers in the microbiology and molecular biology disciplines, it is expected that
teachers will return to their own classroom and use the materials and ideas they have acquired
from this course. Included in the concepts stressed are: 1) the historical routes of molecular
biology, (2) biotechnology and its influence in society, (3) the relationship between viruses and
evolution, order and organization, (4) the immune system and examples that stress structure and
function, change and constancy, and (5) the personal and social impact of pathogens. Teachers
are introduced to new information in virology, molecular biology and immunology using case
studies, practicing scientific inquiry, and recognizing the unifying themes of biology in
microbiology and molecular biology.

Keywords: antiherpetic, curriculum, immunology, microbiology, molecular, professional,
quantitative PCR, virology
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Chapter One - Introduction
The Antiviral Study
Background
Throughout the world, crude extracts are used by millions of people for their primary source
of medicine. It is essential to identify those extracts that can be developed for modern medical
application (Fabricant & Farnsworth, 2001; Farnsworth, 1988; Feeny, 1976). Also it is necessary
to understand the molecular mechanisms involved when a specific plant extract exhibits
antimicrobial activity. Two chapters of the dissertation are devoted to this study. Chapter two is
concerned with the investigation of 61 plant extracts and their antimicrobial effects including
antiherpetic effects in Vero C1008 cells. Chapter three is concerned with specific antiviral
mechanisms that may be at work in the herpes simplex virus types 1 and 2 (HSV 1 and HSV 2)
infected cell, treated with the acetone extract form the root tissue of Kalanchoe pinnata. This
work began in the Natural Product Research Laboratory at Brigham Young University which
continues to identify plants extracts that may suggest positive uses for animals and humans.
Many of these plants had not been investigated in depth, nor had the mechanisms of antiviral
activity been determined. Specifically my interests were to investigate an extract and the
mechanisms of action of that extract against the HSV 1 and HSV 2 infection.
The World Health Organization estimates that today 80% of the people in developing
countries rely on traditional medicine for their primary health care needs and about 85% of the
traditional medicine involves the use of plant extracts. Plant extracts have long sparked the
interest of scientists and nonscientist alike, largely because of their secondary metabolites. The
production of secondary metabolites requires energy otherwise used for reproduction and growth
therefore plants will not typically produce these compounds without specific environmental
1

pressures. The pathways of many unique secondary metabolic systems are derived from primary
metabolism with a variety of enzymes that play roles as signaling molecules and function in
processes as diverse as UV protection, defense against herbivores and pathogens, and recruiting
pollinators and seed dispersers (Coley, Bryant & Chappin, 1985). This suggests that many of
these compounds can be found only in plants growing in their natural habitat and may not be
reproduced in a greenhouse.
Kalanchoe pinnata: history and medicinal uses
Greeks, Native Americans, Chinese, and Africans have treated many afflictions using plants
and plant extracts (Igwe & Akunyili, 2005). One such plant is Kalanchoe pinnata Linn
(Crassulaceae), a fleshly shrub that is about 60–120 cm high and branched from the base with
opposite, simple or trifoliate petiolate leaves. Although this perennial herb probably originated
from Madagascar, K. pinnata abounds in tropical regions of the world, usually growing widely in
hot and humid areas, around dwelling places, along roadsides, and in abandoned farms and
fields. In Nigeria and some other West African countries, the fleshy leaves of K. pinnata are
frequently used as an herbal remedy for an array of human disorders, including hypertension,
diabetes mellitus, bruises, wounds, boils, abscesses, insect bites, arthritis, rheumatism, joint
pains, headaches, and body pains (Ojewole, 2002). Also, the leaves are used for inguinal
lymphadenitis and ear diseases (Adjanohoun, Ahiyi, Ake-Assi, Dramane, Elewude, Fadoju,
Gbile, Goudote, Johnson, Keita, Morakinyo, Ojewole, Olatunji & Sofowora, 1991). There is
extensive documentation on the use of leaves from K. pinnata as an ethnomedicine for the
treatment of earache, burns, ulcers, insect bites, diarrhea and lithiasis (Agoho, 1974; Chopra,
Nayar & Chopra, 1980; Ofokansi, Esimone & Anele, 2005; Ojewole, 2002; Ojewole, 2005). It is
commonly used in traditional medicine as a painkiller, particularly in cases of menstrual pains
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and breast abscesses. For the treatment of earache, the juice from the boiled leaves is squeezed
into the affected ear and for the treatment of breast abscess; the crushed leaves are mixed with
kaolin or china clay and applied externally to the entire breast. In the management of menstrual
pain, kaolin mixture of the whole plant extract is applied to the waist and umbilical region. The
plant has been reported to be used in the treatment of headache, as a diuretic, and also for
shaving (Dalziel & Hutchinston, 1958). It is applied to burns, and when rubbed on bodies of
febrile children the material has an antipyretic effect (Dalziel, 1956).
Secondary metabolites in Kalanchoe pinnata tissue
A number of investigators have shown that a host of secondary plant metabolites found in K.
pinnata possess medicinal properties in experimental animal models (Adzu, Amos, Kapu &
Gamaniel, 2003; Akah & Okafor, 1992; Dongmo, Kamanyi, Dzikouk, Nkeh, Tan, Nguelefack,
Nole, Bopelet & Wagner, 2003; Li, Lin, Myers & Leach, 2003; Liu, 1995; Marles & Farnsworth,
1995; Ojewole, 2002; Price, Johnson & Fenwick, 1987; Simon, Najid, Chulia, Delage & Rigaud,
1992; Singh, Singh, Bani, Gupta & Banerjee, 1992; Sugishta, Sakae & Yukio, 1982; Taesotiku,
Panthong, Kanjanapothi, Verpoorte & Scheffer, 2003). The phenolic compounds in K. pinnata
include a group of secondary metabolites known as flavonoids and tannins. Many of which are
known to be anti-microbial agents. Ofakansi et al. (2005) report that K. pinnata is effective in
the treatment of typhoid fever and other bacterial infections, particularly those caused by
Staphylococcus aureus, Echerichia coli, Bacillus subtilis, Pseudomonas aeruginosa, Klebsiella
aerogenes, Klebsiella pneunoniae and Salmonella typhi. K. pinnata is useful in treating the
placenta and navel of newborn babies because of its healing properties and aid in preventing
infections. Okwu and Josiah, (2006) report that flavonoids are potent water-soluble antioxidants
and free radical scavengers and aid in preventing oxidative cell damage and have strong
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anticancer activity (Del-Rio, Obdululio, Casfillo, Marin & Ortuno, 1997; Okwu & Josiah, 2006;
Okwu & Okwu, 2004; Salah, Miller, Pagange, Tijburg, Bolwell, Rice & Evans, 1995).
Flavonoids in the intestinal tract lower the risk of heart disease, and as antioxidants, provide antiinflammatory activity. Tannins have stringent properties and hasten the healing of wounds and
inflamed mucous membranes. Additionally, hydrolyzable and condensed tannins have been
tested for anti-HSV activity (Fukuchi, Sagagami, Okuda, Hatano, Tanuma, Kitajima, Inoue,
Inoue, Ichikawa, Nonoyama & Kono, 1989; Takechi, Tanaka, Takehara, Nonaka & Nishioka,
1985). Tannic acid was found to inhibit virus adsorption by the cells. However, few studies have
elucidated clearly the antiviral mode of tannins. These authors showed that hydrolysable leaf
tannins of K. pinnata (a) were able to inhibit directly HSV attachment to and penetration into
cells, (b) affected the late event(s) of HSV 2 infection, and (3) exhibited viral inactivation
activity at high concentrations.
The high terpenoid-based saponin in K. pinnata justifies the use of extracts to stop bleeding
and in treating wounds. Saponins are known to precipitate and coagulate red blood cells. Some
characteristics of saponins include formation of foams in aqueous solutions, hemolytic activity,
cholesterol binding properties and bitterness (Okwu & Okwu, 2004; Sodipo, Akiniyi &
Ogunbamosu, 2002). Physiologically active alkaloid compounds have been isolated from K.
pinnata. Synthetic derivatives are used as medicinal agents for analgesic, antispasmodic and
bactericidal effects (Okwu & Okwu, 2004; Stary, 1998)
Use of Kalanchoe pinnata as an anti-HSV agent
Virucidal activity of K. pinnata was evaluated by Carlucci et al. (Carlucci, Ciancia,
Matulewicz, Cerezo & Damonte, 1999). Using virus suspension containing 2 x 107 PFU HSV 2
was mixed with or without multiple leaf extract concentrations of K. pinnata for 6 h at room
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temperature. It was concluded that antiviral activity of K. pinnata was not related to its virucidal
ability. Cheng et al. (Cheng, Lin & Lin, 2002) confirmed that K. pinnata continued to exhibit
antiviral activity even added 12 h after infection. These observations suggest that K. pinnata
affects the late event(s) of HSV 2 infection. Other studies on the mode of action have shown that
K. pinnata inhibits the attachment and penetration of HSV 2 into cells. HSV attachment is
mediated by glycoprotein C (gC), which interacts with cell sulfate proteoglycans carrying
heparan sulphate carbohydrate (Spear, Shieh, Herold, WuDunn & Koshy, 1992). The stability of
attachment between viruses to cells is dependent on the presence of glycoprotein D (gD)
(Rajcani & Vojvodova, 1998). Fusion of the membrane between virion envelope and plasma
membrane of the target cell requires glycoproteins D, B, H and L, or in a combination of all of
them (Roizman & Spears, 1996; Spear, 1993; Spear et al., 1992). According to their results on
viral attachment and penetration assays, K. pinnata possibly affects the attachment and
penetration of viruses into cells through the disturbance of viral glycoproteins.
Aside from studies showing that some root extracts of K. pinnata are used to treat coughs and
burns (Iwu, 1982) there is limited research into the antimicrobial properties and mechanisms
involved in the antiviral properties of root tissue of K. pinnata. As suggested by Cassady and
Whitley (1997), future anti-herpesviruses agents may target enzymes or viral factors essential for
infection or inhibiting other steps in the viral infection cycle such as viral entry, protein synthesis
or capsid assembly.
Herpes simplex virus
Herpes simplex virus types 1 and 2 (HSV 1 and HSV 2) are members of the alphaherpesvirus
subfamily Herpesviridae. The life cycle of HSV is extremely complex and there are numerous
opportunities for the development of a novel antiviral therapy. Successful infection by HSV
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requires the virus particles to attach to and penetrate into cells: uncoat the viral DNA and deposit
it into the nucleus: transcribe genes sequentially to produce immediate early (α), early (β) and
late (γ) mRNAs: synthesize regulatory proteins, DNA replication enzymes and structural viral
proteins from these mRNAs: replicate its DNA genome, assemble new capsids and virions, and
release these particles from the infected cell (Roizman & Spears, 1996). The multiple steps to
HSV encapsidation and egress from cells are targets of interest for antivirals to prevent the
spread of HSV in target cells. Acute and recurrent HSV infections are distributed worldwide and
cause a wide range of diseases including gingivostomatitis, keratoconjunctivitis, genital tract
infections, encephalitis, and infection of neonates and immunocompromised patients (Whitley,
2002; Whitley, Kimberlin & Roizman, 1998). After the primary infection, HSV often persists in
the neurons of nerve ganglia virus types are neurotropic and may spread to the brain during
primary or recurrent infections (Igwe & Akunyili, 2005) . HSV 1 is the most usual cause of
sporadic encephalitis, except in neonates, with a mortality rate of 70-75% and severe permanent
sequelae in survivors (Griffin, 1991). Over the last two decades the number of
immunocompromised patients has increased dramatically. This is the consequence of aggressive
chemotherapy regimens, expanding organ transplantation and the rising incidence of human
immunodeficiency virus infection (Levin, 1993). Reactivation of latent HSV, which is very
common during the deficiency of immunity, causes recurrent herpetic infection. The most
common treatments for herpetic infections include acyclovir (ACV), valaciclovir, famciclovir
and cidafovir (Cassady & Whitley, 1997). Some alpha herpes viruses have become resistant to
ACV and other nucleoside analogues thus the efficacy of these drugs is limited (Englund,
Zimmerman, Swierkosz, Goodman, Scholl & Balfour, 1990). With the rise of
immunocompromised patients and emergence of ACV-resistant herpesviruses, new medications,
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especially novel antiviral agents, are needed for continuous effective treatment of associated
diseases.
The Purpose and Problem
The main purpose of this study was to screen a large collection of plant species for general
antiviral properties and test the inhibitory extracts for levels of cytotoxicity search for the
antiviral molecular mechanisms of the most inhibitory but least cytotoxic extract. The plant
eventually chosen for in-depth examination was K. pinnata. Eventually, quantitative polymerase
chain reaction assays (q-PCR) were used to assess whether or not the acetone extract of the root
tissue extract from K. pinnata reduced gene transcription and DNA replication of the virus itself.
In chapter two the problem begins with the search for antiherpetic extracts of plant tissues
obtained from ethnobotanical collections from Morocco and the U.S.A. Extracts were prepared
and tested and the more promising of the extracts were subjected to further bioassays. This
research began with two extracts (acetone and methanol) made from thirty-one plant species
from Morocco, the Sonoran Desert and Hawaii. These extracts were screened for general cell
toxicity using a sulphorhodamine assay and for activity against infectious microbes and cancer
cells, in vitro. Using the same extracts, I screened for antiviral activity against HSV 1 and HSV
2. These viruses were chosen because viral resistance toward anti-HSV agents is increasing
among HSV infected patients and the need for new effective compounds against HSV exists
(Coen, 1996; Cohen, 2004). Along with the increasing number of immunocompromised patients
and the prolonged administration of antiviral agents, the problem of drug-resistance among
herpes viruses is not expected to fade. While nucleoside analogues such as acyclovir have been
used successfully to treat herpetic infections, resistant strains and drug toxic side effects
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encourage research for new compounds, either synthetic or natural, to improve the current
antiviral arsenal (Cordell, Beecher & Pezzuto, 1991; Cordell & Colvard, 2005).
After initial antiviral screening extracts exhibiting significant plaque reduction were
subjected to a further quantitative measure of cell toxicity using a neutral red assay. To confirm
earlier results and check for reproducibility, repetitive mini-plaque assays using alternative
experimental designs: adding the extract at different times (pre and post-infection) and at
multiple concentrations post infection the few extracts showing more than 50% antiviral
inhibition were tested for cytotoxicity to Vero C1008 cells in vitro.
Changes in cell morphology were continually observed and noted using light microscopy.
These changes included the formation of plaques (holes in the monolayer due to cell death) and
syncytia (masses of cytoplasm containing several nuclei enclosed within a single plasma
membrane and commonly found in HSV infected cell culture). Through all these tests, the list of
plant extracts was eventually narrowed to one specific plant extract from the root tissues of K.
pinnata. Activity of this plant became apparent early on in the initial screening of antimicrobial
activity and was pursued aggressively in search of the mechanisms of action on HSV 1 and HSV
2 infections in vitro. The plant root tissues collected for this study came from the islands of Maui
and Kauai, Hawaii. It’s remarkable ability to nearly eliminate HSV’s capacity to form syncytia
or plaques in C1008 cell cultures led me to further investigate the mechanisms involved.
Chapter three of this dissertation expands to an investigation of the mechanism(s) involved in
the observed antiviral behavior of K. pinnata, and ends with results obtained from q-PCR
experiments to detect areas of molecular influence K. pinnata has on HSV’s reproduction, gene
expression and spread in host cells.
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Research Objectives
1. Define the relationship between the antiherpetic effects of the acetone extract of K.
pinnata root tissue and the molecular mechanism of action in vitro.
2. Pursue a path in discovery of how the extract interferes with HSV replication in the host
cell in vitro.
Research Hypotheses
Hypothesis 1: K. pinnata extract inhibits HSV DNA replication.
Hypothesis 2: K. pinnata extract inhibits immediate early transcription of one or more HSV
genes.
Hypothesis 3: K. pinnata reduces the production of one or more early (β) or late (γ) gene
transcripts responsible for the production of scaffolding proteins, capsid production, DNA
encapsidation or other stage of HSV replication causing the significant reduction in the spread of
the virus in vitro.
Limitations of the Study
A broad screening method to initially identify antimicrobial compounds from ethnobotanical
plants should eventually produce useful drugs, but it is contingent on the availability of adequate
funding and appropriate predictable bioassay systems. It is reasonable to say that many
ethnobotanical plants, kept out of the cultivation and genetic manipulation arena, will contain
chemicals that protect the plant from natural predators and environmental pressures that drive
natural selection. These plants are good choices to study, for their distinct niche and ability to
survive. All plant tissues were taken from reliable and consistent sources. Due to changes in
environmental pressures at collection sites for K. pinnata tissues, there may be some variable
compound profiles over the six years of study but overall, results of the assays were similar. A
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purification process for the crude extract would yield more reliable results and could reduce the
concentration dose at which the final results were obtained.
Significance of the Study
The significance of the laboratory research was that valuable information derived from these
studies will contribute to the body of pharmaceutical knowledge about the less understood
ethnobotanical medicinal plants in certain parts of the world. It is important to identify medicinal
plant species, preserve their natural habitat, and record the history of their uses. It is also
essential that scientists examine medicinal plants against their asserted claims and if found valid
in the laboratory, investigate the molecular mechanisms contributing to the cellular and pathogen
responses. Not only are these plants of significance to many people in less industrialized
societies, but if these plants are truly valuable for the health of human populations, ecological
reasons for protecting and maintaining the plant habitats are that much more compelling
(Heinrich, 2001).

Professional Development Curriculum
Background
Chapter four departs from the laboratory research component of the dissertation and
addresses the need for a well-designed professional development curriculum for secondary
biology teachers needing current knowledge and laboratory experiences in the microbiology and
molecular biology disciplines. The 2007 Trend in International Mathematics and Science Study
offered bad news for the U.S. science education community. The TIMSS results, released in
December 2008, showed statistically no change from the 1995 scores in (National Center
Educational Statistics, 2003). TIMSS measures student performance in science content and
cognitive skills of knowing, applying and reasoning. In 2007, Singapore, Chinese Taipei, Japan,
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Hong Kong, Russia and England had higher average scores than the United States in science.
Factors behind this disappointment include the No Child Left Behind (NCLB) Act, resulting in
less time, resources and focus on science education, including the lack of pre-service preparation
and in-service professional development for science education. Nearly 75% of the teachers
questioned said they needed substantial professional development to deepen their own science
content knowledge (Slater, 2008). In response to the poor results of TIMSS, the education
community has seen a surge of public interest in the training and subject matter competency of
secondary science teachers. This interest has resulted in congressional hearings and high-profile
publications such as Rising Above the Gathering Storm: Energizing and Employing America for
a Brighter Economic Future (Jacobs, Martin & Otieno, 2008). Politicians, business leaders,
teachers and administrators of higher education have taken notice of the crucial link between the
training of qualified secondary teachers and the production of a well-prepared college student
population and workforce. Large sums of money have been awarded on the basis that partnership
with organizations such as the Math-Science Partnership (MSP) and the National Science
Foundation will result in a higher quality teaching force and better prepared teachers and
students (National Science Foundation, 2009).
A high level of expertise should be expected from our science teachers. Real expertise comes
from working in the field. Most experts have what may be called ―
contributory expertise‖—
sufficient knowledge and understanding to make contributions (Collins, 2007). This level of
expertise can be attained only by spending time interacting with other contributory experts in the
field. Most established secondary science teachers do not have ―
contributory expertise‖. And if
they do not have opportunities to update their skills and knowledge, they are unable to maintain
the level of knowledge once they go into the classroom full time. Even among newer life science
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teachers, the course requirements are slim in the molecular and microbiology departments (Table
1, Chapter 4). Therefore, development of a molecular/microbiology in-service course for life
science teachers, involving current curriculum, inquiry activities and discussion about the
epistemology of science is critical to the continuing education and competence of secondary
non-expert‖ scientist such as
biology teachers. Continued education in this field will enable the ―
the secondary life science teacher to acquire science knowledge attained through inquiry,
practice and integration of microbiology and molecular concepts resulting in more confident and
prepared teachers and thus the students they educate.
The current reform effort in science education requires a substantive change in how science
is taught and an equally substantive change in professional development practices (Arzi &
White, 2007). Teacher preparation courses and in-service activities in methods of teaching
science frequently emphasize technical skills rather than decision making, theory and reasoning.
If reform is to be accomplished, professional development must include experiences that engage
teachers in active learning, expands their content knowledge and models ―
best‖ science teaching
practices as described in the teaching standards of the NSTA (National Committee on Science
Education Standards and Assessment, 1996). Professional development courses must answer
serious questions about science education today such as what does a science teacher need to
know, what does it mean to know a lot or a little, what is a sound science foundation and indepth understanding. It is assumed that teachers of science will continue to study science
throughout their careers. Most teachers of science have a broad base of scientific knowledge
extensive enough to understand the nature of scientific inquiry, its central role in science, and
have some skills in scientific inquiry. Teachers understand the fundamental facts and concepts in
major science disciplines. Fewer make conceptual connections within and across science
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disciplines. Beyond the foundation in content standards and objectives, how much more science
a teacher needs to know is an issue of breadth versus depth. Breadth implies a focus on the basic
ideas of science and is central to teaching science at all grade levels. Depth refers to knowing and
understanding the basic ideas within a science discipline and the supporting experimental and
theoretical knowledge. This professional development course focuses on depth in the biological
areas of virology, molecular biology, and immunology learned using methods of inquiry and
investigation.
Traditionally, conventional biology is taught in a very linear style, separating microbiology
and molecular biology concepts into separate chapters. As a result, students leave with a
fragmented opinion of what are a dynamic, socially, politically, and ethically relevant areas of
biology that impact their lives. Moreover, specific areas of microbiology: virology, molecular
biology and immunology, can be used to teach almost every theme and overarching concept in
biology if one is shown the relationships and connections among them. My course uses current
application scenarios for inquiry activities and discussion points concerning science, society and
biotechnology. Aspects of microbiology or molecular biology are discussed and expanded within
every level of the course. Components of this curriculum are meant to be used with confidence
by teachers who have completed this in-service course. It is prepared so teachers can take the
materials and pedagogy and immediately use it in their own classroom.
The Purpose
The purpose for designing a professional development course for secondary biology teachers
is in two parts. First, I wanted to demonstrate my acquired knowledge and experience in
molecular and microbiology disciplines by designing a curriculum that integrates the specific
areas of virology, molecular biology, and immunology into the secondary biology curriculum. I
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see such a course is necessary for the continued education of life science teachers who most
likely did not receive courses in these areas, or who have long ago completed their formal
education and need to update their knowledge and skills in these areas. Second, having
participated in a graduate microbiology and molecular biology program, and as an experienced
and active high school biology teacher, I wanted to establish a curriculum within my own
classroom that integrates these disciplines with the concepts I teach in order to satisfy the state’s
established core standards and objectives.
Objectives of the Professional Development Curriculum
1. Design an in-service curriculum that will contain important, current and necessary
knowledge in the areas of virology, molecular biology and immunology.
2. Increase teacher knowledge base and interest in these specific areas.
3. Create a course where teachers can apply this knowledge to current social and political
events and improve the application standard in their biology curriculum.
This professional development curriculum began with four assumptions about the nature of
secondary science in-service. First, professional development for a science teacher should be a
continuous, lifelong process. The understanding and abilities required to be a masterful teacher
of science are not static. Second, science content increases and changes, and a teacher's
understanding in science must keep pace. Third, knowledge about the process of learning is
continually developing, requiring teachers to stay informed. And fourth, we live in a changing
society that deeply influences events in schools; social changes affect students as they come to
school and affect what they need to carry away with them. Science teachers must be involved in
the acquisition of current, accurate and relevant scientific information as well as development
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and refinement of new approaches to teaching, assessment, and curriculum (National Center
Educational Statistics, 2003).
In this course science learning experiences for teachers will involve teachers actively
investigating phenomena that can be studied scientifically, interpreting results, making sense of
findings consistent with currently accepted scientific understanding, and address issues, events,
problems, or topics significant in science. They will be exposed to scientific literature, media,
and technological resources that can expand their science knowledge and their ability to access
further knowledge. An important aspect of this course is to allow teachers to work in the lab with
experienced graduate students from local universities. Teachers are given the opportunity to be
like a real scientist, asking questions, developing hypotheses, researching background
information and writing an experimental design. This experience will change the way science
teachers think about and prepare laboratory experiences for their own students.
The significance of the professional development curriculum will be to teachers and
ultimately to their students. Microbiology and molecular biology concepts are written into this
course which includes case studies, inquiry activities and organizational skills, without
sacrificing content to meet state standards and core objectives. By fostering independent thinking
and encouraging students to actively work towards understanding the material, teachers prepare
students to approach the material rationally and accurately. The content and skills taught in this
curriculum will help biology teachers help their student to better understand the global
perspective of science, be successful in college biology classes and enhance their success in later
life and providing a pathway for lifelong learning.
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Summary
This dissertation is divided into four chapters. Chapter one is the dissertation introduction.
The research topics were briefly described. The first objective discussed concerned the
identification of a plant extract whose antiherpetic effects and low cytoxicity was worthy of
additional investigation into the mechanisms of action. This part of the study included molecular
examination of potential mechanisms involved in the observed antiviral properties of K. pinnata.
The second objective discussed the need for a professional development course aimed to
secondary biology teachers; to update their molecular and microbiology knowledge and practice
scientific inquiry while integrating these disciplines into the standard core curriculum.
Chapter two is a scientific paper, prepared for Pharmaceutical Biology, a peer reviewed
journal published by Informa Pharmaceutical Science. This journal accepts manuscripts
describing the discovery, methods for discovery, description, analysis characterization, and
production/isolation of biologically-active chemicals or other substances utilized in systems of
traditional medicine. My paper was written and submitted to the journal October 30, 2009 for
request of publication and was accepted for publication on November 7, 2009, as is. In this paper
I report screening sixty-two extracts from thirty-one plant species for cytotoxic activity against
the Vero C1008 cell sub-line and for antiviral activity in cells infected with HSV types 1 and 2.
Initial tests for cytotoxicity and antiherpes activity were performed; both sulforhodamine B
assays and neutral red assays to detect general cytotoxic effects and immunoperoxidase miniplaque reduction assays to detect viral structural protein synthesis. Of the thirty-one species
tested only the acetone and methanol extracts of K. pinnata were acceptably non-cytotoxic to
host cells while showing significant inhibitory effects on HSV 1 and HSV 2. Results of this
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study provided a scientific rationale for further study into potential mechanisms of HSV
inhibition in vitro by the root extracts of K. pinnata.
Chapter three is a scientific paper formatted to conform to Antiviral Research, a peer
reviewed multidisciplinary journal of antiviral agents, natural host defense mechanisms and
interferons and antiviral vaccines, published by the International Society for Antiviral Research.
My work examines possible mechanisms by which a crude acetone extract from root tissue of K.
pinnata inhibits HSV 1 and HSV 2 infection in cultured C1008 cells. The efficacies of
combinations of extract concentrations that inhibit the formation of plaques in relation to their
effects on cell viability were examined. Antiviral mechanisms were investigated using real time
PCR: measuring template number of HSV DNA at different time points post infection and by
measuring transcript number of HSV RNA for four specific genes: beta genes UL23 and UL30,
and gamma genes UL17 and US4 when infected C1008 cells were exposed to the extract. An
examination of transcript number found a significant decrease in these genes. Reduced viral
DNA replication as well as reduced RNA transcription of three viral genes suggested that
multiple modes of herpes virus inhibition by K. pinnata were present and that this extract
contains multiple anti-HSV compounds that interfere with the normal viral life cycle process.
Finally, chapter four of this dissertation diverts attention to meeting the educational needs of
the professional high school biology teacher; specifically in the areas of virology, molecular
biology and immunology. Chapter four is divided into two sections, A and B, for the trainer of
the professional development course and the teacher who is attending the course, respectively.
Each section is divided into four units: 1) Virology, 2) Molecular Biology, 3) Immunology and,
4) Pathogenesis and Society, and each unit consists of specific segments. In Section A, the
segments are entitled 1) Learning Objectives, 2) Essential Prior Knowledge, 3) Trainer
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Preparation Notes, which include misconceptions that should be addressed with the class and
anticipated results 4) Essential Questions, 5) Core Concepts, to be introduce and explained if
necessary, 6) Anticipatory Set, 7) Comprehension and Application Activities, to promote
inquiry, integration and discussion, 8) Higher Order Thinking Skills, 9) Interactive
Notebook/Journal Writing, and 10) Assessment, to monitor the progress and understandings of
the participants. Included in the lesson materials will be suggested organizational tools the trainer
should model for the teachers. Cooperative learning activities are provided where possible so that
teachers will see how the concepts can be presented and practiced in an inquiry based
environment. Section B is subdivided into four units consisting of four segments each. These
segments are entitled: 1) Worthy of Note, which may be copied and given to students to help the
teacher modify his existing ideas based on new information, 2) Moral/ Ethical/ Reasoning/
Dilemma Scenarios, to strengthen the relevance of the lesson and emphasize the relationship
between society and technology, 3) Divergent and Creative Thinking Activity, to emphasize the
process of learning and promote higher order thinking skills in the classroom, and 4) Laboratory
Component, to allow the teachers to become more comfortable and knowledgeable about the
new technology used in a microbiology and molecular biology laboratory and stress the inquiry
aspects of learning.
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Abstract
Context: Thirty-one medicinal plant species from Hawaii, Morocco, and the Sonoran Desert,
USA have been shown in past studies to be highly inhibitory to pathogenic bacteria, fungi, and
certain cancer cell lines. However, none were tested for antiviral activity.
Objective: Acetone and methanol extracts from these species were bio-assayed for antiviral
activity against herpes simplex virus types 1 and 2, and for cytotoxicity to the Vero C1008 cell
line.
Materials and methods: Extracts from these species were tested in vitro for antiviral activity
using an immunoperoxidase mini-plaque reduction assay to detect viral structural protein
synthesis. A 50% inhibitory concentration (IC50 ) was computed. Sulforhodamine B and neutral
red assays were used to qualitatively and quantitatively assess the cytotoxicity of extracts to
C1008 cells, and to compute a 50% cytotoxic concentration (CC50) using a dose response curve.
Results: Eight of the 31 plant species assayed showed significant antiviral activity against HSV
1 and HSV 2 viruses. The acetone extract of Kalanchoe pinnata Pers. (Crassulaceae) produced
an IC50 of 0.025 mg/ml and a CC50 of 1.25 mg/ml yielding a therapeutic index of 50.
Additionally, this extract reduced plaque numbers to zero or near zero at a concentration of 0.1
mg/ml when added 30 min before or 30 min after virus infection.
Discussion and conclusion: The mechanism of inhibition against HSV 1 and HSV 2 viruses is
now being investigated, along with fractionation of the acetone extract in search of the active
compound or compounds.
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Introduction
Natural products play an important role in the discovery of leads for the development of drugs to
treat human diseases (Newman & Cragg, 2007). Over two-thousand compounds extracted from
higher plants are used in a medical setting throughout the world, and at least forty-six percent of
these have not been used in the United States (Fabricant & Farnsworth, 2001). Knowledge about
the medicinal use of these species may be held individually, tribally, or documented in well
established tomes (Newman et al., 2008). But often scientific information is lacking as to
whether these plants contain anti-carcinogenic, antibiotic, antifungal, and antiviral properties
(Cordell et al., 1991).
Researchers in the Natural Products Laboratory, Brigham Young University have collected
and tested 157 medicinal plant species for activity against pathogenic microbial diseases, cancer
cell lines, and for cytotoxicity (Donaldson et al., 2004; Donaldson & Cates, 2005). From these,
31 plant species (one Hawaiian plant, 15 from Morocco, 15 from North America) were selected
that had inhibition levels at 70% or greater against one or more of the above organisms or cancer
cell lines. However, none of these species have been tested for activity against human herpes
simplex virus types 1 or 2 (HSV 1, HSV 2).
HSV 1 and HSV 2 are common human pathogens which cause several symptoms such as
vesiculo-ulcerative lesions at mucocutaneous junctions, gingivostomatitis, keratitis, and
encephalitis (Arduino & Porter, 2007). In immunocompetent hosts these clinical symptoms are
often benign, but in immunocompromised patients they become severe, may be progressive, and
require more time for healing (Whitley, 2002). Life threatening herpes infections may be
transmitted to neonates during delivery where a wide spectrum of clinical manifestations can
occur including encephalitis. HSV may account for 10% to 20% of all viral encephalitis
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infections in the United States (Tang et al., 1999). Many medicinal plants may have a variety of
chemical constituents known to inhibit the replication cycle of various types of DNA or RNA
viruses (Schang, 2006), including herpes simplex. As a consequence attention has been given to
the development of antiviral agents from traditional plant medicines (Jassim & Naji, 2003).
Our objective was to determine if the selected 31 plant species would demonstrate significant
activity against HSV 1 and HSV 2 viruses in vitro. Acetone and methanol extracts from these
species were bio-assayed for activity against these viruses using the immunoperoxidase miniplaque assay. Cytotoxicity was determined using a neutral red assay. A therapeutic index (TI),
defined as the ratio of the cytotoxic concentration in 50% of the cell monolayers (CC50) to the
inhibiting concentration of the extract that showed 50% antiviral effects on the cell monolayers
(IC50) (Burns, 1999), was computed for the four most inhibitory species.

Materials and Methods
Plant tissue collection
Medicinal plant species were collected in Hawaii (2002and 2004), in Morocco (2002 and 2004),
and in the Sonoran Desert, USA, 2000 - 2004 (Donaldson et al., 2005; Donaldson & Cates,
2004). Samples from the USA were labeled and placed in plastic bags, frozen in coolers
containing dry ice, and then shipped to the Natural Products Laboratory, Brigham Young
University. These were stored in a -80°C ultralow until analyzed. Samples from Morocco were
air dried, ground to a fine powder using a Wiley Mill, and stored in labeled sample bags in
boxes. Species analyzed in this study along with their collection number and traditional
medicinal plant use are found in Table 1.

28

Tissue extraction and drug preparation
Three grams of air dried leaves, stems, or roots, or five grams of frozen tissue, were ground
using a mortar and pestle in liquid nitrogen in 15 ml hexane and then filtered through cheese
cloth and VWR grade 415 filter paper. The filtrate was collected in vials. This process was
repeated twice using 10 ml and 5 ml, respectively. These were combined into one pre-weighed
vial and taken to dryness using nitrogen gas. The remaining plant material was extracted in
acetone using the same protocol as above. The 15, 10, and 5 ml aliquots were combined into a
pre-weighed vial and dried using nitrogen gas. The remaining plant material was extracted with
70% methanol following the same protocol as above, combined into a pre-weighed vial, and
dried using nitrogen gas.
Distilled water was added to the dried acetone or methanol extract vial to make an 8 mg/ml
concentration. Each vial was vortexed and sonicated to homogenize the extract, filtered through
0.2 µm Minisart filter (Sartoirus Stedim Biotech, France), placed into 1.5 ml Ependorf tubes, and
stored at -80°C until assayed.
Cell culture and viruses
African green monkey kidney cells (ATCC CRL-1586, sub-line C1008) were maintained at 37°C
and 5% CO2 in Dulbecco modified eagle medium (DMEM, Sigma Chemical Company, St.
Louis, Mo.) supplemented with 5% cosmic calf serum (HyClone Laboratories, Logan, Utah),
10 µM HEPES buffer, and 50 µg/ml gentamicin (Sigma-Aldrich, Inc. St. Louis, MO). Stocks of
HSV 1 (McIntyre strain) and HSV 2 (strain 333) (Jensen & Johnson, 1994) which were stored at
-80°C were used to determine the activity of the plant extracts.

29

Mini-plaque reduction assay
C1008 cell monolayers were used to determine if any of the plant extracts inhibited HSV 1 or
HSV 2 infection in vitro (Table 2). Cells were seeded into 24-well plates, and when cell
monolayers were 90% confluent the extract was introduced to each well. Three concentrations
were used, and each concentration was replicated three times. The old media was removed and to
the appropriate well was added 1 ml DMEM containing 6.25, 12.5, or 25 µl of plant extract
resulting in concentrations of 0.05, 0.1, and 0.2 mg/ml, respectively. Control wells contained
C1008 cells growing in l ml of medium without extracts and were randomly located. After 30
min 0.1 ml virus suspension was added to each well for each concentration at a multiplicity of
infection of one (MOI=1) and incubated at 30˚C and 5% CO2 for 30 h (Taniguchi & Yoshino,
1964).
A concern was that the plant extracts might prevent entry or destroy the virus particles.
Consequently, C1008 cells were seeded into 24-well plates, incubated to 95% confluency, and
then HSV 1 or HSV 2 were introduced to the monolayers 30 min before the extract was added.
Viruses were added by removing the old media and adding 0.1 ml of virus suspension at MOI=1
to test wells; 0.1 ml media was added to the control wells. Plates were incubated at 37°C and 5%
CO2 for 30 min. Then 1.1 ml of media with extract in one of three concentrations (0.05, 0.1, and
0.2 mg/ml) were added and plates were incubated for 30 h.
Microscopic observations and plaque counts to measure extract inhibition
In vitro HSV 1 and HSV 2 infections and plant extracts that induced cytotoxicity might cause
observable changes in C1008 cell monolayers. Consequently, microscopic observations were
recorded to determine if HSV infections and/or plant extracts might adversely affect cell growth,
and therefore indicate cytotoxicity. Plaques due to virus infection appeared as holes in the
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monolayer due to cell death and syncytia formation. In the case of K. pinnata only foci
(individual stained cells indicating the presence of virus structural proteins) were observed, and
these were counted to determine percent inhibition for this species. Observable cellular changes
due to adding plant extracts were minimal, but rounding up of cells and changes in cell
membrane shape was noted for extracts (especially at 0.2 mg/ml) (Table 2). However, none of
the changes influenced quantification of the effects of viruses on cell monolayers.
Immunoperoxidase staining to determine plaque number in cell monolayers
Following Luker et al. (1991) all wells were stained using an immunoperoxidase staining
protocol to detect plaque and syncytia numbers or presence of foci. Each well was separated into
quadrates and plaques were counted manually using an inverted phase contrast microscope
(Nikon Eclipse TS100). Overlapping plaques were deemed individual when lobes were apparent
(Zielinska et al., 2005). Plaque number was calculated as a mean of three replicates, and growth
inhibition of infected cells was given as a percentage of the control (Table 2). If the established
cell monolayer appeared disrupted, detached, or absent from the well after the extract was added
and just before staining, the extract was assumed to be toxic to the C1008 cells. This was noted
as “tx” in Table 2. The IC50 (50% inhibitory concentration of viral effect) was determined from
the dose response curve (Table 3). Positive controls used in the IC50 determination were infected
cell monolayers without extract.
Neutral red assay for cytotoxicity of active extracts
The four extracts confirmed to be inhibitory to HSV 1 and 2 by the mini-plaque assay were
tested for cytotoxicity to C1008 cells using a neutral red (NR) assay (Cytotox NR Kit,
Xenometrix, Switzerland). The assay is based on the ability of viable cells to incorporate and
bind neutral red within lysosomes (Motohashi et al., 2003). C1008 cells were treated with serial
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dilutions of each plant extract (0.0125, 0.025, 0.05, 0.1, 0.2, 0.4, 0.8 and 1.6 mg/ml), and the
concentrations were replicated three times. After 72 h cell viability was measured using a
spectrometer (Fusion α-HT Universal Microplate Analyzer, Packard Instruments, Meriden, CT)
with a 540 nm filter and a 690 nm reference filter. Results were determined from the doseresponse curves and a CC50 (50% cytotoxic concentration) was reported (Table 3) (Rajbhandari
et al., 2007).
Virucidal assay
Antiviral screening assays must be viewed cautiously when apparent antiviral activity is
observed until a determination is made that the extract is not destroying or disrupting the virus
particle. To determine if the acetone extract of K. pinnata interfered with virus particle structure,
the extract was permitted to incubate with the virus prior to exposure to the cell monolayer. The
acetone extract of K .pinnata (0.2 mg/ml) was added to the thawed HSV 2 virus stock of 8 x 107
pfu/ml (plaque forming units per ml) and incubated at 37°C for 30 min. Six, 10-fold serial
dilutions of virus stock (10-1 to 10-6) with and without extract were added to cell monolayers in
24-well plates and incubated at 37ºC and 5% CO2 for 36 h. Staining followed that of the miniplaque assay described above. Plaque numbers were counted as described for the mini-plaque
assay. The concentration of virus, in plaque forming units (pfu as a measure of the number of
particles capable of forming plaques per unit of volume), was calculated for infected wells with
and without extract exposure.
Data Analysis
Cytotoxicity and mini-plaque assays were performed in triplicate in two independent
experiments. The CC50 and IC50 values were calculated and a therapeutic index (TI, selective
index; defined as CC50 /IC50), was reported for the four most promising extracts (Table 3).
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Statistical comparisons were made using a one-sample t statistic (significant differences at
P<0.05).

Results
Inhibition of extracts against HSV 1 and HSV 2 using the mini-plaque reduction assay
Eight of the 31 plant species assayed showed significant (P<0.05) antiviral activity against one or
both of these viruses at one or more concentrations when compared to the control (Table 2).
Also, percent inhibition was not significantly different when cells were infected with viruses
before or after the addition of the extracts. Consequently, the protocol of adding the virus before
the extract was added was chosen for subsequent experiments because this modeled the natural
order of infection.
Species were selected for further tests based on an extract being at least 60% inhibitory to
HSV 1 or HSV 2 infection and showing no obvious cytotoxicity at any concentration based on
microscopic observations (Table 2). This group included the acetone extracts of Atractylis
macrophylla Desf. (Asteraceae) and Hymenoclea salsola Torr. & A. Gray (Asteraceae), and the
methanol and acetone extracts of K. pinnata (Table 2). The other extracts showing significant
inhibition (Clematis cirrhosa L. (Ranunculaceae), Gnaphalium chilense Spreng. (Asteraceae),
Lithospermum officinale L. (Boraginaceae), Psilostrophe cooperi Greene (Asteraceae), and
Tetraclinis articulate Mast. (Cupressaceae) were not pursued due to cytotoxicity (indicated by
“tx” in Table 2).
Cytotoxicity of extracts on C1008 cells
Upon initial contact with any of the four extracts at 0.2 mg/ml, changes in the shape of some cell
membranes were observed. Since these observations may indicate cytotoxic effects, cytotoxicity
of these four extracts was determined using the neutral red assay. Based on CC50 values,
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K. pinnata was two to five times less toxic than the extracts of A. macrophylla and H. salsola
(Table 3). The CC50 for the acetone and methanol extracts of K. pinnata were 1.25 ± 0.123
mg/ml (mean ± se) and 0.95 ± 0.15 mg/ml, respectively. This indicated that the acetone-derived
extract was less toxic to the C1008 cells than the methanol extract. Additionally, K. pinnata
extracts had a 50% cytotoxic concentration up to 50 times higher than the concentration
necessary for 50% virus inhibition as indicated by the TI value (Table 3).
Virucidal activity of the acetone extract of K. pinnata
The virucidal assay for the acetone extract of K. pinnata showed that titers of surviving virus
were 8.2 x 107 pfu/ml for the control culture and 8.3 x 107 pfu/ml for the extract-exposed
cultures. These data indicated that the acetone extract was not directly interfering with the virus
particles before their attachment and entry into the C1008 cells.

Discussion
For all eight of the 31 species that showed antiviral activity, the acetone fractions showed greater
inhibition than the methanol extracts (Table 2). If the acetone extract was toxic to the cell
monolayer, the methanol extract from the same species displayed similar toxicity regardless of
whether the virus was added before or after the extract. In addition virucidal assays indicated that
extracts were not inhibiting entry of the virus or destroying virus particles. Extracts of the
remaining 23 species did not protect C1008 cells from HSV induced cytopathic effects or they
were toxic to the cells. Of the eight species that originally showed activity for at least one of the
extracts, five (C. cirrhosa, G. chilense, L. officinale, P. cooperii and T. articulata) showed high
cytotoxicity at extract concentrations less than 0.1 mg/ml. These observations, and previous
research identifying specific organic compounds responsible for the cytotoxicity of some of the
species, lowered their priority for further testing (Herz et al., 1970).
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Previous studies identified specific compounds in H. salsola and their adverse effects on
cellular activities (Torrance et al., 2006). The neutral red assay in this study confirmed the low
CC50 (0.28 mg/ml) for H. salsola indicating that a low concentration of extract was cytotoxic to
the cell monolayer. Similarly, the acetone extract of A. macrophylla was found to be cytotoxic to
C1008 cells at a low concentration (0.25 mg/ml). Alternatively, the acetone extract (CC50 of 1.25
mg/ml) and the methanol extract (CC50 of 0.95 mg/ml) of K. pinnata showed a higher CC50
indicating a higher concentration of extract was needed to bring about a similar level of
cytotoxicity. Furthermore, K. pinnata TI values of 50 (acetone extract for both HSV 1 and HSV
2) and 19 (methanol extract for HSV 1) indicated significant antiviral activity at lower cytotoxic
concentrations.

Conclusion
Of the thirty-one species tested only the acetone and methanol extracts of K. pinnata were not
cytotoxic to host cells. The acetone extract from the roots of K. pinnata revealed plaque numbers
near zero at concentrations less than 0.1 mg/ml. Due to significant antiviral activity against HSV
1 and HSV 2 and low cytotoxicity to C1008 cells in vitro, the acetone extract was selected for
additional studies. Studies underway include fractionation of the extract in search of an active
compound or compounds, and investigation of the molecular mechanisms involved in the
antiviral properties of the acetone extract of K. pinnata.
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Table 1. Plant species*, family, collection number, and their medicinal use by indigenous
peoples.
Genus/Species(Family)/
Collection Number

Known Uses in Indigenous Cultures

Acacia constricta Benth.
(Fabaceae) (JD67)

Diarrhea, stomach problemsa , conjunctivitis, dysentery,
disinfectant, diaper rashc

Acacia farnesiana L. Wild.
(Fabaceae) (JD30)

Aphrodisiac, astringent, demulcent, emetic, stimulant, cancer,
carbuncles, cholera, conjunctivitis, convulsions, delirium,
dysentery, dyspepsia, epilepsy, headache, inflammation,
insanity, nausea, ophthalmic, parturition, rabies, rinderpest,
snake bite, sore, spasmsa

Aristolochia watsonii Wooton
& Standl. (Aristolochiaceae)
(JD32)

Stimulates immune system, antibacteriali

Atractylis macrophylla Desf.
(Asteraceae) (A3)

None reported

Berberis hispanica Boiss. &
Reut. (Berberidaceae) (B6)

Cough, gastrointestinal disturbance, mouth and skin ailmentsa

Cistus creticus Sibth. & Sm.
(Cistaceae) (C10)

Sclerosis (uterus)a

Cistus ladaniferus Gouan ex
Steud. (Cistaceae) (C8)

Astringent, fumigant, hemostat, nervine, hernia, tumor (anal)a

Cistus salviifolius Boiss.
(Cistaceae) (C9)

Bronchitis, hemorrhagesa

Clematis cirrhosa L.
(Ranunculaceae) (C12)

Antirheumatic, analgesic, vesicatory, relieve rheumatic or
joint paink

Epilobium canum (Greene)
P.H.Raven (Onagraceae)
(JD27)

Infected sores, disinfectant, febrifuge, fever, kidney troubles,
urinary problems, anti-hemorrhagic, cathartic, tuberculosis,
syphilis, soresb; gynecological washf

Gnaphalium chilense Spreng.
(Asteraceae) (JD52)

Skin ailmentsa

Hymenoclea salsola Torr. &
A.Gray (Asteraceae) (JD16)

Rash, rheumatism, swelling, lung, tracheaa
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Hyptis emoryi Torr.
(Lamiaceae) (JD45)

Asthma, cold, dyspnea, earache, toothachea; hemorrhagesg

Inula viscosa L. Aiton
(Asteraceae) (I16)

Malariaa

Isocoma tenuisecta Greene
(Asteraceae) (JD18)

Antimicrobiall

Juniperis oxycedrus
(Cupressaceae) (C6)

Cancer, eczema, leprosy, psoriasis, sores, toothachea

Kalanchoe pinnata Pers.
(Crassulaceae) (RC17)

Asthma, chest cold, fever, headache, mouth soresa;
antileishmaniad

Lithospermum officinale L.
(Boraginaceae) (RC1)

Contraceptive, anodyne, diuretic, litholytic, sedativea

Plumbago europaea L.
(Plumbaginaceae) (P28)

Cancer, itch, scabies, swelling, toothache, poisona

Prosopis juliflora DC.
(Fabaceae) (JD53)

Burns, diarrhea, dysentery, eye ailments, flu, gastrointestinal
disturbances, head colds, hoarseness, itch, measles, mouth
ailments, pink eye, skin ailments, stomach achea; internal
antimicrobial, diarrhea, conjunctivitisc

Psilostrophe cooperi Greene.
(Asteraceae) (P4)

Antimicrobiall

Ruta chalepensis Wall.
(Rutaceae) (R31)

Cough, earaches, stomach pain, paralysisa

Salvia columbariae Benth.
(Lamiaceae) (JD39)

Eye ailmentsa ; disinfectantb ; eye medicineb

Saponaria glutinosa M.Bieb.
(Caryophyllaceae) (A6)

Eczema itch, cough, bronchitis, respiratory tracte

Sarcostemma hirtellum (Vail)
R.Holm (Asclepiadaceae)
(RC3)

Fruits used by Tohono O’Odham peoplem

Satureja calamintha Scheele
(Lamiaceae) (D5)

Cancer, sclerosis (spleen)a
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Tetraclinis articulata Mast.
(Cupressaceae) (D2)

Carcinoma, diarrhea, gout, piles, rheumatisma

Teucrium polium Decne. Ex
Capers (Lamiaceae) (D4)

Abscesses, inflammation, piles, tumora

Tribulus terrestris L.
(Zygophyllaceae) (JD62)

Cancer, cough, dysuria, gonorrhea, rheumatismb; ceremonial
medicine (Navajo)h ; diuretic, kidney stones (Yemen)i

Verbena gooddingii Briq.
(Verbenaceae) (JD51)

Common coldb

Zinnia acerosa A.Gray
(Asteraceae) (JD8)

Diarrheaa

*Sources: aJohnson 1999, bMoerman 1989, c,iMoore 1989, dMuzitano et al., 2006, eChopra et al.
1980, fMoroyoqui, personal communication, gBean and Saubel 1972, hGhazanfar 1994, iHocking
1956, jOhai, personal communication, k Palmese et al. 2003, lHoffman et al. 1993, mEpple 1995
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Table 2. Percent inhibition by methanol and acetone plant extracts of plaque formation of
HSV-1 and HSV 2 as measured by the immunoperoxidase assay.
Genus/
species

HSV 1
.025†

Acetone
0.05 0.1

0.2

HSV 2

Methanol
0.025 0.05 0.1

0.2

0.025

Acetone
0.05 0.1

0.2

0.025

Methanol
0.05 0.1

0.2

A. constricta

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

A. farnesiana

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

A. watsonii

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

21

69

87

-

-

-

-

33

56

63

64

-

-

-

-

B. hispanica

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

C. creticus

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

C.ladaniferus

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

C. salviifolius

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

52

64

tx

-

-

-

-

10

44

50

tx

-

-

-

-

E. canum

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

G. chilense

-

-

23

35

-

-

-

-

-

-

-

-

-

-

-

-

H. salsola

10

22

45

92

-

-

10

-

10

31

89

87

-

-

-

-

H. emoryi

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

I. viscosa

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

I. tenuisecta

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

J. oxycedrus

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

K. pinnata

55

66

76

95

45

52

81

93

65

85

96

98

22

41

44

62

L. officinale

22

42

62

tx

-

-

-

-

31

40

63

tx

-

-

-

-

P. europaea

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

P. juliflora

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

P. cooperi

46

tx

tx

tx

-

-

tx

tx

24

tx

tx

tx

-

-

tx

tx

A.macrophylla

C. cirrhosa
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R. chalepensis

-

-

S.columbariae

-

-

S.glutinosa

-

S. hirtellum

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

S. calamintha

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

T. articulata

10

12

32

tx

-

-

-

-

54

83

tx

tx

-

-

-

-

T. polium

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

T. terrestris

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

V. gooddingii

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Z. acerosa

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

*Values are mean of triplicate readings; (-), no inhibition, “tx” = cytotoxic
†
mg/ml
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Table 3. Cytotoxic concentration (CC50), inhibition concentrations (IC50), and therapeutic
index (TI) values for HSV 1 and HSV 2 infected C1008 cells monolayers in the presence of
four plant extracts.
Virus

Plant
Extract
CC50

HSV1 IC50
TI
HSV2 IC50
TI

A.macrophylla

H. salsola

Acetone

Acetone

Acetone

Methanol

0.25mg/ml

0.28mg/ml

1.25mg/ml

0.95mg/ml

0.1mg/ml

0.1mg/ml

0.025mg/ml 0.05mg/ml

2.5

2.8

50

19

0.05mg/ml

0.1mg/ml

0.025mg/ml

0.2mg/ml

5.0

2.8

50

4.75

46

K. pinnata

Chapter Three - Kalanchoe pinnata root extract interferes with HSV types 1
and 2 DNA replication and early and late gene transcription.
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Abstract
Crude polar extracts of the root tissue from the Hawaiian grown Kalanchoe pinnata were
tested against herpes simplex virus types 1 and 2 (HSV 1 and HSV 2). Cytotoxicity, antigen
expression and quantitative polymerase chain reaction (PCR) assays tested antiviral activity and
searched for antiviral molecular mechanisms. Control virus infected cultures manifested large
multi-cellular plaques and syncytia. In contrast, cultures exposed to acetone and methanol
extracts (100 µg/ml) of K. pinnata showed sparse numbers of infected cells appearing as single,
isolated cells at 30 min before and up to 8 h after infection suggesting the extract inhibited late
stages of the virus life cycle. Real-time PCR was used to determine HSV susceptibility to the
acetone extract. Antiviral mechanisms were investigated by measuring the reduction of viral
DNA at different time points post infection and by measuring the reduction of viral RNA
transcripts for five specific genes: alpha gene UL54, beta genes UL23 and UL30, and gamma
genes US4 and UL17. Examination of transcript number found a significant decrease in viral
DNA replication and early and late gene transcription when infected cells were exposed to K.
pinnata suggesting post entry events were blocked by one or more extract compounds.
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Introduction
Herpes simplex virus

Herpes simplex virus types 1 and 2 (HSV 1 and HSV 2) are members of the alphaherpesvirus
subfamily Herpesviridae. The life cycle of HSV is extremely complex and there are numerous
opportunities for the development of a novel antiviral therapy. Successful infection by HSV
requires the virus particles to attach to and penetrate into cells: uncoat their DNA and deposit it
into the nucleus: transcribe its genes sequentially to produce immediate early (α), early (β) and
late (γ) mRNAs: synthesize regulatory proteins, DNA replication enzymes and structural viral
proteins from these mRNAs: replicate its DNA genome, assemble new capsids and virions, and
release these particles from the infected cell (Roizman, 1996). The multiple steps to HSV
encapsidation and egress from cells are targets of interest for anti-virals to prevent the spread of
HSV in target cells.
Acute and recurrent HSV infections are distributed worldwide and cause a wide range of
diseases including gingivostomatitis, keratoconjunctivitis, genital tract infections, encephalitis,
and infection of neonates and immunocompromised patients (Whitley, 2002). After the primary
infection, HSV often persists in the neurons of nerve ganglia (Baringer & Swoveland, 1973).
Both virus types are neurotropic and may spread to the brain during primary or recurrent
infections. HSV 1 is the most usual cause of sporadic encephalitis, except in neonates, with a
mortality rate of 70-75% and severe permanent sequelae in survivors (Griffin, 1991).
Over the last two decades the number of immunocompromised patients has increased
dramatically. This is the consequence of aggressive chemotherapy regimens, expanding organ
transplantation and the rising incidence of human immunodeficiency virus (HIV) infection
(Levin, 1993). Reactivation of latent HSV, which is very common during the deficiency of
immunity, causes recurrent herpetic infection. The most common forms of treatment for herpetic
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infections include acyclovir (ACV), valaciclovir, famciclovir and cidafovir (Cassady & Whitley,
1997). Some alpha herpes viruses have become resistant to ACV and other nucleoside analogues
thus the efficacy of these drugs is limited (Englund et al., 1990). With the rise of
immunocompromised patients and emergence of ACV-resistant herpesviruses, new medications,
especially novel antiviral agents, are needed for continuous effective treatment of associated
diseases.
Kalanchoe pinnata
For several centuries, indigenous peoples of the world have cured physical afflictions using
plants and plant extracts (Igwe & Akunyili, 2005). One such plant is Kalanchoe pinnatum Linn
(Crassulaceae), a succulent shrub that is about 60–120 cm high and branched from the base with
opposite, simple or trifoliate petiolate leaves. Although this perennial herb probably originated
from Madagascar, its species abound all over tropical regions of the world, usually growing
widely in hot and humid areas, around dwelling places, along roadsides, and in abandoned farms
and fields.
Aside from studies showing that some root extracts of K. pinnata are used to treat coughs and
burns (Iwu, 1982) there is limited research into the antiviral properties of root tissue of K.
pinnata . As suggested by Cassady and Whitley (1997), future anti-herpesviruses agents may
target enzymes or viral factors essential for infection or inhibiting other steps in the viral
infection cycle, such as viral entry, protein synthesis or capsid assembly.
In this study, acetone and methanol extracts of root tissue of K. pinnata were tested against
HSV-1 and HSV-2 as well as cytotoxicity to C1008 cell monolayers in vitro. The aim of the
present study was to evaluate the antiherpetic activities of the acetone extract in mammalian cells
employing a quantitative polymerase chain reaction (q-PCR) assay designed to locate some HSV
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genes with reduced expression as a result of the extract’s presence, thereby elucidating, in part,
mechanisms of antiviral activity by K. pinnata.

Materials and Methods
2.1 Plant tissue collection
K. pinnata root tissue was collected in Hawaii by Rex Cates and Levon Ohai in 2005. Excess
dirt was washed from the tissue, allowed to dry in the shade and then put in labeled plastic bags,
placed in coolers containing dry ice, and shipped to the Natural Products Laboratory, Brigham
Young University. These samples were stored in a -80°C ultralow freezer until analyzed
(Blamires, 2002).
2.2 Tissue Extraction and Drug Production
Five grams of frozen root tissue from K. pinnata collected from Kauai and Maui, Hawaii was
ground using a mortar and pestle in liquid nitrogen in 15 ml hexane and filtered through cheese
cloth and VWR grade 415 filter paper. This was repeated with 10 and 5 ml of hexane,
respectively, removing non-polar terpenoid compounds from the tissue sample. The process was
repeated again with acetone using 15, 10 and 5 ml respectively. These acetone collections were
combined into one pre-weighed vial and taken to dryness using nitrogen gas. Distilled water was
added to the dried extract in each vial to make an 8 mg/ml concentration. Each vial was vortexed
and sonicated to homogenize the extract: dH2O, filtered through 0.2 µm Minisart filter (Sartoirus
Stedim Biotech, France), placed into 1.5 ml Ependorf tubes, and stored at -80°C until assayed.
Using the remaining tissue, the process of grinding, filtering, collecting and drying was repeated
using 70% methanol. Again the dried extract was reconstituted with dH2O in a pre-weighted vial
to make 8 mg/ml concentration.
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2.3 Virus stocks and cell lines
The HSV 1 (McIntyre strain) and HSV 2 (strain 333) (Jensen & Johnson, 1994) isolates were
used for all experiments. African green monkey kidney cells (ATCC CRL-1586, sub-line C1008)
were maintained in Dulbecco modified eagle medium (DMEM, Sigma Chemical Company, St.
Louis, Mo.) supplemented with 5% cosmic calf serum (HyClone Laboratories, Logan, Utah), 10
µM HEPES buffer, and 50 µg Gentamycin per ml media at 37°C.
2.4. Cytotoxicity
2.4.1. Microscopic observations
The inverted phase contrast microscope (Nikon Eclipse TS100) allowed observation to help
determine the extract’s effect on non-infected cell monolayers (Fig. 1). Expected observed
changes due to virus infection of C1008 cells included the formation of plaques, syncytia, and
foci (Fig. 2).
2.4.2. Neutral red assay for cytotoxicity of active extracts
The effect of K. pinnata extracts was evaluated to ensure that they showed no cytotoxic effect
on cell viability at concentrations which blocked HSV infection. Therefore, a neutral red (NR)
assay (Cytotox NR Kit, Xenometrix, Switzerland) was applied. Neutral red is a vital stain used to
quantify viable cell numbers. The assay is based on the ability of viable cells to incorporate and
bind neutral red within lysosomes and Golgi apparatus (Motohashi et al., 2003). To carry out this
test, C1008 cells were treated with serial dilutions of each extract (25, 50, 100, 200, 400, 800 and
1600 µg/ml), replicated three times. After 72 h the supernatant was removed and twice washed
with sterile phosphate buffer saline (PBS) after which 1 ml of 50 μg/ml NR in PBS was added.
The cultures were incubated at 37˚C in an atmosphere of 5% CO2 for 90 min. After washing the
cells twice again NR was eluted with an aqueous solution containing 50% ethanol plus 1% acetic
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acid for 10 min at room temperature. Spectrometry data were collected using a Fusion α-HT
Universal Microplate Analyzer (Packard Instruments, Meriden, CT) with a 540 nm filter and a
690 nm reference filter. Results were reported as 50% cytotoxic concentration (CC50) and were
determined from dose-response curves (Rajbhandari et al., 2007) (Table 2).
2.4.3. Five day proliferation assay
Since other unrelated compounds have been observed to arrest cell proliferation without
affecting an existing cell monolayer, the issue of cytotoxic potential was addressed more
rigorously by analyzing the effects of the extracts on Vero cell proliferation in the absence of
contact inhibition (Boulware et al., 2001). Vero cells were seeded into 6-well plates at a density
of 5×104 cells per well, which was sufficiently low to allow them to proliferate in the absence of
contact inhibition for six days. On the following day the media were removed from the 6-well
plates containing the overnight culture of cells. Each well was given a total of 3 ml fresh media
with enough extract to represent 2-fold serial dilutions (0.10 to 3.2mg/ml). The plates were
incubated for 5 days and then stained with crystal violet. All assays were performed in duplicate
and the maximum nontoxic concentration (MNTC) was determined to be the highest
concentration at which no alteration in cellular proliferation could be detected by inspection of
cell density following crystal violet staining (Table 2).
2.5. Virucidal activity of K. pinnata
To confirm that the acetone extract of K. pinnata was not disabling or disrupting the virus
particles directly, extracts at 200 µg/ml concentration were added to HSV 2 virus stock, a titer of
8 x 107 pfu/ml and incubated at 37°C for 30 min. Six 10-fold serial dilutions (10-1 to
10-6) were made from each supernatant sample and added to C1008 confluent monolayers in
6-well tissue culture plates in triplicate and 24-well plates. After virus adsorption for 1 h, the
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Vero monolayers in the six well plates were overlaid with complete minimal essential medium
containing 5% FBS and 1% methylcellulose to restrict dissemination of progeny virions and the
plates were incubated at 37°C for 5 days. Monolayers were fixed with 37% formaldehyde and
stained with Gram’s crystal violet. Plaques were counted by visual inspection to determine the
number of PFU per milliliter of supernatant. Cells in the 24-well plates were not overlaid but
instead allowed to incubate at 37°C for 24 hours before being fixed and subjected to the
immunoperoxidase staining protocol explained in section 2.6.2.below. Stained foci were counted
as infected cells.
2.6 Antiherpetic assays
2.6.1. HSV antigen expression
In order to determine if the acetone extract of K. pinnata inhibited HSV 1 or HSV 2 infection,
C1008 cells were seeded into 24-well micro-titer plates. K. pinnata acetone extract was
introduced to wells in three concentrations (25, 50, 100, and 200 μg/ml) when the cell
monolayers were 90% confluent. One ml of medium without extract was placed into randomly
placed control wells containing cells only. After 30 min 0.01 ml virus suspension was added to
each well, in triplicate, at a multiplicity of infection (MOI=1) and incubated at 37˚C for 30 h in
5% CO2 atmosphere.
To determine if the extract was inhibiting entry of the virus or destroying the virus particle,
each virus type was introduced to the monolayer 30 min prior to the extracts. C1008 cells were
seeded into 24-well micro-titer plates and incubated to 90% confluence. The old media were
removed and 0.1 ml of virus suspension (MOI=1) was added to test wells and 0.1 ml of media to
the control wells. Plates were incubated at 37˚C for 30 min in a 5% CO2 atmosphere after which
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1.1 ml of media with extract in 50, 100, and 200 µg/ml concentrations was added to the test wells
and incubated for 30 h.
2.6.2. Immunoperoxidase staining to determine plaque number in cell monolayers
All wells were stained using an immunoperoxidase staining protocol to detect viral structural
protein synthesis following Luker (Luker et al., 1991). In short, cell monolayers were fixed for
10 min in FAA fixative (5% formalin, 5% glacial acetic acid, 80% ethyl alcohol in distilled
water), followed by 30 min incubations (39˚C) in each of the three reagents. The first reagent
was a primary HSV antibody (Accurate Chemical and Scientific Corp., Westbury, N.Y.), the
second was a protein A-peroxidase conjugate (Zymed Laboratories, Inc., South San Francisco,
Calif.) and third was a 4-chloro-naphthol- horseradish peroxidase substrate-chromogen reagent.
The cells were washed with distilled water between incubations in each reagent. Following
staining the monolayers were observed for antigen-containing cells and cytopathic effects by
bright-field microscopy using an inverted phase contrast microscope (Nikon Eclipse TS100).
Mean values of triplicates expressed in plaque number were calculated and the growth inhibition
of infected cells was given as percentage of control values (Table 1).
Results were reported as 50% inhibitory concentration (IC50) and were determined by
comparison with positive control wells (Table 2). Positive controls used in the IC50 determination
were infected cell monolayers without extract.
2.6.3. Time of addition studies
In order to investigate K. pinnata’s effect on various stages of the viral life cycle, an
experiment varying the time of extract addition was performed. The acetone extract of K. pinnata
was added at the interval of 30 min pre-infection and 0, 2, 4, 6, 10 and 12 h post-HSV-2
infection. Virus yield was determined by plaque forming assay. The antiviral activity of the
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extract was evaluated at various time periods up to 18 h using a modified procedure of Boulware
(Boulware et al., 2001). Vero cells were seeded into 25 cm2 culture flasks at a density 2 x 106
cells/flask and incubated at 37°C for 24 h. Cell monolayers were infected with 2 x 105 pfu
HSV- 2 per flask. One hundred microgram per milliliter of either extract was added into the
flasks 30 min pre-infection with HSV 2, concurrent with HSV 2 infection (0 h) or at intervals of
2, 4, 6, 8, 10, and 12 h post-infection. After 18 h post infection, cells were collected and viruses
were released from cells by freeze-thawing twice. Cell pellets were removed by centrifugation at
3000 rpm for 10 min. The supernatants were divided into small quantity and stored at -80°C until
use. A virus titer of each supernatant was determined by a plaque assay (Abou-Karam & Shier,
1990).
2.7 In vitro HSV 1 and HSV 2 DNA replication assay
2.7.1 Cell preparation for DNA replication assay:
In preparation for the replication assay C1008 cells were seeded at 2 x 106 cells per 25 cm2
flasks, and the next day, after reaching 100% confluency, they were infected with 2x105 PFU per
flask of either type of HSV. The acetone extract of K. pinnata was added at a final concentration
of 100 µg/ml 30 min post infection and collected at seven time points: 2, 4, 7, 13, 15, 18, and 22
h for HSV-1 and 1.5, 5, 8, 11, 15, 18, and 24 h for HSV-2. Control flasks included flasks
infected with HSV but not subjected to K. pinnata extract and flasks containing only C1008
cells. The experiment was done in triplicate and collected at the same time points. Collection was
accomplished by removing the growth media, rinsing the monolayer with trypsin twice, and
allowing less than 0.2 ml trypsin to remain in the flask to lift the cells from the flask. PBS was
used to collect the cells and placed in 1.5 microcentrifuge tubes. The cells were spun down at
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10,000 g for 1 min and the residual liquid removed with a pipette. The cell pellet was placed in a
-20°C freezer until DNA extraction.
2.7.2. DNA extraction
PureLink Genomic DNA Mini Kit (Invitrogen Life Technologies, Carlsbad, CA) was used to
extract total DNA from each cell collection. Cells were resuspended in 200 µl PBS, proteinase
and RNase added, along with the lysis/binding buffer, incubated at 55°C for 10 min and lysed
with 100% ethanol. The purity and amount of DNA was determined on a NanoDrop ND-1000
spectrophotometer (NanoDrop Technologies, Wilmington, DE) and used immediately for PCR
or kept frozen at -80°C until further analysis.
2.7.3. Quantitative PCR
To assess the amount of viral DNA replication at multiple time points, a quantitative real-time
PCR (q-PCR) assay was performed, in duplicate wells. Quantitative PCR was performed under
the following conditions: 50°C for 2 min, 95°C for 2 min, 45 cycles of 95°C for 30 s and 60°C
for 30 s, with a 500 nM concentration of each primer set. To prepare total DNA for analysis,
3 µg of total DNA from each time point was added to SYBR green real-time PCR master mix
(Toyobo) according to the manufacturer’s instructions and was analyzed on an Applied
Biosystems sequence detection system. Four different primer sets were used (Table 3).
Amplifications were carried out for 45 cycles and a cycle threshold (CT) value was determined
by automated threshold analysis using the Applied Biosystems software for each time point
under each situation (C1008 cells alone, HSV 1 or HSV 2 infected C1008 cells and HSV 1 or
HSV 2 infected C1008 cells with 100 µg/ml of the K. pinnata extract). Dissociation curves were
recorded after each run.
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2.8. In vitro transcriptional activity assay
2.8.1. RNA extraction
Cells were prepared similar to those for DNA extraction, section 2.7.1 except there were four
collection time points (6, 12, 19, and 25 h). To quantify the inhibitory effect of the extract on
HSV infection, the intracellular HSV RNA content of extract-treated and untreated cells was
quantified by real-time PCR. Total RNA was extracted from C1008, C1008/HSV 1 or HSV 2
infected cells and C1008/HSV 1 or HSV 2 infected cells treated with the acetone extract of K.
pinnata at 100 µg/ml using the RNeasy Mini Kit (Qiagen, Valencia, CA). RNA was recovered
from the spin columns in a final elution volume of about 40 µl. The purity and amount of RNA
was determined on a nanodrop spectrophotometer and purified RNA was stored at -80°C until
first strand cDNA was synthesized.
2.8.3. cDNA synthesis
Reverse transcription of RNA to single-stranded cDNA was performed by using the
SuperScript III protocol according to the manufacturer’s instructions (Invitrogen Life
Technologies, Carlsbad, CA). RNA, 10 mM deoxynucloside triphosphates and 50 µm oligo (dT)
were incubated for 5 min at 65°C to denature the secondary structure of the RNA. First strand
cDNA synthesis was carried out in 20 µl reaction mixtures with 1X reverse transcriptase buffer,
40 U/µl of an RNA inhibitor (RNase OUT), and 200 U/µl SuperScript III. The reaction mixture
was incubated at 50°C for 50 min. The reaction mixture was inactivated by heating to 85°C for 5
min followed by RNase H digestion at 37°C for 20 min. The purity and amount of cDNA was
determined on a nanodrop spectrophotometer and used immediately for q-PCR or kept frozen at 80°C until further analysis.
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2.8.4. cDNA amplification using Q-PCR
Because microscopic observations noted a lack of syncytia or plaque formation in HSV
infected extract exposed monolayers with occasional stained single cells, it was suspected that
the extract was interfering with later stages of virion development, such as encapsidation and
egress processes. To detect specific transcripts, forward and reverse primers were used and PCR
was performed under the same conditions as for DNA replication tests. Primer sets for both HSV
types were designed to amplify portions of alpha, beta and gamma genes, specifically UL54,
UL23, UL30, US4 and U17 viral genes (Table 3). UL 54 is an immediate early (α) gene
responsible for reduction of cellular transcription. UL23 and UL30 are early (β) transcription
genes encoding thymidine kinase and viral DNA polymerase, respectively. US4 and UL17 are
late (γ) transcription genes. US4 codes for glycoprotein G (gG), dispensable for virus growth in
culture but necessary for in vivo viral envelope development (Brown & MacLean, 1998). The
UL17 gene is vital for DNA encapsidation, participating in the cleavage of viral DNA
concatemers as the genome enters the procapsid.
2.9 Statistical Analysis
Data sets from q-PCR were analyzed with a general linear model using the SAS system for
Windows 9 (SAS Institute Inc., Cary NC, USA). A log transformation was used to normalize the
data and directly model the ratios of transcript quantification. The analysis of variance
(ANOVA) allowed analysis with unequal variances for all gene targets. Statistical significance
was set at P = 0.05.
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Results
3.1. Cytotoxicity of extract on C1008 cells
3.1.1 Microscopic, qualitative assessments
The possibility existed that extracts might induce cytotoxicity thereby causing observable
changes in cell morphology. It was also important to identify types of C1008 monolayer changes
due to HSV infection in vitro. Non-infected cells in the presence of the acetone extract of K.
pinnata exhibited normal growth and cell morphology compared to untreated control cultures
(Fig. 1). In some cases cellular changes were observed due to the addition of an extract at the
higher concentration, (>1600µg/ml), such as the rounding up of cells and changes in the cell
membrane. Normal plaques and syncytia were prevalent in both HSV 1 and HSV 2 infected cell
monolayers without the extract (Fig. 2). In a few cases single cells showed the presence of the
HSV antigen but there were no syncytia or apparent spread from the originally infected cells.
There was little microscopic observational difference between the infected monolayers with 50,
100 and 200 µg/ml extract concentrations for either HSV type.
3.1.2. Quantitative assessment of cytotoxicity
Cytotoxicity of the acetone and methanol extracts from the root tissues of K. pinnata on the
Vero C1008 cells were reported as a CC50 of 1.25 and 0.95 mg/ml, respectively, using the neutral
red assay. Along with the five day proliferation assay, an MNTC of 1.3 and 1.0 mg/ml
respectively, it seemed clear that C1008 cells were fully capable of growth and reproduction well
above the necessary concentrations of either extract to bring about viral inhibition (Table 1). The
compounds in the acetone extract were effective against clinical isolates of HSV 1 and HSV 2
infections in vitro while being non-toxic to 50% of the C1008 cell monolayers at a concentration
fifty times greater than the 50% inhibitory concentration.
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3.2. Virucidal activity of K. pinnata
The virucidal assay for the acetone extract of K. pinnata showed that titers of surviving virus
were 8.2 x 107 pfu/ml for the control culture and 8.3 x 107 pfu/ml for the extract-exposed
cultures. These data indicated that the acetone extract was not directly virucidal or interfering
with the virus particles before their attachment and entry into the C1008 cells.
3.3. Effect of K. pinnata on viral infectivity pre and post infection
The acetone extract of K. pinnata displayed at least 50% inhibition at the lowest tested
concentration (25µg/ml) when added to C1008 cell monolayers 30 min post infection (Table 1).
In the time of addition study to assess antiviral activity as a function of time of extract
introduction, delaying the time of exposure to the acetone extract of K. pinnata up to 8 h failed to
significantly decrease its anti-HSV 2 activity. In other words, K. pinnata remained active at
inhibiting the virus even when added 8 h post infection. Adding the extract 10 h after infection
yielded plaque formation similar to the positive control wells. This result suggested that the
acetone extract of K. pinnata affected the later stages (>8 h) of HSV 2 infection.
Though both the acetone and methanol extracts produced antiviral effects (Table 1), the
acetone extract was chosen for further experiments. HSV 1 and HSV 2 infected cells in the
presence of the acetone extract of K. pinnata rarely exhibited any more than a few infected single
cells and no virus proliferation was observed (Fig. 2). Syncytia or plaque formation were not
observed in any of the infected wells inoculated with the acetone extract at 50 µg/ml, even if the
extract was added to the cells 8 h post infection. Although results generated from plaque
reduction assays showed that K. pinnata was an HSV inhibitor, these were unable to provide any
information on the mode of action of this compound. However these results demonstrated that K.
pinnata may act as an antiherpetic extract with a mechanism of action on later stages of HSV
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replication cycle, such as viral egress or capsid maturation processes. Therefore, a series of
experiments was carried out to determine the stage at which the acetone extract of K. pinnata
affected the life cycle of both HSV 1 and HSV 2.
3.4 Effects of K. pinnata on HSV DNA replication
Quantitative PCR analyses were performed to assess viral DNA synthesis. DNA replication
was diminished an average (all three primer sets) of 21 fold at t=22 h (P= 0.0026) when HSV 1
infected C1008 cells were exposed to 100 µg/ml of acetone extract. There was almost a 50 fold
decrease in DNA replication at t=22 h (P≤0.001) when HSV 2 infected C1008 cells were
exposed to 100 µg/ml of acetone extract (Fig. 3). Regardless of which primer set was used to
measure the amount of viral DNA present in the infected cells with and without the extract
present, the results were significantly similar.
3.5 Effects of K. pinnata on HSV gene expression
Of the five gene targets, the alpha gene UL54 showed the least significant fold decrease in
transcript number in HSV 2 infected cells treated with the acetone extract of K. pinnata. There
was between a 14 and 18 fold decrease in UL54 gene transcription at 15 and 21 h post infection
for HSV-2 and no significant decrease for HSV 1 (Fig. 4).
When the acetone extract of K. pinnata was present in HSV 1 and HSV 2 infected cell
monolayers, the beta gene UL23 transcripts were significantly reduced with a 14 and up to 23
fold decrease in expression at 15 h post infection and beyond (Fig. 5). Assays for the beta gene
UL30 transcripts showed greatest maximum fold decrease in transcription at 12 and 19 h post
HSV 2 infection by nearly 120 times, though there was also significant reduction in UL30
transcripts for HSV 1 by nearly 20 times (Fig. 6).
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The late gene, US4, showed a 55 and nearly 300 times decrease in transcript number, at 19 h
post infection in extract treated HSV 1 and HSV 2 infected cells respectively. In extract treated
HSV 1 infected cells, the gamma gene UL17 experienced a 544 fold decrease at 19 h post
infection and in extract treated HSV 2 infected cells a 292 fold decrease at 12 h post infection
(Fig. 7).

Discussion
In the present study we have evaluated the efficacies of several extract concentrations to
inhibit the formation of herpes virus plaques in relation to extract effects on cell viability. We
have examined the mechanisms by which an acetone extract from root tissue of K. pinnata
inactivates HSV ability to replicate in cultured C1008 cells. Immunoperoxidase staining of viral
proteins and q-PCR assays indicated that HSV 1 and HSV 2-infected C1008 cells treated with
the acetone extract of root tissue from K. pinnata may be susceptible at various stages of HSV
replication; after viral entry but during viral DNA replication and especially during genome
encapsidation and envelope protein synthesis. The observation that 0.1 mg/ml represented a
concentration where replication inhibition and mRNA expression were reduced up to 500 times
in some cases confirmed that the acetone extract could specifically inhibit HSV replication and
transcription with little detectable consequences to the host cell.
Microscopically observed lack of syncytia and plaque formation in the presence of the
acetone extract may be explained by the dramatic reduction in transcripts from both beta and
gamma genes, UL23, UL30, UL17 and US4. Because the fold decrease in transcript number for
the alpha gene UL54 and the beta gene UL23 were a fraction of that for the other three genes, it
is suspected that they were not reduced due to the presence of the extract but rather as a result of
the limited new virus particles and spread beyond the initial infection because new virus egress
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and further cell infection in vitro begins near this time (Aquilar et al., 2005) and reduced DNA
replication. The absence of a significant reduction in UL54 transcription previous to 15 h post
infection may indicate that compounds in the acetone extract of K. pinnata do not interfere with
immediate early transcription. This would explain why, when the extract was added 8 h post
infection thus allowing the virus to attach, enter, uncoat and begin immediate early transcription,
there was little to no new virion production or egress from initial infected cells.
The γ gene, US4, responsible for glycoprotein G and found in the viral envelope responsible
for cell-to-cell spread of new virion particles experienced impressive reduction at 19 h post
infection with a 55 fold decrease in transcription in HSV 1 and 288 fold decrease in transcription
in HSV 2 in the presence of the acetone extract of K. pinnata. It would be beneficial to examine
the level of US4 transcription after 12 h but before 19 h post infection to assess if there was a
significant reduction in transcript number prior to a second infection cycle. Transcription of the γ
gene UL17, whose protein product is required for cleavage of viral concatemeric DNA into unitlength genomes (Salmon et al., 1998, Taus et al., 1998) and is conserved in all subfamilies of
Herpesviridae (Klupp et al., 2005) also experienced significant reduced expression in extract
treated HSV 1 and HSV 2 infected cells (Fig. 7). Along with UL25 proteins, UL17 proteins are
necessary for stable encapsidation of the DNA genome (Snow, 2001). It is suggested that the
mechanism responsible for the antiviral activity observed in this study is due to interference with
at least these 2 strategic γ gene transcripts, explaining why little to no infected cells are found in
C1008 monolayers treated with the acetone extract of K. pinnata up to 8 h post HSV 1 or HSV 2
infection.
Based on previously documented antinociceptive, anti-inflammatory, antimicrobial properties
of K. pinnata and present results of antiviral activity, we believe one or more of the root extract
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compounds in K. pinnata represent promising molecules for future anti-HSV drug design. It is
known that there are high quantities of flavonoids, saponins and alkaloids in K. pinnata leaf
tissues and that phenolic compounds and tannins are found in trace amounts (Okwu & Josiah,
2006). Due to the lack of literature on the pharmacological actions of root tissue extracts of K.
pinnata, it is suggested that the acetone and methanol extracts be carefully fractionated and a
quantitative determination of the phytochemical constituents be assessed. The common
compounds in the acetone and methanol root extracts may explain the mutual antiviral activity
observed from each extract. The variability between the acetone and methanol extracts’ toxicity
to C1008 cells may result from distinctive compounds found in each and, if removed from the
extracts, may result in a higher therapeutic index for each and allow a more accurate dosage for
HSV-inhibitory observations.
Our proposed hypothesis for the mechanism of HSV inhibition is that at least two γ genes,
US4 and UL17, whose expression results in cell to cell spread and DNA encapsidation is
affected by the presence of polar extracts from the root tissues of K. pinnata. The significant
reduction in transcription of at least five viral genes at some point in the HSV replication cycle
suggests there are multiple compounds working alone or synergistically to reduce HSV
replication and spread, multiple gene transcripts have a common transcription control, or a
common early product is blocked.
The chemical constituents of root tissue from K. pinnata associated with the reduction of
specific viral mRNA transcripts and reduction of HSV cytopathic effects is still not clear. These
findings encourage additional studies, such as the delineation of compounds in the roots of K.
pinnata and repeating the assays using the individual components of the crude extract and the
examination of antiviral activity against other Herpes family viruses.
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Table 1
*Percent inhibition of plaque and syncytia formation from HSV-1 and HSV-2 infection
due to methanol and acetone extracts of K. pinnata: 4 different concentrations (†µg/ml) as
measured by an immunoperoxidase mini-plaque assay.
HSV 1
Acetone
†

K.pinnata

HSV 2
Methanol

Acetone

Methanol

25

50

100

200

25

50

100

200

25

50

100

200

25

50

100

200

*55

66

76

95

45

52

81

93

65

85

96

98

22

41

44

62

Table 2
Results of neutral red assay for cytoxicity (CC50) and mini-plaque assays for percent
inhibition (IC 50) with resulting TI values and MNTC values for acetone and methanol
extracts of K. pinnata.
K. pinnata
Acetone

HSV1

CC50

1.25 mg/ml

0.95 mg/ml

MNTC

1.3 mg/ml

1.0 mg/ml

IC50

0.025 mg/ml

0.05 mg/ml

TI
HSV2

Methanol

IC50
TI

50
0.025 mg/ml
50
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19
0.2 mg/ml
4.75

Table 3: Primer Sets
For mRNA expression assays
Gene Name
FUNCTION/PROTEIN
PRIMER SEQUENCE (5’-3’)a
HSV 1
F CGTCATCCACACCTTATCGTTT
cell to cell spread/envelope
US4
R GGACCAACCGCCACACA
glycoprotein G
HSV 2
F CTACCACGCGTCGCTTTTG
US4
R ATAAACGTGCGGCCCGTAA
HSV 1
F TTTACTCTGCTCGCGTTTACTA
UL17
R GGCTTAACAATCGTCCAATCG
DNA encapsidation, capsid
HSV 2
transport, DNA packaging
F ACCGCTCCGAAGCCTTTC
UL17
R TTTCAACAACTGGGCGAAGTC
HSV 1
F GGCGTGCGTGACATTCAAG
UL30
R CCTTTTTAACAGACTCTCGGTATC
DNA replication/DNA
HSV 2
polymerase catalytic subunit
F GGGTGATCGGCGAGTATTGT
UL30
R GTGCGGCAGAAACTTGAAGAA
HSV 1
F CAGTAGCGTGGGCATTTTCTG
UL23
R CTCGCCGGCAACAAAAAG
Nucleotide
HSV 2
metabolisms/thymidine kinase F CCCGATATGAGGAGCCAAAA
UL23
R ACCAGCGCCCAGATAACAAT
HSV 1
F CGGGCCTGATCGAAATCC
Gene regulation, RNA
UL54
R CGCAGACACGACTCGAACA
metabolism and
HSV 2
transport/multifunctional
F CGCCAGGAAAATCTCATCGA
expression regulator
UL54
R TGGTGAATGCACATCTTGCA
For DNA replication assays
HSV 1
DNA
F AAGTGGCTGTCGAGCACGTA
UL12
processing/deoxyribonuclease R CCCGTCACCCGAACTTTAAG
HSV 1
F TTTACTCTGCTCGCGTTTACTA
UL17
R GGCTTAACAATCGTCCAATCG
DNA encapsidation, capsid
HSV 2
transport, DNA packaging
F ACCGCTCCGAAGCCTTTC
UL17
R TTTCAACAACTGGGCGAAGTC
HSV 1
F GGTGTGAAAGTTGGCTGTGGTT
UL13
R CAAGTCCCCCCGGATGTT
Protein phosphorylation/ PK
HSV 2
family
F TGCGTGCGCTGGTAATTTATA
UL13
R CTTCGCAATCCCAAGATTCG
HSV 2
Terminase protein, processing F ACCGCTCCGAAGCCTTTC
UL15
and packaging of DNA
R TTTCAACAACTGGGCGAAGTC
Housekeeping Primers for all q-PCR
Chlorocebus aethiops
F GCGCGGCTACAGCTTCA
Vero β-actin
African Green
R CTTAATGTCACGCACGATTTCC
Monkey
a

NCBI reference Sequence NC_001806.1 and NC_001798.1
Sequence of forward (F) and reverse (R) primers in 5' to 3' orientation
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Fig. 1. Cytotoxicity of K. pinnata acetone extract at a concentration of 100 µg/ml, a) confluent,
uninfected C1008 cells, b) confluent, uninfected C1008 cells (100x).

a

b

Fig. 2. Reduction in plaque, syncytia and infected cells due to K. pinnata acetone extract at a
concentration of 0.1 mg/ml, a) HSV-1 infected C1008 cells, b) HSV-2 infected C1008 cells,
c) HSV-1 infected C1008 cells with 100 µg/ml K. pinnata acetone extract, d) HSV-2 infected C1008
cells with 100 µg/ml K. pinnata acetone extract (100x).

a

b

c

d
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Fig. 4. Effects of K. pinnata on HSV types 1 and 2 alpha gene UL54
mRNA expression. *P≤ 0.05
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Fig. 5. Effects of K. pinnata on HSV types 1 and 2 beta gene UL23
mRNA expression. *P≤ 0.05
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Fig. 3. Effects of K. pinnata on three different gene targets to assess difference in HSV DNA
replication in vitro using Q-PCR. Data represents mean ± S.E.M. of three independent
experiments. *P≤ 0.05, P≤0.001
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Fig. 6. Effects of K. pinnata on HSV types 1 and 2 beta gene UL30 mRNA expression. Data
represents mean ± S.E.M. of three independent experiments. *P≤0.05, **P≤0.001
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Fig. 7. Effects of K. pinnata on HSV types 1 and 2 gamma genes, US4 and UL17,
mRNA expression. Data represents mean ± S.E.M. of
three independent experiments. *P≤0.05, **P≤0.001
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Chapter Four - Professional development curriculum: Integrating molecular
biology and microbiology into the existing secondary biology curricula.
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“Those who know, do.
Those who understand, teach”
Aristotle, Greek critic, philosopher, physicist and zoologist
(384-322 BC)
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Overview
Effective science teaching is more than having knowledge of science content and some
teaching strategies. Skilled science educators tailor learning situations to the needs of individuals
and groups and integrate unique understandings and abilities into their curriculum. This special
knowledge, called "pedagogical content knowledge," distinguishes the science knowledge of
teachers from that of scientists (National Science Foundation, 2009). It is one element that
defines a professional teacher of science. Research demonstrates that teachers' background
knowledge and the methods they use to teach science have a very strong impact on how much
their students learn and on their attitudes about science (Elfring, 2002). One of the best ways to
ensure the quality of undergraduates in the biological sciences is to have them arrive at the
university with solid knowledge and skills. For this to happen, students must be taught by
teachers who are well informed and current in their content and teaching methods. The most
important resource to a science student is a professional science teacher (Llewellyn, 2005).
To effect a positive impact on students, teachers must know the content they teach,
understand the nature of learning, and use a range of teaching strategies to accomplish the
primary job of a teacher: to promote learning. It follows that teachers should be dedicated
learners; to stay current in the science disciplines they teach, and continue to learn new skills,
technology and information in their field. Teachers do not leave pre-service programs with a
complete understanding of all the science they will need in their teaching careers, and they need
to continue to clarify and deepen their understanding of the science content that is part of their
teaching responsibility. Since biology in general and molecular and microbiology in particular
are so dynamic in scope and content, it is imperative that teachers have an opportunity to
continue learning; made clear by the observation that tomorrow's students will have markedly
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different needs from today's students. Even today's employers require employees who can frame
problems and design their own tasks, think critically, and work together (Krajcik et al., 2007).
This professional development course offers teachers and their school district an opportunity to
develop and enhance these needed skills for effective science teaching emphasizing the
molecular biology and microbiology disciplines.

The Rationale
The 2007 Trend in International Mathematics and Science Study offered bad news for the
U.S. science education community. The TIMSS results, released in December 2008, showed
statistically no change from the 1995 scores in science (National Center for Education Statistics,
2008). TIMSS measures student performance in science topics/content and cognitive skills of
knowing, applying and reasoning. In 2007, Singapore, Chinese Taipei, Japan, Hong Kong,
Russia and England had higher average scores than the United States in science. Factors behind
this disappointment include the No Child Left Behind (NCLB) Act, resulting in less time,
resources and focus on science education, including the lack of pre-service preparation and inservice professional development for science education. Nearly 75% of the teachers questioned
said they needed substantial professional development to deepen their own science content
knowledge (Slater, 2008). In response to the poor results of TIMSS, the education community
has seen a surge of public interest in the training and subject matter competency of secondary
science teachers. This interest has resulted in congressional hearings and high-profile
publications such as Rising Above the Gathering Storm: Energizing and Employing America for
a Brighter Economic Future (Jacobs et al., 2008a). Politicians, business leaders, and higher
education have taken notice of the crucial link between the training of qualified secondary
teachers and the production of a well-prepared college student population and workforce. Large
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sums of money have been awarded on the basis that partnership with organizations such as the
Math-Science Partnership (MSP) and the National Science Foundation will result in a higher
quality teaching force and better prepared teachers and students (National Science Foundation,
2009).
A high level of expertise should be expected from our science teachers. Real expertise comes
from working in the field. Most experts have what may be called ―
contributory expertise‖—
sufficient knowledge and understanding to make contributions (Collins, 2007). This level of
expertise can be attained only by spending time interacting with other contributory experts in the
field. Most established secondary science teachers do not have ―
contributory expertise‖. And if
they do not have opportunities to update their skills and knowledge, they are unable to maintain
the level of knowledge once they go into the classroom full time. Even among newer life science
teachers, the course requirements are slim in the molecular and microbiology departments (Table
1). Therefore, development of a molecular/microbiology in-service course for life science
teachers, involving current curriculum, inquiry activities and discussion about the epistemology
of science is critical to the continuing education and competence of secondary biology teachers.
Continued education in this field will enable the ―
non-expert‖ scientist such as the secondary life
science teacher to acquire science knowledge, not just articulated in a text, but attained through
inquiry, practice and integration, resulting in more confident and prepared teachers and thus the
students they educate. In the past two decades, programs with similar goals have been
introduced, primarily by universities. The American Association of Immunologists (Cobb, 2009)
Summer Research Fellowships for Middle and High School Teachers program provides summer
research support for teachers to work in the laboratories of AAI members for a four-week period
coupled with one to two weeks of curriculum development. The John H. Wallace High School
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Teachers Program, in which science teachers work with ―me
ntor‖ scientists at immunology
laboratories is designed for a four to six week workshop where teachers participate in research
and devise lab exercises to take back to the classroom. The program’s goal was to engage
teachers who may not have had experience in a research lab setting (American Association of
Immunologists, 2005).
The current reform effort in science education requires a substantive change in how science
is taught and an equally substantive change in professional development practices (Arzi and
White, 2007). Teacher-preparation courses and in-service activities in methods of teaching
science frequently emphasize technical skills rather than decision making, theory, and reasoning.
If reform is to be accomplished, professional development must include experiences that engage
best‖
practicing teachers in active learning, expands their content knowledge and models ―
science teaching practices as described in the teaching standards of the NSTA. Professional
development courses must answer serious questions about science education today such as what
does a science teacher need to know, what does it mean to know a lot or a little, what is a sound
science foundation and in-depth understanding? It is assumed that teachers of science will
continue to study science throughout their careers. Most teachers of science have a broad base of
scientific knowledge extensive enough to understand the nature of scientific inquiry, its central
role in science, and have some skills in scientific inquiry. Teachers understand the fundamental
facts and concepts in major science disciplines. Fewer make conceptual connections within and
across science disciplines. Beyond the foundation in content standards and objectives, how much
more science a teacher needs to know is an issue of breadth versus depth to be debated. Breadth
implies a focus on the basic ideas of science and is central to teaching science at all grade levels.
Depth refers to knowing and understanding the basic ideas within a science discipline and the
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supporting experimental and theoretical knowledge. This professional development course
focuses on depth in the biological areas of virology, molecular biology, and immunology while
learning through the perspectives and methods of inquiry. The curriculum presented here is quite
different. It is designed by an experienced high school biology teacher who has currently
completed a graduate degree in the microbiology and molecular biology disciplines and who is
returning to the secondary classroom. It is designed to be taught by and for life science high
school teachers; taking materials and pedagogy learned in this course and immediately
implementing it into their own classroom. Inquiry experiences will focus on what materials the
teacher has available in their high school laboratory.
This professional development curriculum began with four assumptions about the nature of
secondary science in-service. First professional development for a science teacher should be a
continuous, lifelong process. The understanding and abilities required to be a masterful teacher
of science are not static. Second, science content increases and changes, and a teacher's
understanding in science must keep pace. Third, knowledge about the process of learning is
continually developing, requiring teachers to stay informed. And fourth, we live in a changing
society that deeply influences events in schools; social changes affect students as they come to
school and affect what they need to carry away with them. Science teachers must be involved in
the acquisition of current, accurate and relevant scientific information as well as development
and refinement of new approaches to teaching, assessment, and curriculum (National Center
Educational Statistics, 2003).
In this course science learning experiences for teachers will involve teachers actively
investigating phenomena that can be studied scientifically, interpreting results, making sense of
findings consistent with currently accepted scientific understanding, and address issues, events,
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problems, or topics significant in science. They will be exposed to scientific literature, media,
and technological resources that can expand their science knowledge and their ability to access
further knowledge. An important aspect of this course is to allow teachers to work in the lab with
experienced graduate students from local universities. Teachers are given the opportunity to be
like a real scientist, asking questions, developing hypotheses, researching background
information and writing an experimental design. This experience will change the way science
teachers think about and prepare laboratory experiences for their own students.

Goals
There are three primary goals of this in-service course curriculum. First, it must be
integrative in nature. The lesson information and inquiry activities offered must not add to the
already overload of biological information a life science teacher must include in one year’s
instruction. This course uses the disciplines of virology, molecular biology, and immunology to
meet many of the standards and objectives in the science core of the state. This course supports
the trainer with specific examples. Second, the course must include time for teachers to make
connections between what they already know and new information and concepts through inquiry.
Thirds, the curriculum must allow teachers to be creative and versatile in their lessons by
modeling for them a variety of pedagogical techniques (best practices) for teaching high school
students. Emphasis is placed on the role of teacher as a coach and facilitator.
While the main intent of this course is to improve the knowledge base for secondary life
science teachers in the microbiology and molecular biology disciplines, one would expect that
teachers will return to their own classroom and use the materials and ideas they have acquired
from this course. As a result, this course is written with the teacher and their students in mind.
The ongoing information explosion in biology makes these goals challenging. Just as science is
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built on curiosity and a sense of wonder, this curriculum is not intended to be a stagnant or
deteriorate but will require constant modification over time.
Primary emphasis will be on developing an understanding of concepts rather than on
memorizing terms and technical details. Specifically, included in the concepts stressed are: 1) the
historical routes of molecular biology, (2) biotechnology and its influence in society, (3) the
relationship between viruses and evolution, order and organization, (4) the immune system and
examples that stress structure and function, change and constancy, and (5) the personal and
social impact of pathogens. Teachers in this course will be given opportunities to experience
scientific inquiry, recognition of unifying themes that integrate the major topics of biology,
application of biological knowledge, and critical thinking about environmental and social
concerns.
Biology teachers will be encouraged to maintain an open and questioning mind, to pose their
own questions about historical events and discoveries in microbiology and molecular biology
fields. They will be instructed on methods that integrate virology, molecular biology and
immunology into the general biology curriculum: to develop connections between these
emphasized disciplines and the dynamic biological activities of the present day. Personal
relevance will be a focal point. This will allow teachers to see current application of what they
are teaching and, in turn, help their students value science. Teachers will create their own
interactive notebook/journal in preparation to teach their students how to improve writing skills
in science.
Science instruction should cultivate and build on the teachers’ present knowledge and
understandings. After attending the in-service, teachers will be able to write lessons that will
integrate specific examples of molecular and microbiology disciplines into their current
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biological units as well as increase the number of investigative activities and discussion sessions
relevant to current science issues.

Research Design and Questions
I am interested in epistemic practices: posing questions and developing theories about
phenomena, learning to make representations, and learning by inquiry, reflecting the reality of
studying the nature and practice of science. To design a curriculum that will contain important,
current and necessary knowledge in the areas of molecular biology, immunology virology and
general microbiology in an integrative approach requires consideration of the following research
questions:
If teacher education curriculum materials mediate integrating concepts in biology and inquiry
practices, is there an increase in knowledge base and interest in the specific areas of
molecular and microbiology from teachers in training?
For what level of scientific expertise should the curriculum aim?
With newly acquired knowledge in molecular and microbiology, will teachers take it and
implement it into their lessons and discussions in the classroom?
Will new and experienced teachers demonstrate this new information by improving inquiry
exercises, case study discussion, questioning and problem solving, integration of concepts,
drawing relevance to their students’ lives, and add more depth to their lectures?
Will students increase in knowledge, application and interest in the molecular and
microbiology areas of science as assessed informally? (See appendix: Possible Assessment
Products)
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The Audience, the Time, the Place, and the Funding
This course is designed for current secondary biology teachers who have not participated in a
detailed lecture and/or laboratory courses in microbiology, molecular biology, virology and
immunology or who have not taken these science courses at a college in the past 3 years. This
course will be held two weeks in the summer for a total of 80 hours and may offer college credit
to the attendees. The course will meet at the biotechnology lab located at Mountain View High
School in Orem, UT. This lab is equipped with necessary materials that allow teachers to acquire
hands-on application experiences. Funding for this course will be provided by grants from NSF
and the Alpine School District. The term ―te
acher‖ refers to the beginning and continuing high
school biology teacher participating in this course of study. The term ―tr
ainer‖ refers to the
instructor for this teacher education science course.

Key Components of the Course: Inquiry, Integration, and Application
Teacher learning is analogous to student learning: learning to teach science requires that the
teacher articulate questions, pursue answers to those questions, interpret information gathered,
propose applications, and fit the new learning into the larger picture of science teaching. This
course includes opportunities and modeling exercises that allow teachers to question, interpret,
apply and integrate new science concepts and information into classroom lessons, without adding
to the overload of information science teachers feel compelled to cover each year. Learning is
also a developmental process that takes time and is hard work. As does any professional,
teachers of science will stumble, wrestle, and ponder while realizing that failure is a natural part
of developing new skills and understanding. However, effective teachers know how to access
research-based resources and, when faced with a learning need, pursue new knowledge and skills
that are based on research or effective practice (National Research Council, 1996). The content
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emphasized will include basic and more current information in the areas of virology and
bacteriology, molecular biology, and immunology. Differing degrees and forms of expertise
represented in the participants were kept in mind in the design process. An important goal of this
course was to deepen and enrich understanding and ability as well as impart current science
content knowledge and include a range of strategies for teachers to use as they instruct their own
students.
Inquiry
Reform in science education has highlighted that science consists of ―
habits of mind‖ that
rely on modes of thinking and reasoning to make sense of phenomena in the world
Epistemic practices (including inquiry) imply asking questions, collecting data, making
descriptions of observations, finding patterns in the data, and developing scientific reasoning. An
important stage of inquiry and of students’ learning is the oral and written discourse that focuses
the attention on how students know what they know and how their knowledge connects to larger
ideas, other domains, and the world beyond the classroom. Teachers directly support and guide
this discourse in two ways: they require students to record their work, teaching the necessary
skills as appropriate, and they promote many different forms of communication (for example,
spoken, written, pictorial, graphic, mathematical, and electronic). Teachers are models for the
students they teach. A teacher who engages in inquiry with students models the skills needed for
inquiry. Students engaged in inquiry understand the nature of science as well as procuring a more
in-depth knowledge of key concepts in biology. Tai and colleagues found that students
participating in high school courses examining fewer concepts in more depth as well as working
meaningful problems and engaging in inquiry activities performed much better than students
whose teachers sped through more concepts in a textbook-centered, teacher-driven class (Tai et
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al., 2009). More and more university science courses are inquiry based and using active learning
strategies (Knight and Wood, 2005; Udovic et al., 2002). Students engaged in inquiry
experiences are more likely to be drawn to careers in science. As a result, these students
complete college science courses in greater numbers than students in non-inquiry based courses
(Gibson and Chase, 2002). Teachers who exhibit enthusiasm and interest and who speak to the
power and beauty of scientific understanding instill in their students some of those same attitudes
toward science. This course asks the in-service teacher to participate in questioning, describing
observations, finding patterns in data, and developing scientific reasoning as they learn about the
specific disciplines in this course and practice laboratory techniques specific to those disciplines.
Integration
Although the literature on integrated science shows that there is a lack of any consensus on
the definition and conceptualization of 'integration', it is obvious that integrated science is
consistent with the aim of raising the level of scientific literacy of all students in primary and
secondary schools (National Committee on Science Education Standards and Assessment, 1996).
The initial motivation for the design of this curriculum was to create an integrated molecular and
microbiology curriculum that secondary life science teachers could learn, practice and share with
their students in a compressive but timely manner. The course does not cover all topics that are
in the science curriculum. However, it does provide a background in virology and bacteriology,
molecular biology, and immunology that can integrate into almost any unit of a high school
biology course. By emphasizing depth rather than breadth, this course seeks to empower teachers
rather than intimidate them with a collection of isolated and forgettable facts.
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Application
College professors want students who are problem solvers and are able to ―
think their way
out of a brown paper bag.‖ Merely memorizing information does not adequately prepare students
for the rigors of college where deciphering, interpreting, and reasoning is critical to success in
science courses. High school teachers allowing discussion of real-life scenarios that focus on
biological concepts provide the opportunity for greater understanding in their students. These
scenarios allow students the opportunity to apply their knowledge of concepts in a practical,
thoughtful manner. For example, when high school students are confronted with a problem about
an oil spill in the ocean and are encouraged to use both ecological and microbiology concepts,
(such as carrying capacity, biotic and abiotic composition of ocean biome, bacterium and
protozoan populations, etc.) they must work with these concepts first-hand rather than learn them
passively. During their initial biology course in college, the students recall these scenarios to
assist them in deepening their knowledge of the concepts. If students do not actively work with
relevant issues in the high school, then the college courses can be a frustrating experience
because the concepts learned in high school are one-dimensional. This course will include
activities that require the use of problem solving skills, application discussions, inquiry activities,
and integrating themes in biology.

Biotechnology Skills
Safe use of lab materials, set up and organization, and responsible storage and disposal of
reagents are important components of any science teacher’s ―
lab skills‖ tool box. This course
moves beyond the typical laboratory skills into discussions about research laboratories and how
data are presented and results interpreted in the molecular and microbiology disciplines. Ideas
about the purpose and uses for buffers, measuring small volumes using micropipettes,
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configuring molar concentrations, % mass/volume, cell culturing, contamination, cytopathic
effects, and working with bacteria and viruses will be discussed. Teachers will have the
opportunity to perform a concentration assay and various forms of chromatography. They will be
introduced to the study of proteins and nucleic acids and the tools used in the research
laboratory. The use of monoclonal antibodies, determination of protein concentration,
understanding the differences between precision, accuracy and reproducibility, DNA and RNAextraction, reverse transcription of RNA, PCR technology and gel electrophoresis, the use of
primers and how they work, an introduction to flow cytometry technology and analysis of data
are included in discussion and demonstration. Though most teachers will not have means to
provide equipment and materials in their own schools, teachers having multiple experiences with
the molecular tools and microbiology techniques can go back to the classroom lab with
confidence that they can demonstrate and explain what students are reading about in the case
studies as well as current biology textbooks.

Organizational Tools and Resources
High school science teachers using teacher-directed instruction involving lecture, with a few
labs scattered throughout the year. To substantiate their methods, teachers claim it is necessary
because ―
student need to be able to be good note-takers in college.‖ But these methods provide a
cursory view of the content where students learn for an exam but forget soon after. When notes
are taken, the students need to work with the notes, and personalize them with sketches, charts,
schematics and summary statements (Einstein et al., 1985). Merely taking notes without
synthesizing the ideas involves little thought and consideration. In this course, teachers practice
concept mapping and use of an interactive notebook to adequately connect scientific concepts in
a meaningful way. Using concept maps during high school facilitates students’ understanding of
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concepts and their relationship to one another. Concept maps also provide a useful skill for
working with concepts as a study skill once in college. The more high school teachers can
provide ways for students to study content in a meaningful manner, the more prepared students
will be to handle the challenges of college. Concept maps are vital for integration of themes and
concepts, and are included in this curriculum.
Other skills to be addressed are: how to teach students how to keep a laboratory notebook –
the right hand rule, interactive notebook, organization, documentation, etc., laboratory
organization and logistical problems managing a lab with twenty-eight plus 15 to 18 year-old
students, how to mediate case study discussions, and how to use the inquiry methods as a means
of delivering new information to students. This concern will be addressed in the course.
Reading science for understanding is critical and those high school teachers who have their
students read actual scientific papers and science articles in magazines such as Discover,
Skeptical Inquirer, and National Geographic provide opportunities to engage in the scientific
literature (Sadler and Tai, 2009). Having students examine and critically evaluate science based
websites also aids in developing scientific literacy. Being able to summarize key ideas presented
in the readings assists students in developing their own understanding of concepts. Courses in
science should allow teachers to develop understanding of the logical reasoning that is
demonstrated in research papers and how a specific piece of research adds to the accumulated
knowledge of science (Windschitl et al., 2008). Courses should support teachers in using a
variety of technological tools, such as computerized databases and specialized laboratory tools.
This in-service course includes a book list and websites to be used as resources for teachers and
their students, along with a compilation of case studies relative to the course materials. Teachers
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choosing to use these materials will offer students the opportunity to read for understanding and
experience, in a small way, the ―
science‖ of experimentation and discovery.

Teaming with the Local University Graduate Students
This curriculum proposes a cooperative project with the local university. The proposed
project combines laboratory research and educational experiences of university graduate students
with the teaching experience of 9th-12th grade science teachers to create a new life science
teaching synergy. Graduate students will work on location with students and their teachers,
sharing their experience with research practices and graduate science education. They will be
role models for young people as they direct and organize projects with students, share their
knowledge of current research and life science issues and be a facilitator and mentor to students
and teachers. Workshops, forums and collaborative meetings will be organized for team building
and information exchange necessary to yield an improved science curriculum and a growing
interest in science among young students (Spillane, 2004). This in-service course includes an
opportunity for biology graduate students (American Association of Immunologists) and high
school teachers to network together, plan time during the school year when they can collaborate
on lesson planning and instruction by leveraging the research experience of the fellows. As
modern role models, fellows and teachers can provide classroom and laboratory learning
experiences that will instill a robust understanding of science’s dynamic role within modern
society. Fellows can recognize the role their research plays in shaping future 11th and 12th grade
science education and inspire students to explore and pursue careers in science.

Assessment of the Professional Development Course
In evaluating the success of teacher development programs, valid and scalable measures of
teaching practice are needed. The Science Lesson Plan Analysis Instrument (Jacobs et al., 2008)
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for quantitative evaluation of teacher-generated multiday lesson plans was developed by Jacobs
(2008) as a complement to surveys and classroom observation, and demonstrates its use in two
pilot studies. The SLPAI was used formatively to measure the teaching practices of incoming
program cohorts and tailor program instruction. It was also used to track changes in teaching
practice and pedagogical knowledge of participants over time, providing summative evidence of
program effectiveness. It is suggested that this instrument be used to evaluate this in-service
curriculum as well as the individual teachers’ lessons they develop as a result of this course.
SLPAI consists of four major subscales: Alignment with Endorsed Practices (AEP), Lesson
Design and Implementation-Cognitive and Metacognitive Issues (CMI), Lesson Design and
Implementation-Sociocultural and Affective Issues (SCAI), and Portrayal and Uses of the
Practices of Science (PUPS) (Jacobs et al., 2008).

Components and Arrangement of the Curriculum
Dividing science teaching into separate components oversimplifies a complex process. This
integrative approach to the teaching and learning of biological concepts found in the
microbiology and molecular biology disciplines includes subcomponents for optimal structure,
organization, balance and presentation to teachers in the course that will ultimately be used as
models in their own classrooms. Conceptual and procedural schemes unify science disciplines
and provide students and teachers with powerful ideas to help them understand the natural world
(National Science Foundation, 2009). Since underlying principles are emphasized in respectable
science organization such as the American Association for the Advancement of Science,
National Committee on Science Education Standards and Assessment, Utah State Office of
Education, Advance Placement College Board, and National Science Teachers Association, a set
of overarching themes are included and provide focus for the individual concepts in the
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designated disciplines of the course. As the course is presented, these unifying concepts will be
emphasized. They include 1) Systems, Order and Organization, 2) Change, Constancy and
Measurement, 3) Evidence, Models and Explanation, 4) Evolution and Equilibrium, and 5) Form
Fits Function
This curriculum includes two major sections, A and B, for the trainer of the professional
development course and the teacher who is attending the course, respectively. Each section is
divided into four units and each unit consists of specific segments. The four units are entitled:
1) Virology, 2) Molecular Biology, 3) Immunology and, 4) Pathogenesis and Society. Any of the
materials may be shared, copied and altered to meet the needs of the participants in the course.
Section A begins with the course objectives, a time table for the two week course, and a preassessment to be given on the first day of class. Section A is then subdivided into four units
consisting of up to ten segments each. These segments are labeled 1) Learning Objectives, 2)
Essential Prior Knowledge, 3) Trainer Preparation Notes, which include misconceptions that
should be addressed with the class and anticipated results 4) Essential Questions, 5) Core
Concepts, to be introduce and explained if necessary, 6) Anticipatory Set, 7) Comprehension and
Application Activities, to promote inquiry, integration and discussion, 8) Higher Order Thinking
Skills, 9) Interactive Notebook/Journal Writing, and 10) Assessment, to monitor the progress and
understandings of the participants. Included in the lesson materials will be suggested
organizational tools the trainer should model for the teachers. Teachers must be given
opportunities to share what they do in their classroom as well. Levels of rigor should be
discussed wherever possible. Cooperative learning activities are provided wherever it is possible
so that teachers will see how the concepts can be presented and practiced in an inquiry based
environment.
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Section B is subdivided into four units consisting of four segments each. These segments are
entitled: 1) Worthy of Note, which may be copied and given to students to help the teacher
modify his existing ideas based on new information, 2) Moral/ Ethical/ Reasoning/ Dilemma
Scenarios, to strengthen the relevance of the lesson and emphasize the relationship between
society and technology (Loucks-Horsley et al., 2003), 3) Divergent and Creative Thinking
Activity, to emphasize the process of learning (Wei, 2009), and promote higher order thinking
skills in the classroom and, 4) Laboratory Component, to allow the teachers to become more
comfortable and knowledgeable about the new technology used in a microbiology and molecular
biology laboratory and stress the inquiry aspects of learning.
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Section A: Trainer Materials
Course Objectives
The National Science Education Standards envisioned change throughout the system. The
science content standards encompass the following changes in emphases and were kept in mind
as this course was developed (National Science Foundation, 2009).
LESS EMPHASIS ON

MORE EMPHASIS ON

Knowing scientific facts and information

Understanding scientific concepts and
developing abilities of inquiry

Studying subject matter disciplines

Learning subject matter disciplines in the

(physical, life, earth sciences) for their own context of inquiry, technology, science in
sake

personal and social perspectives, and history and
nature of science

Separating science knowledge and science

Integrating all aspects of science content

process
Covering many science topics

Studying a few fundamental science concepts

Implementing inquiry as a set of processes

Implementing inquiry as instructional strategies,
abilities, and ideas to be learned

Activities that demonstrate and verify

Activities that investigate and analyze science

science content

questions

Investigations confined to one class period

Investigations over extended periods of time

Process skills out of context

Process skills in context

Emphasis on individual process skills such Using multiple process skills—manipulation,
as observation or inference

cognitive, procedural
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Getting an answer

Using evidence and strategies for developing or
revising an explanation

Science as exploration and experiment

Science as argument and explanation

Providing answers to questions about

Communicating science explanations

science content
Individuals and groups of students analyzing Groups of students often analyzing and
and synthesizing data without defending a

synthesizing data after defending conclusions

conclusion
Doing few investigations in order to leave

Doing more investigations in order to develop

time to cover large amounts of content

understanding, ability, values of inquiry and
knowledge of science content

Concluding inquiries with the result of the

Applying the results of experiments to scientific

experiment

arguments and explanations

Management of materials and equipment

Management of ideas and information

Private communication of student ideas and Public communication of student ideas and work
conclusions to teacher

to classmates
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10-Day Time Table
Enveloped viruses – how having an

Day 1
General Molecular Biology –

envelope affects characteristics

Learning from the virus world

Complex virus structures –

Historical perspective - Science as a

antireceptors, matrix proteins

Process

Genome diversity

The Central Dogma of Molecular

Single stranded and double stranded

Biology: Overview of Replication,

RNA and DNA

Transcription and Translation

Overview of viral replication,

Expression of genetic information,

replication cycle, replication patterns

Transcriptional control of expression

Protein – nucleic acid interactions

Posttranscriptional control of

and genome packaging

expression

Day 3

Day 2

General Immunology – Systems,
General Virology

Order and Organization

Model Viruses: Herpes (DNA) and

How to use bacteria and viruses to

Influenza (RNA)

teach immunology

Components of a virus –

Immune response to virus infection

Relationship of Structure and

in host cells

Function

Immune response to bacterial

Capsid symmetry, variations,

infection in host cells

relationship to genome size and

Apoptosis

diversity
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Interferons – Regulation and

Basic principles

Communication

Culture media and cell culturing.

Day 4

Microscopy
Evolution and Diversity

Good practices in the micro lab

The course of virus infections

Practice in a micro and molecular lab

Virus vectors

Equipping a microbiology lab.

The ecology of viruses and their

What is practical to do in a high

hosts

school laboratory classroom?

Zoonosis

Experiments and activities you can
do in your lab

Day 5
Evolution

Day 7

Virus evasion of host immune

Application and Comprehension

system

Activities – Science as a Process

Virus-host interactions

Why use case studies?

Pathogenesis

How to develop them, what are the

Cellular injury

components?

Viruses and immunodeficiency

Bioterrorism – Science, Technology

Viruses and cancer

and Society

Interesting and relative diseases –

New and emerging viruses

relative issues to students.

Vaccinations – Past, present and
future

Day 6
Past, present and future of a

Viruses for gene delivery

molecular biology lab.

Viruses to destroy other viruses
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Viruses and nanotechnology

Day 9
Wrap it Up – So, What Does the

Day 8
Writing a Case Study for your

Secondary Life Science Teachers

classroom

Need to Know About Micro and

Why use case studies? Science as a

Molecular Biology in the Year 2010

Process

and Beyond?

How to develop them, what are the

―
Don’t give me more, tell me what to

components?

replace!‖

Writing a Case Study for your

Review of all the THEMES in this

classroom using examples in

course

Technology and Society

Compiling and evaluating a personal

How to assess the learning outcomes

course binder, to be used in your

when using case studies.

classroom (part of your grade)
Day 10

How to assess your case study before
giving it to students.

Sharing case studies by presentation

Bioterrorism – Science, Technology

(each teacher will need to prepare

and Society

enough copies for all the other

New and emerging viruses

teachers in the class as part of your

Vaccinations – Past, present and

grade)

future

Personal evaluation of your case

Viruses for gene delivery

study (part of participant’s grade)

Viruses to destroy other viruses

Final Exam

Viruses and nanotechnology

Course evaluation
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Promoting Higher Order Thinking Skills
To allow in-service teachers to learn as much as possible in the ten day period about virology,
molecular biology and immunology while modeling good pedagogical techniques to scientific
inquiry, the following 18 methods of presenting and discussing these concepts should be used
with specific examples and identified as such for teachers (A working definition of the method is
indicated in parentheses). A list of alternative assessment products that encourage higher order
thinking skills can be found in Appendix: Possible Assessment Products.
1. PARADOXES: (Common notion not necessarily true in fact. Self-contradictory statement
or observation.
2. ATTRIBUTES: Inherent properties. Conventional symbols or identities. Ascribing qualities
3. ANALOGIES: Situations of likeness. Similarities between things. Comparing one thing to
another.
4. DISCREPANCIES: Gaps of limitations in knowledge. Missing links in information. What
is not known.
5. PROVOCATIVE QUESTIONS: Inquiry to bring forth meaning. Incite knowledge
exploration. Summons to discovering new knowledge.
6. EXAMPLES OF CHANGE: Demonstrate the dynamics of things. Provide opportunities
for making alterations, modifications, or substitutions.
7. EXAMPLES OF HABIT: Effects of habit-bound thinking. Building sensitivity against
rigidity in ideas and well-tried ways.
8. ORGANIZED RANDOM SEARCH: Use familiar structure to go at random to build
another structure. An example from which new approaches occur at random.
9. SKILLS OF SEARCH: Search for ways something has been done before (historical
search). Search for the current status of something (descriptive search). Set up an
experimental situation and search for what happens (experimental search).
10. TOLERANCE FOR AMBIGUITY: Provide situations which puzzle, intrigue, or
challenge thinking. Pose open-ended situations which do not force closure.
11. INTUITIVE EXPRESSION: Feel about things through all the senses. Skill of expressing
emotion. Be sensitive to inward hunches or nudges.
12. ADJUSTMENT TO DEVELOPMENT: Learn from mistakes or failures. Develop from
rather than adjust to something. Develop many options or possibilities.
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13. STUDY CREATIVE PEOPLE AND PROCESS: Analyze traits of eminently creative
people. Study processes which lead to problem solving, invention, incubation, and insight.
14. EVALUATE SITUATIONS: Decide upon possibilities by their consequences and
implications.
15. CREATIVE READING SKILL: Develop a mind-set for using information that is read.
Learn the skill of generating ideas by reading.
16. CREATIVE LISTENING SKILL: Learn the skill of generating ideas by listening. Listen
for information allowing one thing to lead to another.
17. CREATIVE WRITING SKILL: Learn the skill of communicating ideas in writing. Learn
the skill of generating ideas through writing.
18. VISUALIZATION SKILL: Express ideas in visual forms. Illustrate thoughts and feelings.
Describe experiences through illustrations.
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First Day Pre-Assessment
NOTE TO TRAINER: It is important that you review the unifying themes in biology and
connect with the content of this curriculum. To assess the teachers’ knowledge and discover the
level of understanding, the following activity should be used at the beginning of the course.
Enlarge the form below and provide one for each teacher. Ask the teachers to work in small
groups and discuss specific biological concepts and examples, writing them in boxes that would
be relevant to the branch of microbiology listed in the left column and overarching biological
theme along the top row. The ideas should be recorded, presented in the large group, in
preparation for further instruction. This activity will allow the trainer to assess the current
understandings of virology, immunology and molecular biology and may be used as both a pre
and post assessment for the course.
Systems,
Order, and
Organization

Change,
Constancy and
Measurement

Virology

Molecular
Biology

Immunology

Pathogenesis
and Society

105

Evidence,
Models and
Explanation

Evolution
and
Equilibrium

Form
Fits
Function

Unit 1: Virology
Learning Objectives:
A virus is an infectious organism that reproduces within the cells of an infected host.
A virus is not alive until it enters the cells of a living plant or animal.
A virus contains genetic information wrapped in a protein coat.
Viruses can be useful as well as harmful.
A virus that mutates ensures its own survival by making itself unrecognizable to immune
systems and vaccines.
Even viruses engineered for useful purposes can be harmful if unchecked.
Essential Prior Knowledge:
It is not expected that teachers will be very familiar with the study of viruses with the
exception of the typical bacteriophage that is introduced in the high school text book. This unit
will begin with the basics and move as far as possible within the time constraint of three day.
Trainer Preparation Notes:
The following basics should be explained, discussed and informally assessed the first day of
training.
Basic Virology - Components of a virus – Structure for Function
Capsid symmetry, variations, relationship to genome size and diversity
Enveloped viruses – how having an envelope affects characteristics
Complex virus structures – antireceptors, matrix proteins
Genome diversity
Single stranded and double stranded
RNA and DNA
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Overview of viral replication, replication cycle, replication patterns
Protein – nucleic acid interactions and genome packaging.
Essential Questions:
How have microscopes changed the way we picture microbes?
What kinds of organisms do scientists study with a microscope?
How do scientists study and use viruses in the laboratory?
How do viruses replicate in host cells?
How do microbes evolve, where did they come from?
Core Concepts:
The Nature of Viruses
Size, comparison of structures
Genomes, size, structure, modification at the ends of virus genomes
Virus proteins
Virus capsids and envelopes
Discussion of living or nonliving
Replication models
Transcription and translation models
Characteristics of the proteins and nucleic acids of viruses and the interactions between these
molecules and molecules of host cells.
Some viruses are useful
Phage typing of bacteria
Vaccines
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Sources of enzymes such as reverse transcriptase from retroviruses and RNA polymerases
from phages
Pesticides, such as baculovirus and myxoma virus
Gene vectors for protein production
Gene vectors for treatment of genetic disease
Virus studies contribute to knowledge of molecular biology, cell biology and cancer
Hershey and Chase, 1952, T2 and E. coli
First enhancers characterized in genes of simian virus 40
First transcription factor to be characterized, T antigen of SV40
First nuclear localization signal of protein identified in the T antigen of SV40
Introns discovered during studies of adenovirus transcription
Role of the cap structure at the 5’ end of mRNA discovered in studies with vaccinia virus and
reovirus
First internal ribosomal entry site discovered in the RNA of poliovirus
First RNA pseudoknot discovered in genome of turnip yellow mosaic virus.
Virus attachment and entry into cells
Cell receptors and co-receptors
Virus attachment sites
Enveloped vs. naked viruses
Intracellular transport
Genome uncoating
Virus transcription, translation and transport
Intro to transcription, translation and transport
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The four main categories of virus genomes and their distinct modes of transcription
Transcription – A Comparison with eukaryotic cells (promoters, enhancers, transcription
factors, transcriptase, capping transcripts, polyadenylation of transcripts, splicing)
Translation – A comparison with eukaryotic cells (ORF, initiation and translation, bicistronic
mRNAs, co and post translational modifications
Transport within and between cells
Virus genome replication
Virus enzymes and cell enzymes (DdDp, RdRp, RdDp)
Locations of virus genome replication
Initiation of genome replication
Types of genome replication (dsRNA, ssRNA, dsDNA, ssDNA, reverse transcription
Virus assembly and exit from cells
Nucleocapsid assembly
Formation of viral membrane proteins and virus envelope
Exiting the host cell – immune responses can be picked up here
Origins and evolution of viruses
Possible virus origins
New viruses may evolve as a result of viruses infecting new host species (HIV)
Mechanisms of virus evolution (mutations, recombination, reassortment, acquisition of cell
genes)
Co-evolution of viruses and their hosts
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Anticipatory Set:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Comprehension and Application Activities:
Case Study: A Case Study Involving Influenza and the Influenza Vaccine by John Bennett,
Carroll College. This case study presents a discussion about the benefits of the influenza vaccine
between Mary, a nursing student, and her coworker, Karen. Karen is not convinced by Mary’s
arguments in favor of vaccination, and she counters with several common rationalizations for not
getting the vaccine. Students work in small groups to evaluate the arguments for and against
vaccination from the perspective of each woman. In addressing the questions associated with the
case, students learn about the general biology of viral infections, treatment of infections, and
immunity.
Interactive Notebook/Journal Write:
The success of some viruses lies in their ability to evolve within the host. Such a virus evades the
host’s defenses by rapidly mutating and producing many altered progeny viruses before the body
can mount an attack. Thus, the viruses present late in infection differ from those that initially
infected the body. Discuss this as an example of evolution in microcosm. Which viral lineages
tend to survive and how do they survive?
Assessment:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
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Resources:
Virology: Principles and Applications by John Carter and Venetia Saunders, Wiley
Publisher, 2007 ISBN:978-0-470-02387.
How Pathogenic Viruses Work by Lauren Sompayrac, Jones and Bartlett Publishers, 2002
ISBN: 0-7637-2082-8.
http://www.biologyteacher.uconn.edu/teachers.html - From DNA to Organism: A Study in
DNA Function for the High School Biology Classroom.
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Unit 2: Molecular Biology/Microbiology
Learning Objectives:
To understand the structure of proteins, their purification and properties and introduces the
teachers to enzyme kinetics.
Discuss the practical aspects of using important tools of biochemistry such as gel
electrophoresis, ways to purify proteins, the use of radioisotopes and techniques for studying
cell membranes.
To understand the fundamentals of prokaryotic biology that lie at the heart of modern
molecular techniques.
To describe the prokaryotic structure and function including bacterial growth, differences
between Gram-positive and Gram-negative bacteria, mechanisms of action of antibiotics and
antibiotic resistance.
To apply the concepts of gene regulation and protein synthesis including positive and
negative regulation of transcription to specific examples: the lac, arabinos, and tryp operons.
To discuss gene transfer in bacteria including conjugation in Gram-positive and Gramnegative bacteria.
To explain transformation including natural competence in bacteria and artificial competence
(i.e. technological transfer systems).
To explain transduction including specialized vs. general transduction, bacteriophage
genetics.
Restriction and modification systems including different types of restriction enzymes (class I,
II and III).
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In all cases emphasis will be on both the basic science behind these phenomena, and how
they are exploited in modern research strategies.
Essential Prior Knowledge:
Historical perspective - Science as a Process
Central Dogma of Molecular Biology - Overview of Replication, Transcription and
Translation
Expression of genetic information,
Transcriptional control of expression
Posttranscriptional control of expression
Trainer Preparation Notes/ Essential Questions/Core Concepts – Two possible lessons
1. This first lesson will meet Standard II: Students will understand that all organisms are
composed of one or more cells that are made of molecules, come from preexisting cells, and
perform life functions (from the Utah State Department of Education).
Somatic cell cloning – how it is done, why it is done, who does it.
What information will be discussed as a result of teaching about cloning?
Nucleus and components
Mammalian egg structure
Somatic vs. germ cells
Cell membrane structure
Chromatin structure, DNA wrapping, cellular controls to RNA transcription
Hormonal regulation
WHY? Real life examples help students’ awareness, interest and understanding.
2. This second lesson to meet Standard IV: Students will understand that genetic information
coded in DNA is passed from parents to offspring by sexual and asexual reproduction.
Chromosome Smears – how it is done, why it is done, who does it.
What information will be discussed as a result of doing chromosome smears?
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Cell and particularly nuclear structure
Cell cycle, particularly components of mitosis
DNA structure, packaging, different formations
Genes on DNA, location, markers
Karyotyping
Genetic Counseling
WHY? Doing this activity is fun, we photograph the smears and print them, students do a
karyotyping activity.
Other Core Concepts:
Maintenance of the Genome
DNA as genetic material – evidence
Chromosomes, chromatin and nucleosome
DNA mutability, proofreading and repair
DNA replication, base pairing, models of, assisting proteins, recombination
DNA replication in prokaryotes
DNA structural model, scientific process of building
Ends of the DNA molecules
RNA structure
Site-Specific recombination and transposition of DNA
Expression of the Genome
Mechanisms of Transcription
RNA splicing
Translation
The Genetic Code
Regulation
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Gene regulation in Prokaryotes
Gene regulation in Eukaryotes
Gene regulation during Development
Comparative genomics and evolution of animal diversity
Molecular Methods
Nucleic acids – electrophoresis, restriction enzymes, DNA hybridization, DNA cloning,
plasmid vectors, DNA libraries, PCR, Forensics
Proteins – purification, column chromatography, affinity chromatography, Polyacrylamide
gels, antibody use for visualization, proteomics
Why do Scientist use these Model Organisms?
Bacteriophage
Bacteria
Saccharomyces cervisiae
Caenorhabditis elegans
Drosophila melanogaster
Mus musculus
Transforming Bacterial Host Cells
Transformation is a process through which bacteria can take up DNA from outside
themselves. Its most famous use was the Griffith experiment that demonstrated the
heritability of traits even from dead bacteria. (review this experiment)
Discuss how to transform specially prepared competent E. coli. The E. coli will then replicate
the plasmid for us, expressing a protein from a gene inserted into the plasmid. Bacteria that
take up the plasmid are selected using the ampicillin resistance gene that is also on the
115

plasmid. Only ligated plasmids will function in the bacteria and allow for antibiotic
resistance.
Discuss the two primary methods of getting cells to take up plasmids. Chemically competent
cells will take them up after heat shock. Electroporation can also be used to punch tiny holes
in the bacterial cell wall and drive in the DNA.
Bacteriology – Overview of a Few Representative Pathogens
For each of these, discuss their life cycle, general mechanisms for evasion of the immune system,
spread, symptoms and treatments
Staphylococcus
Streptococcus pneumonia
Yersinia pestis
Yeast - Candida albicans
Molds - Aspergillus
Intestinal protozoa – Giardia, Cryptospiridium parvum, Entamoeba histolytica
Malaria - Plasmodium falciparum
Leishmania – Tropicana, brasiliensis, Donavani
Gut helminthes – Ascaris lumbricoides
Anticipatory Set:
Read article: ―
The Ivory Trail‖. The illegal slaughter of African elephants for ivory is now
worse than it was at its peak in the 1980s. New forensic tools based on DNA analysis can help
stop the cartels behind this bloody trade (Scientific American, July 2009). After reading the
article, discuss how molecular biology tools are at work in a variety of settings.
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Do You Really Know What
Case Study: Introduce and discuss the following case study, ―
You’re Eating? A Case Study on Genetically Modified Foods‖ by Wayne Shew, BirminghamSouthern College, and Mary Celeste Reese, Mississippi State University. Starting from a
fictional ―ne
ws‖ report about an apparent allergic reaction to a taco tainted by genetically
modified corn, students consider some of the techniques and procedures used in modern
molecular genetics and microbiology as well as some of the issues associated with genetically
modified organisms (GMOs). Originally designed for role-play and PowerPoint assignments,
suggestions for a shortened version are also provided. Suitable for a general microbiology
course, the case could also be used in an introductory molecular biology course with appropriate
modifications. Various levels of coverage of the topic of recombinant DNA are possible.
Comprehension and Application Activities:
Case Study: Tazswana’s Story: How Alternative mRNA Splicing Leads to Genetic Disease and
Cure by S. Catherine Silver Key, North Carolina Central University. While students easily grasp
the concepts of gene mutation, their effect on protein function, and their association with disease
states, the concept of RNA processing is often foreign and less easily understood. In this directed
case study, students read about a little girl with β-thalassemia, a life-threatening disease. Through
a series of increasingly complex activities, they learn how alternative pre-mRNA processing
(splicing) has caused her disease and how gene therapy that targets the process may provide a
cure.
Case Study: ―
SNPs and snails and puppy dog tails, and that’s what people are made of ...‖A
Case Study on Genome Privacy by Debby Walser-Kuntz, Sarah Deel, and Susan Singer,
Carleton College. In this case on genome privacy, students work together to research one of six
assigned lobbying groups’ views in this area and then present their groups’ position before a
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mock meeting of a U.S. House of Representatives Subcommittee as they consider voting on the
Genetic Information Nondiscrimination Act. In working through the case, students learn about
single nucleotide polymorphisms (SNPs), common molecular biology techniques, and current
legislation governing genome privacy. The case was developed for use in an introductory
biology course entitled ―
Genes, Evolution, and Development.‖
Case Study: Chimpanzee Droppings Lead Scientists to Evolutionary Discovery by Erica F.
Kosal, North Carolina Wesleyan College. This case study focuses on the research of Dr. Beatrice
Hahn, who investigates DNA sequences in chimpanzee droppings in order to explore the origins
of the human immunodeficiency virus (HIV). Students first consider the types of data that can be
gained through collecting chimpanzee feces and studying the behavior of these animals. Students
then apply this information to learn more about microevolution when they compare DNA
sequences. Finally, students learn about ELISA tests and consider the role of basic and applied
science.
Interactive Notebook/Journal Write:
1. A biologist inserts a gene from a human liver cell into the chromosome of a bacterium. The
bacterium then transcribes and translates this gene. The protein produced is useless and is
found to contain many more amino acids than does the protein made by the eukarytotic cell.
Explain why.
2. A plant biologist observed a peculiar pattern when a tropical shrub was attacked by
caterpillars. After a caterpillar ate a leaf, it would skip over nearby leaves and attack a leaf
some distance away. The researcher found that when a leaf was eaten, nearby leaves started
making a chemical that deterred caterpillars. The biologist suspected that a damaged leaf sent
out a chemical that signaled other leaves. How could the researcher test this hypothesis?
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Assessment:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Resources:
Medical Microbiology and Infection at a Glance by Stephen Gillespie and Kathleen
Bamford, Blackwell Publishing, 2007 ISBN: 1-4051-5255-9
The Microbiology Coloring Book by I. Edward Alcamo and Lawrence M. Elson, Harper
Collins College Publishers, 1996 ICBN:0-06-500941-X
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Unit 3: Immunology
Learning Objectives:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Essential Prior Knowledge:
This unit is intended to be taught to high school biology teachers, who will already have a
very good understanding of the following: basic cell structure, prokaryote and eukaryote cell
organization, organelles of eukaryotic cell, cytoskeleton role and components, extracellular
components and connections, eukaryotic cell membrane structure, transport, basics of cellsignaling, basic definitions of innate and adaptive, humoral and cell-mediated immunity, reason
behind blood types and familiar with diseases from bacteria, viral and fungal pathogens. The
trainer will be able to assess the breadth and depth of the teachers’ understandings of these
subjects and immunology from the anticipatory set activity.
Trainer Preparation Notes:
The following is an overview of basic concepts that will need to be discussed in class
followed by narrative that may be used in the presentation. A typical high school level biology
textbook should be used for teachers to read, add to and begin drawing connections from the
immunological concepts to other biological concepts found throughout the chapters of the text.
General features of innate immunity: phagocytosis, target cell lysis, inflammation
General features of adaptive immunity: specificity, division of labor, memory, diversity,
tolerance.
Interplay between the innate and adaptive responses
Cellular Components of the immune system
120

Leukocyte communication
The complement
Antigen recognition and receptors
Immune cell surface and signaling molecules
Closer look at T cells- development, sub-populations, memory, receptors
Closer look at B cells and their development, differentiation, expansion and memory
Antibodies – structure and function
A closer look at Natural Killer cells
A closer look at dendritic cells
Apoptosis
The Prokaryote – general structures and their functions, the immune defenses, the host
response, model organisms (Staphylococcus, Pseudomonas)
Fungi and ectoparasites – general structures and their functions, the immune defenses, the
host response, model organisms (Chalmydia, Rickettsia)
Viruses – general structures and their functions, the immune defenses, the host response,
model organisms (Herpesviruses, Influenza) [More in-depth material is found in Unit 2:
Molecular Biology and Virology]
What happens when thing go wrong in the immune system?
Technology in research and medicine- Hemagllutination, ELISA, Immunoblotting,
Immunofluorescence, and Flow cytometry
Essential Questions/Core Concepts –A possible lesson that meets Standard I: Students will
understand that living organisms interact with one another and their environment.
Case Study: ―Boy with fever and rash‖
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DISCUSSION POINTS: Symptoms, diagnosis (PCR – detects DNA of the spirochete), infecting
organism, transmission of disease (arthropod), other diseases with same mode of transmission,
host response to infecting organism, organism’s response to host defense system, environmental
conditions, treating the disease – how and why is it necessary?
In early June a 15-year old boy comes to your practice with his mother. He had been fine
until about five days ago when he developed a fever. He has a stiff neck and a rash on his back.
He and his family live in Connecticut near the New York State border. His mother reports that he
was playing in the woods with some friends recently.
Begin with this story:
Cows, Beer, and Beyond
―
Gradually, through a series of discoveries over hundreds of years, scientists have
learned about the way the immune system works and how to safely harness its
protective power. One of the most signiﬁcant advances in immunology—the creation
of the ﬁrst vaccine, in 1796—resulted from the effort to protect people against
smallpox, a disﬁguring viral scourge throughout history (and one that has recently
risen again as a bioterrorism threat). Over the centuries, people around the world
tried to protect themselves against smallpox by exposing themselves to the actual
disease (a method known technically as inoculation). An early Chinese emperor, for
example, inhaled dried smallpox scabs in an effort to inoculate himself. George
Washington inoculated his troops against smallpox during the Revolutionary War by
introducing the virus into the skin, then keeping troops in isolation until they were no
longer contagious. But these early inoculation efforts, which involved exposure to the
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unaltered—and therefore quite virulent—smallpox virus itself, killed some people
and made others extremely ill.
The world’s ﬁrst vaccine, developed for smallpox, relied on a similar strategy but
provided a much safer alternative. The road to discovery began in the late 1700s,
when Edward Jenner, a country doctor, sought to explain why milkmaids and other
farmhands exposed to cowpox, a relatively mild disease, did not come down with
smallpox. To test the theory that cowpox exposure somehow bolstered a person’s
defenses against smallpox, Jenner took pus from a milkmaid infected with cowpox
and injected it into a healthy eight-year-old boy. Jenner then exposed the child to
smallpox, but the child never succumbed. After several additional experiments,
Jenner proved that it was possible to prevent an infectious disease with a vaccine—a
word derived from the Latin word vacca, or cow—derived from a substance that was
similar but not identical to the real culprit.
Although Jenner’s discovery represented a signiﬁcant advance, it took many
more years before scientists began to understand how diseases occur and to recognize
clues that, in the late nineteenth and early twentieth centuries would reveal why
vaccines confer protection‖(The Dana Foundation, 2008).
Historical Perspective
Edward JENNER 1749-1823, credited as a pioneer of smallpox vaccine and sometimes
referred to as the ―
Father of Immunology‖.
Ignaz Philipp SEMMELWEIS, 1818-1865, Also known as the ―
savior of mothers‖ because
he discovered that the incidence of childbed fever could be drastically cut by use of hand
washing standards in obstetrical clinics.
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Louis PASTEUR 1822-1895, the germ theory of disease.
Robert KOCH 1843-1910, Isolated Bacillus anthracis, Tuberculosis bacillus, and Vibrio
cholera for his development of Koch’s Postulates, awarded the Nobel Prize in Physiology or
Medicine for his tuberculosis findings.
Eli METCHNIKOFF 1845-1916, Russian zoologist and microbiologist who received (with
Paul Ehrlich) the 1908 Nobel Prize for Physiology or Medicine for his discovery in animals
of amoeba-like cells that engulf foreign bodies such as bacteria—a phenomenon known as
phagocytosis and a fundamental part of the immune response.
Paul EHRLICH 1854-1915, theory that the germicidal capability of a molecule depended
on its structure, particularly its side-chains, which could bind to the disease-causing organism
(among many other things pertaining to staining and a most successful product of this quest,
Salvarsan—dihydroxydiaminoarsenobenzenedihydrochloride—and Neosalvarsan, the most
effective drugs for treating syphilis until the advent of antibiotics in the 1940s.
Theobold SMITH 1859-1934, pioneering epidemiologist and pathologist and is widelyconsidered to be America's first internationally-significant medical research scientist
Clemens Von PIRQUET 1874-1929, in 1906 he noticed that patients who had previously
received injections of horse serum or smallpox vaccine had quicker, more severe reactions to
a second injection. He, along with Bela Schick, coined the word allergy (from the Greek allos
meaning "other" and ergon meaning "reaction") to describe this hypersensitivity reaction.
John Berdon Sanderson HALDANE 1892 – 1964, Host-Pathogen interaction, one of the
most important factors in evolution.
Immunology Basics
General mechanisms of innate and adaptive immune system
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Recognition and receptors – the keys to immunity
Evolution of immune mechanisms
Cells involved in immunity, the hematopoietic system
Innate immunity
Receptors of the innate system
Complement
Acute inflammation
Phagocytic cells and phagocytosis
Adaptive immunity
The molecular basis – immunoglobulins, MHC, T-cell receptor, antibody structure and
function
The cellular basis – lymphocytes, lymphoid organs
The adaptive response – antigen processing and presentation, antibody response, antigenantibody interaction and complexes, cell-mediated immune response
Regulation – tolerance, cytokine network
V(D)J recombination – molecular biology: genes can change in somatic cells!
Potential useful immunity
Antimicrobial immunity – the general scheme
Immunity to viruses (herpesviruses, influenza, mumps and measles, polio, hepatitis,
retroviruses)
Immunity to bacteria (streptococcus, staphylococcus, mycobacteria, salmonella, tetanus)
Immunity to fungi (Candida albicans, Cryptococcus, Aspergillus)
Immunity to protozoa (malaria, Leishmania, Entamoeba histolytica, Giardia)
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Undesirable effects of immunity
Harmful immunity – overview
Allergies and anaphylaxis
Immune complexes, complement and disease – rheumatoid arthritis
Chronic and cell-mediated inflammation - granulomas, Crohn’s Disease, Chronic
Granulomatous Disease
Autoimmunity – Diabetes, Rheumatoid arthritis, Systemic lupus
Immunodeficiency – SCID, DiGeorge syndrome, Agammaglobulinemia
HIV and AIDS
Vaccinations and immuno-stimulation – passive, active
Antibacterial agents
Anticancer agents being investigated
Outcomes of infection
Abortive, latent to persistent, productive to persistent or apoptosis
Innate immunity response, Adaptive immunity
Anticipatory Set:
In a high school biology class, students are circulating the room, test tubes of clear liquid in
hand. At a nod from their teacher, they exchange the contents of their test tubes with as many
other students as they wish. Three minutes later, when the teacher stops them, she reveals that
while all the test tubes looked identical, one originally contained an "infectious agent."
Distributing a chemical that signals the presence of the agent by turning dark, she invites the
students to test the liquids now in their test tubes. With a unanimous shudder of dismay, they
watch more than half of their test tubes test "positive."The "infectious agent" is "fake"—diluted
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horseradish—but the underlying scientific principles are incontrovertibly real, as is the ensuing
discussion on HIV and other infectious diseases. (From the Third Faculty of Medicine: Charles
University, http://www.lf3.cuni.cz/en/studium/magisterske/studijni-programy/i-cyklus/1rocnik/modul-1b/CCBGMI21.html).
Comprehension and Application Activities:
Materials:
♦ 4 groups of students
♦ 4 index cards
♦ 4 transparencies and markers
Procedure:
1. The class will be divided up into four groups, with one person being responsible for writing,
and one person responsible for speaking.
2. One index card will be distributed to each group that describes the scenario that they are
responsible for working on.
3. The job of each group is to place themselves in a particular scenario and determine what
course of action they would take.
4. All possible options must be explored and written down, and actions must be justified. After
the groups have discussed their scenario and plan, the writer should write down the scenario they
were given and describe how they dealt with it.
5. Each of the four index cards will have one scenario.
Scenario I: You are home alone and it is 12:30 at night. Your parents are out of town and are not
expected back until the following day. You wake up from a deep sleep when you hear a loud
noise outside in the street. What are your options and which one would you be most likely to
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take? The sound is nonspecific, and could generate many different responses. The main point
that this should be used to illustrate is that the immune system has primary and secondary
defenses as well as specific and nonspecific defenses. This loud noise in the street could be a
potential danger (such as somebody who sitting next to you in class who is visibly sick), but, at
this point it probably will generate no significant response from the person in the house (your
immune system).
Scenario II: You are home alone and it is 12:30 at night. Your parents are out of town and are
not expected back until the following day. You are awakened from a sound sleep when you hear
a loud noise downstairs. What are your options and which one would you be most likely to take?
The sound is once again nonspecific, however, it would most likely generate a different response
from the one generated from scenario I. The possible responses are many and analogously could
be applied to a nonspecific secondary immune response. The potential danger is in the house
(body), and the person who was sleeping in the house could respond to this situation in several
different ways. The immune system has phagocytes and macrophages, which are leukocytes that
can provide nonspecific secondary defense against pathogens.
Scenario III: You are home alone and it is 12:30 at night. Your parents are out of town and are
not expected back until the following day. You wake up from a sound sleep when you hear a
window break downstairs. What are your options and which one would you most likely take?
This situation could generate several different responses, and these all should be explored and
and developed. This scenario, however, could be used to develop an understanding for an
inflammatory response generated from a foreign object penetrating the surface of the skin. The
broken window (Enfield) could cause the person sleeping (histamines) to call the police
(phagocytes) who will respond and remove the potential threat (pathogen/bacteria).
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Scenario IV: You are home alone and it is 12:30 at night. Your parents are out of town and are
not expected back until the following day. You wake from a sound sleep when you hear
somebody downstairs. What are your options and which one would you take? This situation
could also generate several different responses; however, these all can be used to generate an
understanding for specific secondary defense mechanisms in the immune system. The role of
pathogens, antigens, b lymphocytes, antibodies, t lymphocytes, and helper and suppressor t
lymphocytes should be developed and explained.
6. After each group has had approximately 10-15 minutes to work on the activity, each group is
asked to explain their scenario and the actions they decided to take as a result.
Input:
The class will be introduced to the new unit on immunology and asked to share what they
know about the immune system with the rest of the class. What does our immune system do?
The general ideas will be written down on the chalkboard as a word splash, and these
concepts will be related back to the stranger in the house scenario in order to define their
functions.
What are pathogens and how do they relate to diseases? Discuss Koch’s Postulates, viruses,
bacteria, protists, and fungi. How are pathogens transmitted? What are the means of detection
that the immune system utilizes and how can these factors be related back to the stranger in
the house scenario? How do antigens, antibodies, and B and T lymphocytes relate to this
system?
Closure: What is the difference between humoral and cell-mediated immunity and how do they
conceptually relate to the stranger in the house scenario?
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Interactive Notebook/Journal Write:
Case Study: Immunological Malfunction? by Karen A. Pinco, Westfield State College, MA
This problem-based case study was developed to complement the study of the immune system
and to emphasize the crosstalk that occurs at the cellular level between B and T cells for proper
immune system function. In reading the story of a young couple trying to understand the cause of
their infant boy’s constant bacterial infections, students will review the different classes of
antibodies, their specific functions, and how they arise through isotope switching.
Case Study: The Case of Baby Joe: Chronic Infections in an Infant by Kristen L.W. Walton,
University of North Carolina–Chapel Hill
This interrupted case study follows the declining health of an infant who suffers from recurrent
infections and finally is diagnosed with severe combined immunodeficiency (SCID). The case
was developed for use in an undergraduate upper-level immunology course to supplement
discussion of B and T cell development and the generation of antibody diversity. It could also be
modified for use in a genetics class, with emphasis on the molecular aspects of RAG-mediated
recombination and the inheritance patterns of the disease.
Assessment:
The post assessment may be the use of the questions below or creating a formal assessment
with multiple choice and essay questions. For this unit to be used with teachers, the concept grid/
themes/topics grid should be used. Teachers complete the table, placing immunological concepts
they are comfortable discussing in their classroom. This assessment will not only be useful for a
personal evaluation of their understanding but useful for their curriculum planning in their own
classroom.
How would a macrophage deficiency likely affect a person’s immune defenses?
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How do allergy medications work?
In myasthenia gravis, antibodies bind to and block acetylcholine receptors at neuromuscular
junctions, preventing muscle contractions. Explain the type of altered immunity that occurs.
Severely burned patients generally must receive numerous skin grafts. What is the advantage
of using skin from an unburned part of a patient’s own body?
What cells and functions would be deficient in a child born without a thymus?
What is the major difference in the types of antigens bound by B cell receptors and T cell
receptors?
One of the reasons for the success of invertebrates, which make up more than 90% of living
animal species, is their effective defense against microbes. Describe some mechanisms by
which invertebrates combat such invaders and discuss how thieve mechanisms comprise an
evolutionary adaptation that is retained in the vertebrate immune system.
Resources:
Immunology at a Glance by J.H.L Playfair and B.M. Chain, series of at a glance, 9th edition
Wiley-Blackwell, Oxford, 2009, 109 pages, ICBN: 978-1-4051-8052-8
Kuby Immunology by Thomas J Kindt, Richard A Goldsby, and Barbara A Osborne, W H
Freeman and Company, New York, 2007, 6th edition, 574 pages
Immunity: The Immune Response in Infectious and Inflammatory Disease, by Anthony L
DeFranco, Richard M Locksley, and Miranda Robertson
Series called: Primers in Biology, New Science Press Ltd. London, 2007, 387 pages
Primer to Immune Response by Tak W Mak and Mary E Saunders
Academic Press, San Diego, 2008, 436 pages
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Unit 4: Pathogenesis and Society
Learning Objectives:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Essential Prior Knowledge:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Trainer Preparation Notes:
This unit focuses on the strategies employed by pathogenic bacteria, fungi, and viruses to
subvert the human immune defenses and cause disease. Representative examples of intracellular
bacterial pathogens, extracellular bacteria pathogens, fungal pathogens, and viral pathogens are
discussed in detail. Other topics include epidemiology and disease, innate defenses and normal
flora, host/parasite interactions, and bacterial virulence factors.
Essential Questions:
To appreciate the relationship between microbes, the immune system, and disease outcomes.
To understand how the immune system functions in a specific and non-specific way, to
defend the host against infections by bacteria, fungi and viruses.
To recognize the structural components of microbes (bacteria, fungi and viruses) and how
these impact the pathogenesis of disease.
To know the common microorganisms associated with specific clinical diseases and what
factors are involved in pathogenesis.
To appreciate the role of vaccines in disease prevention.
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To appreciate the role of the clinical laboratory in diagnosis and management of infectious
diseases.
To develop the ability to correlate the clinical picture with laboratory information to establish
a diagnosis.
Core Concepts:
Emerging viruses
New host species (Bunyaviruses, Paramyxoviruses)
Viruses in new areas (West Nile virus)
Viruses in new hosts species in new areas (Ebola, Monkeypox)
New viruses (SARS, new strains of Influenza)
Recently discovered viruses (human metapneumovirus)
Re-emerging viruses (measles, mumps)
Bioterrorism
Viruses and cancer (cover at least two of these)
Kaposi’s sarcoma (Kaposi’s sarcoma associated herpesvirus)
Hepatocellular carcinoma (Hep B and Hep C)
Adult T cell leukemia (HTLV-1)
Burkitt’s lymphoma
Nasopharyngeal carcinoma (Epstein-Barr virus)
Anogenital carcinomas (HPV)
B-cell leukemia/lymphoma
Sarcoma (retroviruses)
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Anticipatory Set:
Discussion Point: The Vaccine Search Goes On. The unfinished quest for an AIDS vaccine has
become a search for new approaches to the problem (Scientific American, Nov 2008).
Discussion Point: Can HIV Be Cured? Eliminating HIV from the body would require flushing
the virus out of its hiding places and preventing those reservoirs from being refilled. A tall order
but perhaps not impossible (Scientific American, Nov 2008).
Comprehension and Application Activities:
Case Study: Between the Living and the Dead by Kari Mergenhagen, University at Buffalo
As Jen pores over her introductory biology textbook, she falls asleep and enters a nightmarish
world in which bacteria and viruses dwarf human beings. This engaging case explores the
differences between viruses and bacteria while teaching about the basic components and ―
life‖
cycle of a T-even bacteriophage. The case includes a follow-up assignment in which students
explore the risks and potential benefits of using bacteriophage to control bacterial disease.
Interactive Notebook/Journal Write:
Case Study: The Unfortunate Nurse: A Case Study of Dengue Fever and Social Policy by Karen
M. Aguirre, Coastal Carolina University, Conway, SC
Based on an actual incident in which dengue virus was transmitted by an accidental needle stick,
this case study introduces students to ―
emerging pathogens‖ and other concepts in parasitology,
immunology, epidemiology, public policy, and science writing. Students also read a primary
paper and learn about two modern techniques widely used in medical and research settings (i.e.,
EIA and Taqman RT-PCR).
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Assessment:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Resources:
Lewin, B. (2008) Genes IX, (Lewin, 2008).
Watson, J. D., Baker, T. A., Bell, S. P., Gann, A., Levine, M. & Losick, R. (2004) Molecular
Biology of the Gene, (San Francisco, Benjamin Cummings).

The Take-Away for Teachers
Teachers will leave the course with a compilation of relevant reading materials for students,
case studies, lists of websites, problem solving questions, inquiry activities and internet research
activities. They will also be aware of sources to check out materials for lab activities or facilities
that provide ―
in-house‖ experiences for high school biology classes. Each participant will be
responsible for locating a possible grant proposal from which they may begin building their own
classroom with micro and molecular materials to more fully allow the teacher to transfer what
they learn from this course into their classroom.

Evaluation of the Course
Evaluation of this course will include the teachers’ ability to use the information, case studies
and activities in their own classroom. This will be done in the following manner:
Each teacher will:
Prepare at least one comprehension/application activity over the two week period that will be
discussed in a group setting, re-worked and improved, if necessary, and shared with the other
teachers in the course, each teacher leaving the course with all the case studies developed.
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At the end of the school year following participation in this course, the participant (teacher)
will write a final paper that includes quantitative and qualitative documentation concerning
what they did in their class as a direct result of the summer in-service.

Summary
High school teachers play a vital role in the preparation of students for college science
courses. Through inquiry, content integration, epistemological pedagogy techniques, relevant
case studies, augmenting organizational tools and resources, and fostering interdependence
among professional scientists and educators, students most assuredly will be more successful in
science courses and approach science careers as a possibility. In this course, teachers are
encouraged to use examples from microbiology and molecular biology disciplines as they
discuss case studies, introduce inquiry activities and teach organizational skills, without
sacrificing content to meet state standards and core objectives. By fostering independent thinking
and encouraging students to actively work towards understanding the material, teachers prepare
students to approach the material rationally. Not only will these skills help our students be
successful in college, but will enhance their success in later life as well as provide the pathway
for lifelong learning.
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Section B: Teacher Materials
Unit 1: Virology
Worthy of Note:
A virus is a non-cellular particle that consists minimally of protein or nucleic acid (DNA or
RNA). Except for a few cases, viruses are not surrounded by a membrane. In order to survive, it
must replicate inside another cell, such as a bacterium or a plant and animal cell.
Depending on their host species, viruses are distinguished between plant viruses multiplying
almost exclusively within plant cells, bacterial viruses (bacteriophages) that depend on living
bacteria, and animal viruses. For the sake of discussion I will refer to animal viruses as "human
viruses."
Human viruses cannot grow in foods. Since viruses are very host-specific, a human virus will
rarely multiply even in foods that are still alive (like oysters). However, they can persist for a
long time.
The cell walls of plants are tough and plant viruses have no specific mechanism for entering
the host cell. Plant viruses depend therefore on a mechanical breach (injury) of the integrity of a
cell wall to directly introduce a virus particle into a cell or on transmission via invertebrates
(insects, nematodes, etc.). While bacterial and fungal diseases are common in sprouts, plant
virus diseases of sprouts are relatively rare. Infection is scarcely strong enough to kill the plant.
Food Safety Implication
Although human viruses don't grow on food, food serves as a transportation device to get
viruses from one host to another. Once the contaminated food is eaten, a virus can multiply in
living cells and cause foodborne illness in humans. Sprouts can become contaminated with
viruses in a number of ways, such as:
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A Production Worker - who handles seed or sprouts and is shedding (excreting the virus in
their stool). If the person practices poor hygiene, he or she may transfer the virus to sprouts
or other foods.
Contaminated Water - used to irrigate or wash sprouts.
Cross-Contamination - of sprouts by contaminated food.
Insects - can transport viruses as they move about.
Seeds - may transmit virus infection either due to external contamination of the seed with
virus particles, or due to infection of the living tissues of the embryo. The latter only occurs
in plant pathogens. Chlorine is ineffective as a sanitizer against viruses.
How It Causes Disease
A free virus particle may be thought of as a packaging device by which viral genetic material
can be introduced into appropriate host cells, which the virus can recognize by means of proteins
on its outermost surface. A bacterial virus generally infects the cell by attaching fibers of its
protein tail to a specific receptor site on the bacterial cell wall and then injecting the nucleic acid
into the host, leaving the empty capsid outside.
Within the cell the virus nucleic acid uses the host machinery to make copies of the viral
nucleic acid as well as enzymes needed by the virus and coats and enveloping proteins, the coat
proteins of the virus. Release of virus particles from the host may occur by lysis of the host cell,
as in bacteria, or by budding from the host cell's surface that provides the envelope of
membrane-enveloped forms.
More simply put, viruses cause disease in humans by tricking healthy cells into duplicating
the virus's nucleic acid instead of its own, which lets the virus multiply. Once the virus is
duplicated, the healthy cell usually dies.
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A retrovirus (HIV) is thought to cause AIDS, several viruses cause particular forms of cancer
in humans, and many have been shown to cause tumors in animals. Other viruses that infect
humans cause measles, mumps, smallpox, yellow fever, rabies, influenza, and the common cold.
Some Examples of Human Viruses:
Influenza (causes the flu)
HIV (causes AIDS)
Polio (causes poliomyelitis)
Rhinovirus (causes colds)
Rubella (causes German measles)
Some Examples of Foodborne Human Viruses:
Norwalk Virus and other Norwalk-like viruses
Hepatitis A
Rotavirus (mainly affects young children)
Some Examples of Plant Viruses:
Mosaic virus
Mottle virus
Ringspot virus
What’s the difference between viruses and bacteria?
The differences between viruses and bacteria are numerous. Viruses are the smallest and
simplest life form known. They are 10 to 100 times smaller than bacteria. The biggest difference
between viruses and bacteria is that viruses are parasites, so they must have a living host - like a
plant or animal - to multiply, while most bacteria can grow on non-living surfaces.
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Also, unlike bacteria, which attack the body like soldiers mounting a pitched battle, viruses
are guerilla fighters. They don’t attack so much as infiltrate. They literally invade human cells
and turn the cell’s genetic material from its normal function to producing the virus itself. In
addition, bacteria carry all the machinery needed for their growth and multiplication, while
viruses carry mainly information - for example, DNA or RNA, packaged in a protein and/or
membranous coat. Viruses harness the host cell’s machinery to reproduce. In a sense, viruses are
not truly ―
living," but are essentially information (DNA or RNA) that float around until they
encounter a suitable living host.
Which sprouts are especially ―friendly‖ to viruses?
Sprouts that are grown in uncompensated manure or unsanitary soil.
Sprouts irrigated with contaminated water.
Sprouts harvested by production workers with poor hygiene practices.
The complex, multi-layered surfaces of sprouts are more difficult to clean than, for example,
the surface of an apple or potato. Finally, because many sprouts are eaten raw, there is no
heating step that would inactivate the viruses. (From International Specialty Supply website,
http://www.sproutnet.com/Reports/viruses.htm).
Moral/Ethical/Dilemma Scenario:
Case Study: Rabbit Calicivirus Disease: Magic Bullet or Pandora’s Box? A Case Study on
Biological Controls by Gary M. Fortier, Delaware Valley College
The characters in this dilemma case, representing the scientific community and government,
must make a decision about whether or not to release a virulent pathogen into the environment in
order to control the rapidly expanding population of European rabbits in New Zealand. As they
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work through the case, students grapple with the complex issues associated with introduced
species and biological controls.
Smallpox: To Be or Not to Be?
Smallpox disease was eliminated in 1979 after a worldwide effort to inoculate every man,
woman, and child on Earth. Two collections of frozen smallpox virus have been preserved, one
in Atlanta and the other in Moscow. Have students form discussion groups to talk about what
they would do with the two collections. Students should list the pros and cons of keeping the
smallpox virus in research laboratories, focusing on the ethics of eradicating life-forms that
threaten the human population. Students can continue their study by researching how the CDC
(Centers for Disease Control and Prevention) in Atlanta works to protect us from other viral
invaders. They might also create fictional stories or plays exploring possible consequences that
could result if smallpox should ever be reintroduced into society.
Divergent and Creative Thinking Activity:
Explain the way in which a virus is able to reproduce and cause disease in a host.
Explain how World War I contributed to the flu pandemic of 1914. If there were no war,
what probably would have happened to the flu strain? Give supporting statements to back
your explanation.
Compare and contrast the work of Edward Jenner to that of Jonas Salk. How can the
triumphs of these two virologists set an example for modern scientists researching new
threats?
How might viruses help cure genetic diseases?
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Describe two instances from the documentary in which disease was used as a weapon. How
effective were the weapons? Is this practice still in use today? What are some of the potential
consequences of using viruses in this manner?
How might the destruction of rain forests help spread new viral diseases?
Laboratory Component:
Microscopy Skills Observing cell samples on slides and in culture plates
Plaque formation
Syncytia
Fluorescent and confocal microscopy
Electron microscopy
Counting cells with a hemocytometer and calculating concentrations in cell suspension.
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Unit 2: Molecular Biology
Worthy of Note:
The genetic material is able to specify a large variety of proteins. The nature of the genetic
material was unknown for a long time. The cell is composed of lipids , carbohydrates , and
nucleic acids , which do not have a lot of variety, and proteins which do have a lot of variety. It
was thought for a long time that only proteins had enough diversity to give the orders to a cell to
make other proteins. Then it was suggested that the information to build protein could be carried
in a coded form. Such a coding mechanism could impart a lot of information with very simple
building blocks. Consider for example that a computer codes all information in sequences of O's
and 1's. With such simple coding, it is possible to display this text on the computer screen as well
as diagrams and photographs.
Both proteins and DNA satisfy the fundamental requirement of the genetic material, and both
are found in the chromosomes. Which one are genes made of?
Where does the genetic information reside? What gives a cell orders to make proteins? Several
teams of researchers worked hard to help us understand what carries the information.
Griffith, 1928 : the transforming principle is genetic material
Avery, McLeod, and McCarty, 1940 : the transforming principle is DNA
Hershey and Chase, 1952 : only DNA enters the cell
Moral/Ethical/Dilemma Scenario:
Case Study: Tazswana’s Story: How Alternative mRNA Splicing Leads to Genetic Disease and
Cure by S. Catherine Silver Key, Department of Biology, North Carolina Central University,
Durham, NC. While students easily grasp the concepts of gene mutation, their effect on protein
function, and their association with disease states, the concept of RNA processing is often
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foreign and less easily understood. In this directed case study, students read about a little girl
with β-thalassemia, a life-threatening disease. Through a series of increasingly complex
activities, they learn how alternative pre-mRNA processing (splicing) has caused her disease and
how gene therapy that targets the process may provide a cure. The case was developed for a
junior-level genetics course, but could be modified for use in a cell, molecular genetics, or
molecular biology course.
Divergent and Creative Thinking Activity:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Laboratory Component:
How to Extract DNA and the Purpose – Biotechnology Laboratory Exercises
From plant tissues
From animal tissues/cells
PCR and sequencing
A comparison of DNA extraction methods used in research labs as opposed to classroom
labs.
DNA precipitation
Washing and Resuspension
Basic protocols
Amplifying DNA by PCR
Checking for quality using electrophoresis
Analyzing DNA samples in a classroom lab
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Possible laboratory exercises:
Laboratory One: Safety, laboratory equipment and introduction to pipetting
Description: Designed as a hands-on training session that introduces all students to the
equipment in a modern Molecular Biology. Future labs build upon this initial training, such that
teachers (will refer to as a student from this point on in the laboratory components) from diverse
educational backgrounds start with a level playing field. Each student practices using three single
channel, and two multi-channel pipettors (one manual and one electronic). Each student also
receives instruction using basic laboratory equipment such as micro-centrifuges, centrifuges, a
balance and programming a PCR machine.
Learning Objective: Students are given a first iteration of hands-on use of common molecular
biology laboratory equipment. The procedures are designed to give the instructor the maximum
amount of time to identify those students who need immediate, one on one instruction.
Laboratory Two: Collection of samples, extraction of genomic DNA and polymerase chain
reaction setup
Description: Students are taken outside and encouraged to select plants from a region of
campus that has several different plants. In addition, each student is required to draw the area
from which they took their sample and a digital picture is taken of the plant. Students then
extract DNA from his/her plants using a single tube extraction protocol. Dilutions of these DNA
extractions are used in PCR with different RAPD primers (RAPD primers are used for PCR
setup due to their likelihood of success on unknown genomic DNA).
Learning Objective: This is the first step in getting the student personally involved in
learning molecular biology. The student picks their plant, draws the area that they have chosen

146

and extracts DNA from their plant. This is also the first chance to actively use the skills
introduced in lab 1 and to improve documentation skills.
Laboratory Three: Electrophoresis of collected PCR samples, Design assigned gene
primers and practice for lab practical.
Description: Students load their RAPD PCR samples from lab 2, then design primers for
assigned gene(s). Students are currently assigned multiple genes to increase their probability of
success.
Learning Objective: This is usually the first time that each student uses online scientific
research databases and tools. This is also the first time that students may have to make a decision
on what organism to use if there is not a representative gene from soybean. This is the first
reinforcement of the concept that genes can be highly conserved between organisms. This
protocol personally involves the student in the research to be performed in the lab.
Laboratory Four: Lab Practical Exam
Description: Placement of the lab practical at this point in the course assures the instructor
that the student is ready for the next phase of the project, which requires competency in
laboratory techniques and forces the student to learn proper techniques earlier, rather than later.
Timing the practical after the primer design lab also allows additional time for the primers to be
ordered and delivered
Laboratory Five: Primer dilution and initial PCR test of Soybean and Pea
Description: Primers ordered from lab three are processed by re-suspension in TE, then
dilution to a working concentration of 10 mM. An initial test of these primers is conducted on
soybean and Pea DNA. The students are given a PCR protocol and are required to program the
PCR machines de-novo. Learning Objective: Resuspension of primers, pipetting accuracy
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Laboratory Six: Electrophoresis of initial PCR test: PCR setup based on electrophoresis
results
Description: Students load PCR product from lab five. After electrophoresis, the
amplification profile is analyzed and based on these data, each student could begin an
independent study project if they choose. The course can end at this time, or can continue by
screening all functional primer pairs on a larger population of organisms. Learning Objective:
Electrophoresis, post-translational modifications (product is larger than predicted from EST
sequence), gel loading and pipetting
Laboratory Seven: Electrophoresis of populations.
Description: Electrophoresis of PCR product from lab six. Collect and analyze data as
instructor desires (phylogeny trees, statistical analysis, etc)
Other Laboratory Skills to be discussed if time allows
How and Why an SDS-Polyacrylamide Gel is Used to Separate Proteins?
Background on SDS-PAGE
Basic Procedure
Chemical ingredients and their roles such as SDS and DTT or beta-mercaptoethanol
Stacking and resolving gels
Chemicals for processing and visualization using BPB and coomassie blue
What is a Western Blot, Why is it Used?
A way to detect proteins using antibodies
Steps in tissue preparation, gel electrophoresis, transfer, blocking, detection (one step or two
steps) and analysis.
Discuss how chemiluminescence works
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Preparation and dilutions of solutions
How do you use a dilution factor
How to use concentrations
How to use an amount
Serial dilutions
Pipetting skills
Reagent preparation
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Unit 3: Immunology
Worthy of Note:
To study immunology today is to be on the cutting edge of research that is important in our
lives. Immunology is revealing astonishing things about the system in our body that defends us
from foreign germs that could do us harm, much like a country’s military defends the country
from invaders.
The microbial world is continuously evolving and producing new infectious threats. In this
unit, you will learn that the immune system has many strategies designed to cope with these
threats as they evolve. Our immune defense is intricate, cunning, and in many ways beautiful
(The Dana Foundation, 2008). All living organisms need to protect themselves against
infections. In multi-cellular organisms this defense system is normally called the immune
system. The immune system consists of a number of organs, cells and soluble factors. These
components cooperate to detect and to remove infectious organisms like viruses, bacteria and
parasites. The immune cells of mammals usually have very different functions. Neutrophilic
granulocytes are, for example, very important for our defense against bacteria, and cytotoxic T
cells are essential for our defense against many viruses. The immune system can be separated
into two branches, innate and adaptive immunity. Adaptive immunity differs from innate
immunity by the ability to acquire memory and to develop specificity against different molecular
structures. Innate immunity does instead react against common structures that we during millions
of years have learned to recognize as typical for certain groups of microorganisms, as for
example cell wall components of bacteria or double stranded RNA from viruses. In mammals the
adaptive immunity consist primarily of two cell types, T and B lymphocytes. To recognize
different pathogens these cells use highly variable molecules, i.e. antibodies and T-cell receptors.
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The immune system is normally sufficient to protect us from different infections, but there is
a constant battle between host and infectious organism, an arms race, where the immune systems
always have to be prepared to encounter new and more aggressive pathogens. The immune
system is a very powerful system that normally works in silence. However this system
sometimes overreacts, which may cause us large medical problems, such as allergies and
autoimmune diseases.
The Big Picture
Germs breaches the body’s natural barriers. This alerts the immune system and triggers the
ﬁrst line of defense (innate immune system). If the first line needs reinforcement, it recruits and
triggers the second line of defense (adaptive immune system) to ultimately eliminate the
pathogens and generate ―
memory‖.
Considering a daily barrage of microbes from all directions, it’s a wonder that we aren’t sick
all the time. Fortunately, the human immune system has evolved to handle this onslaught,
operating like a highly efficient killing machine to fend off germs wherever and whenever they
appear. Although the immune system employs a variety of weapons and strategies based on the
speciﬁc threat, in general your immune system mounts a three-step defensive process.
Step 1: Sounding the Alarm
The ﬁrst defenders on the scene of a germ attack are components of your innate immune
system. The white blood cells that make up the innate immune system circulate throughout the
body constantly, much like police on patrol, always on the lookout for biological suspects. These
patrolling white blood cells belong to the phagocyte family, but they have many subtypes (just as
a police force consists of detectives, sergeants, captains, and patrol officers). Phagocytes consist
of macrophages, dendritic cells, and granulocytes. In various ways, the different types of
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phagocytes identify, engulf, and ingest germs and other invaders. Phagocytes lead the way in
many critical innate reactions.
Knowing that where one harmful virus or germ lurks more may be hiding, phagocytes sound
chemical alarms to bring the more specialized immune cells to the scene. First, dendritic cells
display an antigen—a chemical that identiﬁes the invader—so that the appropriate immune
system specialist cells are able to recognize the culprit. The specialists, which consist of B and T
cells, are known collectively as lymphocytes, and they make up the body’s adaptive immune
system. As its name implies, the adaptive immune system adapts and adjusts to speciﬁc threats as
the need arises, whereas the innate immune system is pre-existing and less speciﬁc. Although B
cells can recognize and respond to antigens without much assistance, T cells require a second
―
danger‖ signal in the form of a biological ﬂag, known as an MHC molecule, which an antigenpresenting cell (such as a macrophage or dendritic cell) uses to clearly designate that an invader
is foreign. The phagocytes also release chemical messengers known as cytokines.
A foreign substance triggers the innate and subsequently the adaptive immune systems. In a
successful response the pathogens are killed and antibodies are produced to more efficiently
respond to future attacks.
Step 2: The Battle Escalates
Lymphocytes mount a two-pronged attack, one directed at infected cells and the other at
hostile microbes circulating in the blood. The cell-targeting attack is directed by T cells. Killer T
cells directly kill infected cells that have been marked for destruction by the phagocytes, while
helper T cells coordinate the attack and send for reinforcements as needed. Meanwhile, B cells
produce antibodies that bind to free-ﬂoating microbes circulating in the blood so that they cannot
infect other cells. Phagocytes then engulf and destroy the antibody-studded invaders. Antibodies
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also activate complement proteins, which destroy microbes by punching holes in them. As the
battle rages at the microscopic level, you may start to be aware that something is amiss. If you’ve
been infected with a cold virus, for example, your throat will become sore, your eyes watery, and
your sinuses congested. These are the physical signs of inﬂammation, the buildup of ﬂuid and
cells that occurs as the immune system ﬁghts a hostile invader.
Step 3: Remember and Recover
Once all invaders and infected cells have been destroyed, the immune system soldiers that
once multiplied so quickly decline in number. Inﬂammation subsides, and symptoms gradually
disappear. But certain memory B and T cells remain, to remember how to attack the invader if it
returns. Even with all these physiological weapons at our disposal, microbes occasionally
manage to outsmart our immune sentries or elude detection. One reason is that microbes evolve
rapidly and humans do not, giving the germs an advantage over our immune defenses. Moreover,
if our defense system is impaired in any way—either by an inherited condition or because we’ve
been exposed to certain environmental toxins or medical treatments that suppress immunity—we
are more susceptible to infection (The Dana Foundation, 2008).
Failing to Protect: Immune Dysfunction Spells Trouble
For all its highly evolved mechanisms for identifying and ﬁghting off the daily onslaught of
germs, the immune system sometimes fails to provide the protection we need. Because the
system is so complex, relying on a battalion of specialized units (in the form of T cells, B cells,
macrophages, and an arsenal of antibodies and other biochemicals) to perform speciﬁc defense
tasks and to coordinate with one another, dysfunction in any one of these units can render the
entire system inadequate.
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One might compare the immune system to the U.S. Department of Defense. When waging a
war, the Defense Department relies on all of its forces—Army, Navy, Air Force, Marines, as
well as specialized intelligence units, paramilitary forces, antiterrorist teams, etc., together in a
coordinated fashion to defeat the enemy. It also relies heavily on its weapons—bombs, missiles,
guns, tanks, battleships, warplanes, and so forth. As with the immune system, the effectiveness
of the war machine, as a whole, depends largely on the ability of each component to efficiently
fulfill its individual role. If a reconnaissance plane spies an enemy battalion approaching, but it
can’t get the message to troops on the ground, or if the troops don’t have the ammunition or
armor they need to fend off the attack, the enemy is free to wreak havoc.
In the same way, if any one component of the immune system is not up to par, germs can
quickly get the upper hand. This is the case in immune deﬁciency diseases (IDDs), which result
when one or more parts of the immune system are missing or defective. An IDD can be inherited
or acquired through an infection (such as HIV) or illness, or it can result as a side effect of
certain immunosuppressive medical treatments, or treatments that suppress natural immune
responses. Acquired immunodeﬁciency syndrome (AIDS) is the best-known immune deﬁciency
disease but there are many other less well-known and less prevalent examples. Some cancer
treatments, including chemotherapy drugs, radiation, and high doses of a group of medicines
called steroids, can weaken the immune system and render a person more vulnerable to infection.
When the Problem is in Your Genes
Primary immune deﬁciency (PID) diseases are the result of an inherited genetic defect that
interferes with the immune system’s normal development in one way or another. More than
eighty different PID diseases have been identiﬁed, each one producing a constellation of
symptoms depending on which piece or pieces of the defensive system are faulty. Symptoms of
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individual diseases can range from mild or nonexistent to devastatingly severe. About 25,000 to
50,000 Americans have been diagnosed with a severe form of primary immune deﬁciency
disease, but there are probably many thousands more who have milder forms.
One of the most common of these diseases, affecting about 1 in 600 Americans, is selective
immunoglobulin A (IgA) deﬁciency. IgA is a particular type of antibody that defends against
infections at mucous membranes that line the mouth, airways, and digestive tract. IgA deﬁciency
results when B cells do not mature properly and fail to produce IgA antibodies at the levels
required. Many people with the deﬁciency remain healthy; others may suffer recurrent infections
of the ear, sinuses, or lungs.
Living in a Bubble
Far less common is severe combined immunodeﬁciency disease (SCID), sometimes called
―
bubble boy‖ disease, which affects about one child in a million and is usually fatal. Infants born
with this inherited condition have dramatic abnormalities in both innate and adaptive immunity,
leaving them utterly defenseless against infections of any type and necessitating that they remain
in a germ-free environment (the plastic ―
bubble‖ in which such children often must live acts as a
barrier to infectious microbes).
At least a quarter of SCID cases are linked to a defect in a gene that speciﬁes the genetic
code for a particular enzyme, adenosine deaminase (ADA). The absence of ADA interferes with
metabolic processes within the cell, setting off a cascade of molecular events that are particularly
lethal to T and B cells. Scientists have tested controversial gene therapy approaches to treating
SCID, with the goal of replacing the missing gene and restoring production of ADA. While this
approach has proven successful in some cases, treated children died as a result of complications
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from the therapy, prompting an end to clinical trials until scientists conduct further laboratory
research
Inducing Disease: ―Friendly Fire‖ from the Immune System
Like tragic cases of ―
friendly ﬁre‖ on the battleﬁeld of war, sometimes the immune system
mistakenly attacks ―se
lf‖ tissue. This self-attack can cause symptoms that range from the
annoyance of a runny nose, as in allergies, to the devastating progressive degeneration of joints
and organs associated with rheumatoid arthritis.
A disease in which the immune system attacks the body is called an autoimmune disorder.
Autoimmune disorders comprise at least 80 different conditions that together affect 5 to 9
percent of Americans, or between 14 million and 22 million people. The misdirected attack on
self tissue may target one or several body parts, depending on the disease. For example, in type 1
diabetes the immune system zeroes in on the pancreas, damaging cells that secrete the hormone
insulin and rendering the body inefficient at processing glucose (a type of sugar). In multiple
sclerosis, the objects of attack are cells in the central nervous system (the brain and spinal cord),
particularly those in myelin, the fatty substance that sheathes nerve ﬁbers and enhances the
transmission of nerve signals. In psoriasis, skin cells are targeted. Systemic lupus erythematosus,
on the other hand, is an example of a non-organ-speciﬁc autoimmune disease: organs and tissues
throughout the body may be affected, and different people experience different sets of
symptoms.
No Tolerance for Self
Each autoimmune disorder is associated with a unique combination of health problems. All
of them seem to result from the malfunctioning of immune tolerance mechanisms. ―T
olerance‖
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refers to the process by which the developing immune system normally eliminates any immune
cells that are auto reactive, that is, immune cells that mount a response to the body’s own tissue.
Tolerance is a multilayered system, with a series of checks and balances built in to prevent selfattack from either innate or adaptive immune cells. In some cases, the self-reactive cells are
removed or deleted. In other cases, they are silenced by immune cells called regulatory or
suppressor cells.
Unfortunately, the process is somewhat leaky, and each of us ends up having a subpopulation
of auto reactive immune cells ﬂoating around our body. If at some point in our life we are
exposed to a microbe that happens to carry antigens resembling those on a particular organ—a
situation immunologists call molecular mimicry—then the self-reactive cells that slipped through
the checkpoints of tolerance mistakenly take aim at the body, striking out against the very tissue
that they are supposed to be defending. Some scientists reason that such a scenario may trigger
multiple sclerosis, for example.
A combination of many factors, inherited and environmental, increases one’s susceptibility to
autoimmune disease. On the genetic side, scientists are trying to identify the speciﬁc genes
involved in various disorders, but that search has proved difficult because these disorders do not
appear to result from single genetic defects. Rather, it is likely that a combination of genes, each
of which may increase one’s vulnerability, interact with environmental and lifestyle factors to
produce disease. Environmental risks for autoimmune disease may include exposure to certain
toxins or chemicals that are in the air, the ground, or the food we eat, or to certain viral
infections. For reasons that are not clear, autoimmune disorders strike women more than men.
Some scientists believe the female hormone estrogen may contribute to this increased
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incidence among women, but estrogen’s role in immune function is complex and still being
sorted out.
In 2002 the National Institutes of Health committed $51 million to a ﬁve-year research
initiative aimed at unraveling the puzzle of autoimmune disorders (Dalakas et al., 2001). The
plan, which established nine Autoimmune Centers of Excellence at large academic research
institutions, funds both basic research on the underlying biology of these disorders and clinical
trials to test potential treatments. The goal is to speed the translation of scientiﬁc discoveries
about the basic biology of autoimmunity into new therapies that will beneﬁt patients.
Sneezing and Wheezing
Though they are not technically autoimmune disorders, allergies and asthma also result from
an inappropriate immune response. An allergic reaction occurs when normally harmless
substances, such as pollen or chemicals in pet dander, trigger an immune response. In people
prone to allergies, the response produces an overabundance of the antibody called IgE, or
immunoglobulin E, which in turn triggers plasma cells in the blood and mast cells in the skin,
tongue, lungs, nose, and intestinal tract to release histamine, a biochemical that produces
common allergy symptoms
Interleukins are proteins that help regulate the immune system, particularly the interaction
among white blood cells, or leukocytes. B cells recognize the allergen and produce antibodies. A
reaction follows, producing the symptoms commonly referred to as allergies. (Adapted from
NIAID, NIH).
Asthma results when mast cells in the lungs and airways are provoked into producing
histamine as a result of contact with an allergen, or because of some other precipitating factor
such as exercise. The airways can become constricted, causing the difficult breathing, wheezing,
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and coughing that are typical of an asthma attack. Without treatment, asthma can be deadly.
Although the overall number of deaths from asthma is low, at least 17 million Americans have
asthma, and its prevalence appears to be increasing. Researchers are trying to understand why.
(The Dana Foundation, 2008)
Losing Battles: Why the Immune System Can’t Beat Every Enemy
If the immune system is such an efficient germ-killing machine, why do so many people get
sick with the ﬂu at certain times of the year? Or why, if our immune system can ﬁght off cancer
cells and other life-threatening illnesses, it can’t protect us from the common cold. Why do we
hear so much in the news these days about ―n
ew‖ viral diseases (such as West Nile, SARS, and
bird ﬂu) and resurging ―
old diseases‖ (such as tuberculosis, malaria, and whooping cough)?
Despite the remarkable efficiency of the normally functioning immune system, people who
manage to escape unscathed from every infectious microbe they encounter are rare. The highly
adaptable nature of germs means that new threats are always emerging as microbes reinvent
themselves, learn to outsmart our medicines, and jump from other species to humans.
Adapting to Change
Perhaps the biggest reason our immune systems can’t seem to keep up with every ―
bug‖ out
there waiting to infect us is a simple one: microbes are more adaptable to changing environments
than we are. Bacteria, parasites, and viruses replicate rapidly in response to environmental
pressures and, while doing so, alter their structures in subtle ways that make them undetectable
to the immune system.
Flu viruses are among the most changeable of microbes; the genes that compose them are in
a continual state of ﬂux and reassortment. This is why last year’s ﬂu vaccine is unlikely to
protect fully against this year’s dominant strain (or strains) of ﬂu, and why the ﬂu vaccine is
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reformulated every year. It is also why, without immunization, we are more likely to catch the
ﬂu: since the virus has morphed into a new composition, our immune system doesn’t recognize
it, and we end up suffering the classic symptoms: fever, chills, muscle aches, and fatigue. These
symptoms are the result of our immune system trying to rid the body of the virus. Annually,
many Americans come down with the ﬂu and an average of 20,000 to 40,000 people die from it.
The elderly, young children, and people whose immune systems are compromised are most at
risk for serious complications from the ﬂu.
The common cold, like the ﬂu, is the result of a viral infection, usually called a rhinovirus.
Scientists have identiﬁed more than 110 different strains of rhinovirus and at least another
hundred viruses that cause colds in humans. Nearly half of all adult colds are of unknown origin,
which makes the sought-after ―
cure for the common cold‖ a distant goal. School-age children get
colds most often, probably because they are in such close proximity to one another. Children
have an average of six to ten colds a year, compared with adults’ two to four a year, on average.
People over 60 have even fewer colds—less than one a year, on average—which may simply
reﬂect the fact that many older people have less day-to-day contact with other people who could
infect them with a cold virus.
Pandemics and Emerging Microbes
Every few decades a particularly virulent strain of the ﬂu emerges and produces a pandemic,
an epidemic that occurs across a wide geographic area. The last ﬂu pandemic occurred in 1968,
and many scientists believe we are long overdue for the next. Global health experts are keeping a
close watch on bird ﬂu (also known as avian ﬂu), which many fear might produce a pandemic.
First identiﬁed in chickens, this ﬂu strain began causing alarm because it was found in humans
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for the ﬁrst time in 1997, and by 2005, many dozens of human cases had been documented in
several countries.
What Are ―Emerging Microbes‖?
One of the biggest subjects in contemporary microbiological research (the study of microbes)
is that of ―
emerging microbes.‖ In the last two decades alone, more than thirty newly recognized
infectious diseases have emerged, including AIDS, toxic shock syndrome, Lyme disease,
hantavirus, hepatitis C, and SARS. In most cases, these diseases are not really new, but rather
their incidence is rising more rapidly than ever, making them an ever greater threat to humans.
Also of concern are old diseases that are now re-emerging, even though they were mostly wiped
out thanks to improved public health measures and widespread immunization. Tuberculosis is
one example. Driving the spread of these diseases is increasing globalization, with the growing
world population traveling greater distances than ever before, carrying disease-causing microbes
with them. Climate changes and the widespread logging of Earth’s forests are also factors in the
spread of infectious diseases to new geographic areas and populations.
Moral/Ethical/Dilemma Scenario:
Both an injectable inactivated (killed) vaccine and an oral attenuated (live) vaccine are
available for immunization against polio-virus, which can cause paralysis by destroying nerve
cells in the brain and spinal cord. The oral vaccine is no longer recommended in western
countries, where polio has been eradicated, because the live virus in this vaccine may mutate to a
more virulent form, and be reintroduced into the population. However, the oral vaccine continues
to be used in countries where polio persists because it is easy to administer (no needles) and
highly effective. Moreover, the attenuated virus can spread to (and immunize) unvaccinated
individuals. Do you feel this risk of mutation to virulence (about 1 in 12 million) is acceptable
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when compared with the benefits of oral vaccination? How do you think public health decisions
of this type should be made?
Divergent and Creative Thinking Questions:
Case Study: To Spray or Not to Spray: A Debate Over Malaria and DDT by Frank J. Dinan and
Joseph F. Bieron, Canisius College. In this case study, students grapple with the complex issues
surrounding the use of DDT to control malaria. In their examination of the issue, students study
the cause of malaria, the life cycle of the protozoan, how it affects the human host and why there
are no vaccines for malaria. Students consider risk/benefit analysis and the precautionary
principle, two techniques used when making policy decisions involving the impact of science
and technology on society.
Science, Technology and Society: The ability of the pathogen Plasmodium to evade the human
immune system is one reason developing a malaria vaccine is so difficult. Another reason is that
less money is spent on malaria research than on research into disease that affects far fewer
people, such as cystic fibrosis. What are the possible reasons for this imbalance in research
effort? What could a group of high school students do to help in the fight against Malaria in the
world?
Case Study: The Case of a Tropical Disease and Its Treatment: Science, Society, and Economics
by Cathy Santanello and Jennifer Rehg, Southern Illinois University at Edwardsville. Designed
for a Costa Rican study abroad course, but appropriate for traditional science courses as well,
this case highlights the epidemiological and socioeconomic factors associated with Chagas
disease. Adrian is a banana plantation worker who develops a mysterious illness. By reading his
story, students learn about infectious diseases, pathogens, and vectors endemic to this area of
Central America. Students are asked to diagnose Adrian’s illness and consider his dilemma with
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respect to treatment options. Students also examine alternate approaches to treating this illness
that plagues thousands of Central and South American citizens.
Science, Technology and Society: Kidneys were the first organs to be successfully transplanted.
A donor can live a normal life with a single kidney making it possible for individuals to donate a
kidney to an ailing relative or even an unrelated individual with a similar tissue type. What are
some ethical problems that arrive as a result of being able to successfully transplant so many
types of tissues in this age of medicine? What are some of the implications for the recipient of a
donated organ or tissue?
Laboratory Component:
Discuss the use for monoclonal antibodies: for research, medicine, diagnosis, therapy, analysis
and measurement of biological molecules. Include discussion and demonstrations of
hemagllutination, ELISA, immunoblotting, immunofluorescence, and describe flow cytometry,
with output data samples; practice interpreting results.
Connect with the Internet
In the past few years, two diseases have received a lot of media attention: West Nile virus
and SARS. They received so much attention because they were new, at least to the United
States. Using the Internet, research one of these diseases and find out how it infects people
and how it spreads. Based on your research, create a poster that provides information on how
to protect yourself from the disease you select. Your poster should include information on
how people are infected by the virus and steps for preventing the spread of the disease.
Multiple sclerosis (MS) is an autoimmune disorder that affects the central nervous system.
You may recall that autoimmune disorders are diseases where the immune system attacks the
body. Use the Internet to research information in order to write a report about MS. In your
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report you should include how the disease affects the human body and treatments that combat
symptoms. You may want to use the following Web sites as resources for your research: the
National Multiple Sclerosis Society (http://www.nationalmssociety.org), the National Library
of Medicine (http://www.nlm.nih. gov), and the Multiple Sclerosis Foundation
(http://www.msfacts.org).
In order for children to remain healthy, it is important that they receive certain
immunizations. Using the Internet as a resource, create a poster that explains to parents why
and when their children should receive certain immunizations. Helpful sources for your
poster include: the U.S. Centers for Disease Control and Prevention (http://www.cdc.gov),
the American Academy of Pediatrics (http://www.aap.org), and KidsHealth®
(http://www.kidshealth.org) Web sites.
About two-thirds of the people in the world who are infected with HIV/AIDS live in subSaharan Africa. Imagine that you are in charge of a fundraiser to support the fight against
AIDS in Africa. Using the Internet as a resource, design a brochure that will encourage
people to contribute to your cause. Your brochure should inform people of the serious
conditions in Africa. Information for your brochure can be found on Web sites for groups
such as the World Health Organization (http://www.who.org), The World Bank
(http://www.worldbank.org), and One: The Campaign to Make Poverty History
(http://www.one.org).
Avian (bird) flu is considered to be a potentially dangerous strain of influenza. Use the U.S.
Centers for Disease Control and Prevention (http://www.cdc.gov) and the World Health
Organization (http://www.who.org) Web sites to find information about avian flu. Create a
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presentation that explains the origins of bird flu and why there is potential for this virus to be
the next worldwide pandemic.
Until the 1950s, there was no way to prevent polio, a viral disease that mostly affected
children and could cause paralysis. Use the Internet to find out how this disease was virtually
eliminated in the United States and what is being done today to eradicate the disease
throughout the world.
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Unit 4: Pathogenesis and Society
Worthy of Note:
Upon course acceptance, to be taught as a professional development course, this portion of the
curriculum will be completed.
Moral/Ethical/Dilemma Scenario:
Explain how the excessive or inappropriate use of antibiotics poses a health hazard for a
human population. Give current examples of this problem.
Humans have engaged in genetic manipulation for millennia, producing plant and animal
varieties through selective breeding and hybridization processes that modify the genomes of
organisms on a significant level. Why do you think modern genetic engineering, which often
entails introducing or modifying only one or a few genes, has met with so much public
opposition? Should some forms of genetic engineering be of greater concern than others?
Explain (Campbell and Reece, 2005).
Both an injectable inactivated vaccine and an oral attenuated vaccine are available for
immunization against polio-virus, which can cause paralysis by destroying nerve cells in the
brain and spinal cord. The oral vaccine is no longer recommended in western countries,
where polio has been eradicated, because the live virus in this vaccine may mutate to a more
virulent form, and be reintroduced into the population. However, the oral vaccine continues
to be used in countries where polio persists because it is easy to administer (no needle) and is
highly effective. The attenuated virus can spread to and immunize unvaccinated individuals.
Do you feel this risk of mutation to virulence (about 1 in 12 million) is acceptable when
compared with the benefits of oral vaccination? Explain.
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Divergent and Creative Thinking Activity:
Case Study: Is Guaiacum sanctum Effective Against Arthritis? An Ethnobotany Case by Eric
Ribbens, Barbra Burdett, and Angela Green, Western Illinois University. Dr. Beth Tonoany, a
tropical population ecologist, is studying an unusual tree, Guaiacum sanctum, in the tropical
forests of Central America. Interestingly, several local Ticos have told her that they use the tree
for medicinal purposes. Students read the case and then answer questions designed to explore the
process of screening and testing the medicinal value of plants identified as having potential
health benefits.
Case Study: MDR Tuberculosis: A Case Study for Non-Science Majors Focused on Social
Justice by Katayoun Chamany, Eugene Lang College of the New School University. In this case
on multi-drug resistant (MDR) tuberculosis. students consider ways in which to preserve health
as a human right without subjecting already marginalized communities susceptible to the disease
to further discrimination. Students learn about the science behind TB diagnostics and current
treatment protocols as well as the political and social history of TB outbreaks and the
development of MDR TB. The case makes use of video clips, news stories, public health press
releases and reports, and other secondary and primary literature.
Case Study: Biological Terrorism: The Anthrax Scare of 2001 by Kathleen A. Cornely,
Providence College. In the weeks following the September 11, 2001, terrorist attacks on the
World Trade Center and the Pentagon, anthrax-laced envelopes were mailed to individuals in
government and the news media by an as-yet-unidentified bioterrorist. Thousands were treated
for exposure, and five people were killed. At the same time, scientists solved the last remaining
pieces of the anthrax puzzle, and the mechanism of infection of the anthrax toxin is now well
understood. This case presents students with a wealth of biochemical, microbiological, and
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immunological material to analyze while exploring important societal issues related to national
preparedness against bioterrorist attacks, funding for bio-defense research, and the use and
misuse of antibiotic therapy.
Laboratory Component:
Scientific Inquiry: In April 1989, an accident at a nuclear power plant in Chernobyl, Ukraine,
scattered radioactive fallout for hundreds of miles. In assessing the biological effects of the
radiation, researcher found mosses to be especially valuable as organisms for monitoring the
damage. Radiation damages organisms by causing mutations. Explain why the genetic effect of
radiation can be observed sooner in bryophytes than in plants from other groups. Imagine that
you are conducting tests shortly after a nuclear accident. Using potted moss plants as your
experimental organism, design an experiment to test the hypothesis that the frequency of
mutations decreases with the organism’s distance from the source of radiation.
Evolution Connection: The history of life has been punctuated by mass extinction events. Fossil
records indicate that many forms of animal life were wiped out yet plants were less severely
affected by mass extinctions. What adaptations may have enable plants to withstand these
disasters better than animals?
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Summary
High school teachers play a vital role in the preparation of students for college science
courses. Through inquiry, content integration, epistemological pedagogy techniques, relevant
case studies, augmenting organizational tools and resources, and fostering interdependence
among professional scientists and educators, students most assuredly will be more successful in
science courses and approach science careers as a possibility. In this course, teachers are
encouraged and offered organizational tools, case studies, and inquiry activities in more depth,
without sacrificing content to meet state standards and core objectives. By fostering independent
thinking and encouraging students to actively work towards understanding the material, teachers
prepare students better able to approach the material rationally. Not only will these skills help
our students be successful in college, but will enhance their success in later life as well as
provide the pathway for lifelong learning.
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Table 1: Present Life Science Teacher Education Programs in Utah and Nevada
Brigham Young
University
BIO 220A :
Biological
Diversity:
Animals.
BIO 220B :
Biological
Diversity: Plants.
BIO 350 :
Ecology

Utah Valley
University
BIOL 1610/1615
College Biology 1
and lab

Utah State
University
BIOL 1610 Biology
I

University of Utah

BIOL 1620/1625
College Biology 2
and lab
BIOL 3500
Genetics

BIOL 1620 Biology
II

BIOL 2010 Evolution and
Diversity of Life

BIOL 2220 General
Ecology

BIOL 2020 Principles of Cell
Biology

BIO 420 :
Evolutionary
Biology

BIOL 3700
General Ecology

BIOL 2420 Human
Physiology

BIOL 2030 Genetics

BIO 421 :
Evolutionary
Biology
Laboratory
MMBIO 240 :
Molecular
Biology
PDBIO 120 :
Science of
Biology

BIOL 4200
Teaching
Methods in
Science
BIOL 4500
Principles of
Evolution
BIOL 4500
Principles of
Evolution

BIOL 3060
Principles of
Genetics

BIOL 3215 Cell Biology Lab

BIOL 3065
Genetics
Laboratory
BIOL 3220 Field
Ecology

BIO 3900 Teaching of
Biology

PWS 340 :
Genetics

BIOL 494R
Seminar

BIOL 3330 General
Microbiology

BIO 235 : Field
Botany

MICR 2060
Microbiology for
Health
Professionals OR
MICR 3450
General
Microbiology
ZOOL 2320
Human Anatomy

BIOL 5250
Evolutionary
Biology

BIOL 3230 Developmental
Biology, OR BIOL 3310
Comparative Vertebrate
Morphology, OR BIOL 3320
Comparative Physiology, OR
BIOL 3330 Behav
Neurobiology, OR BIOL 3350
Plant Physiology, OR BIOL
3370 Microbial Biology, OR
BIOL 5364 Plant Structure
15 elective credit (Rogers and
Abell) hours in Biology, two
courses with labs and one at a
5000 level.

BIO 370 :
Bioethics

BIO 380 :
Comparative
Animal
Physiology and

ZOOL 2420
Human
Physiology

BIOL 4400 Plant
Physiology OR
BIOL 5300
Microbial
Physiology
BIOL 5100
Neurobiology OR
BIOL 5600
Comparative
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BIOL 1200 General Biology

BIOL 5900 Teaching
Experience

University of
Nevada
BIOL 190 Intro
to Cell and
Molecular
Biology
BIOL 192 Intro
to Organismal
Biology
BIOL 192
Biological
Investigation
BIOL 223
Human
Anatomy and
Physiology
BIOL 251
General
Microbiology
BIOL 200
Principles of
Genetics
BIOL 314
Ecology and
Population
Biology
EDSC 464
Environmental
Science Tchg
Mthds

9 more credits
(3 classes in
biology
electives)

Anatomy
BIO 441 :
Entomology
BIO 470 : History
and Philosophy of
Biology
Recommended:
BIO 352
Introduction to
Marine Biology
BIO 430 Plant
Classification
BIO 443
Ichthyology,
BIO 445
Herpetology, BIO
446 Ornithology
BIO 447
Mammology

ZOOL 3100
Vertebrate
Zoology
ZOOL 3200
Invertebrate
Zoology
BOT 2050 Field
Botany OR BOT
2100 Flora of
Utah OR BOT
4300 Wildland
Shrubs

Animal Physiology
OR BIOL 5620
Medical Physiology
BIOL 5610 Animal
Physiology Lab
SCI 4300 Science
in Society
Other upper
division courses,
advisor
recommended

BOT 3340 Plant
Biology OR
another approved
upper-division
botany course

Highlighted areas indicate courses in molecular or microbiology required.
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Table 2: Science Concepts in this Course
COURSE

CONTENT CONCEPTS AND INTEGRATION

INQUIRY AND EXPERIMENTATION

CORE INFORMATION -Components, genomes and

Cell culturing, observing cytopathic effects,

types of viruses, historical view, connect to molecular

setting up a lab activity using cells and viruses,

biology, replication, transcription, translation, and

lab notebook keeping and organization

MATERIAL
INCLUDED IN THIS

COURSE
VIROLOGY

protein struct. polymerases, RNA splicing, frame
shifting, promoters, codons, cistronic, use of
antibodies in study of virology,
BACTERIOLOGY

CORE INFORMATION- Components, specific

Bacteria cell culture, use of bacteria for cDNA

glycoproteins, cell walls, bacteriophages, relate to

library, setting up a lab activity using bacteria,

immune responses, how bacteria are used by

lab notebook keeping and organization

molecular biologist.
PATHOGENESIS

Diseases, relates with virology, bacteriology,

Writing case studies, integrating immunology,

parasitology, relating to immune response

virology, bacteriology

MOLECULAR

REVIEW CORE INFORMATION- Components of

Immunofluorescence, ELISA, PCR,

BIOLOGY

DNA, RNA, RNA processing, transformations

microscopy, electrophoresis, setting up a lab
activity using cells molecular tools, writing
case studies,

IMMUNOLOGY

CORE INFORMATION – plants,, invertebrates,

Background on Flow Cytometry, how to read

vertebrate HUMAN, mechanisms in response to

output data, lab notebook keeping, writing

pathogens, knock-out mice

case studies
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Appendix
Divergent and Creative Thinking Models:
The following are examples of free response prompts that can be used for the trainer and the
teacher in the classroom. These prompts will encourage divergent and creative thinking and,
when used with the case studies included in this course, will lead to interactive discussions and
opportunities for the learner to make connections to the content materials.
The Brainstorm Model
Brainstorm all of the ___________________
Brainstorm as many _____as you can think of.
How many ways can you come up with to _______________?
Viewpoint Model (Human or Animate)
How would _______look to a(n) ___________?
What would a _____mean from the viewpoint of a(n)_____________?
How would ________view this?
Involvement Model (Personification/Inanimate object brought to life)
How would you feel if you were __________?
If you were a _____________, what would you see, taste, smell, feel, etc.?
The Forced Association Model
How is ______________like _________________?
Get ideas from ____________to improve ________________.
I only know about _________. Explain __________to me.
Reorganization/Synectics Model
What would happen if ___________________?
Suppose ________________happened. What would be the consequences?
What would happen if there were no __________________?
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Possible Assessment Products:
This list of informal assessment instruments may help the trainer and teacher create alternative
assessments in their classrooms.
A Dance/A Letter
A Lesson
Advertisement
Animated Movie
Annotated Bibliography
Art Gallery
Block Picture Story
Bulletin Board
Bumper Sticker
Chart
Choral Reading
Clay Sculpture
Code
Collage
Collection
Comic Strip
Computer Program
Costumes
Crossword Puzzle
Database
Debate
Demonstration
Detailed Illustration
Diorama
Diary
Display
Edibles
Editorial Essay
Etching
Experiment
Fact Tile
Fairy Tale
Family Tree
Fiction Story
Film

Filmstrip
Flip Book
Game
Graph
Hidden Picture
Illustrated Story
Interview
Jingle
Joke Book
Journal
Labeled Diagram
Large Scale Drawing
Learning Center
Letter to the Editor
Map with Legend
Mazes
Mural
Museum Exhibit
Musical Instruments
Needlework
Newspaper Story
Non-Fiction
Oral Defense
Oral Report
Painting Pamphlet
Pantomime
Paper Mache
Petition
Photo Essay
Pictures
Picture Story for Children
Plaster of Paris Model
Play
Poetry
Political Cartoon
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Pop-Up Book
Postage Stamp,
Commemoratives
Press Conference
Project Cube
Prototype
Puppet
Puppet Show
Puzzle
Rap
Radio Program
Rebus Story
Recipe
Riddle
Role Play
Science Fiction Story
Sculpture
Skit
Slide Show
Slogan
Soliloquy
Song
Sound
Story Telling-Tall Tales
Survey
Tapes–Audio–Video
Television Program
Timeline
Transparencies
Travel Brochure
Venn Diagram
Web Home Page
Working Hypothesis
Write a new law
Video Film

Literature / Language Arts - ―Read A Book‖ List
The following list sets out to describe a selection of books that include immunology among their
themes and serve as additional sources for descriptions of diseases, what it is like to live with
such diseases, and the battle against them that rages in the body and in the laboratory. This list is
by no means exhaustive, but these readable books are a good place to begin your exploration of
immunology.
VIROLOGY
West Nile Story
By Dickson Despommier. Apple Trees Productions LLC, 2001, 134 pgs.
In 1999, infection with the West Nile virus killed several people in New York City. Despommier
describes these cases and discusses theories on the spreading of disease, including details about
speciﬁc mosquito species and the migratory patterns of crows. The book helps explain an
outbreak of a somewhat mysterious disease and also delves into the manner in which the virus
moves through the population.
When Plague Strikes: The Black Death, Smallpox, AIDS
By James Cross Giblin. HarperCollins, 1995, 212 pgs.
Giblin compares the development and impact of the three diseases, starting with the bubonic
plague of the fourteenth century. He also compares perceptions and treatment of victims of the
diseases, citing similarities between the treatment of people living with AIDS and that of people
who had plague and smallpox in previous centuries.
Pox Americana: The Great Smallpox Epidemic of 1775–82
By Elizabeth Anne Fenn. Hill & Wang, 2001, 370 pgs.
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Fenn takes a close look at smallpox outbreaks during the Revolutionary War and describes
General George Washington’s efforts to contain their spread. She also examines the results when
these efforts were insufficient, including an analysis of the impact of the disease on the
indigenous American population. The book is a case study in early epidemic response
techniques.
The Demon in the Freezer
By Richard Preston. Random House, 2002, 240 pgs.
Smallpox, at one time a leading cause of death around the world, was eradicated in the twentieth
century. Preston weighs the pros and cons of destroying the remaining stocks of smallpox virus.
Some are worried that scientiﬁc testing involving the virus will set off a biological-weapons arms
race. Others are concerned that if the stocks are destroyed, efforts to ﬁnd a cure for the disease
will be hampered.
The Hot Zone: A Terrifying True Story
By Richard Preston. Anchor, 1995, 442 pgs.
In the winter of 1989 the Ebola virus—airborne, very contagious, and lethal to 90 percent of its
victims—made an appearance in a primate laboratory in suburban Washington, D.C. Soldiers
and scientists working at an army research facility worked feverishly and in secret to stop the out
break. The Hot Zone gives a gripping account of the historical occurrence of rare and lethal
viruses among humans.
The Great Inﬂuenza: The Epic Story of the Deadliest Plague in History
By John M. Barry. Viking, 2004, 546 pgs.
Barry provides a look at a global health crisis. He describes how the frequently mutating
inﬂuenza virus, coupled with the world’s preoccupation with World War I, resulted in the
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inﬂuenza pandemic of 1918. The response from the scientiﬁc community laid the groundwork
for the modern ﬂu vaccine.
Flu: The Story of the Great Inﬂuenza Pandemic of 1918 and the Search for the Virus That
Caused It
By Gina Kolata. Farrar, Straus and Giroux, 1999, 330 pgs.
Kolata explains how the plague spread, examines its possible origins, and describes the search
for a strain of the virus once science had advanced, making it possible to better investigate the
virus. She also considers whether health officials today are prepared for a similar threat.
The Swine Flu Affair: Decision-Making on a Slippery Disease
By Richard E. Neustadt and Harvey V. Fineberg. University Press of the Paciﬁc, 2005, 189 pgs.
In 1976, the U.S. government launched a nationwide vaccination campaign to respond to what it
thought was a resurgence of the ﬂu strain that caused the 1918 epidemic. The side effects
patients suffered as a result of taking the vaccine caused some to sue the federal government for
millions of dollars and now serve as a cautionary tale as the government addresses the prospect
of new microbial threats.
Living with Hepatitis C: A Survivor’s Guide
Third revised edition
By Gregory T. Everson and Hedy Weinberg. Hatherleigh Press, 1997, 274 pgs.
Nearly 4 million Americans are estimated to have hepatitis C, a viral infection that targets the
liver. Everson and Weinberg provide much information about the disease, including means of
transmission, how to avoid it, signs of abnormal liver function, and the latest in research. Their
overview of the disease also suggests how to deal with it.
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Hepatitis C: The Silent Killer
By Carol Turkington. Contemporary Books, 1998, 188 pgs.
Turkington describes for the general reader the potentially fatal illness hepatitis C, one of several
related viral diseases that attack the liver. Doctors are still learning how best to treat the disease,
and the author describes the current methods being used.
MOLECULAR BIOLOGY
Timebomb: The Global Epidemic of Multi-Drug-Resistant Tuberculosis
By Lee B. Reichman with Janice Hopkins Tanne. McGraw Hill Companies, 2002, 240 pgs.
Tuberculosis, a terror of the past and once thought to be near eradication, has recently
experienced a rebirth of sorts. Reichman suggests that the seeds for a pandemic of multi-drugresistant tuberculosis are being sown in, among other places, Russia, where the disease is
thriving. This epidemic is being worsened by the presence of HIV, which enhances TB’s impact.
Timebomb provides an introduction to the science and history of the disease, as well as a review
of current attempts to control its spread.
Conquering Rheumatoid Arthritis: The Latest Breakthroughs and Treatments
By Thomas F. Lee. Prometheus Books, 2001, 255 pgs.
Lee, who has worked on the Human Genome Project, provides the reader with an up-to-date
account of research efforts to combat the autoimmune disease, including several molecular and
gene-based therapies. He also explores the ethical implications for future human genome
research. The book is a detailed look at a relatively prevalent autoimmune disorder.
The Malaria Capers: More Tales of Parasites and People, Research and Reality
By Robert S. Desowitz. W. W. Norton, 1991, 288 pgs.
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Desowitz cites the shortcomings of research as he explains worsening health and health systems,
especially in poorer countries. He says a vaccine against malaria has not been found because of
misrepresentation, poor use of funds, and blatant incompetence.
The Miraculous Fever-Tree: Malaria and the Quest for a Cure That Changed the World
By Fiammetta Rocco. HarperCollins, 2003, 348 pgs.
Rocco follows the intricate history of the tree from which quinine, the most common antidote to
malaria, was produced. A native Kenyan who was infected with malaria as a child, she combines
her experience with the history of quinine and its development as a medicine.
E. coli 0157: The True Story of a Mother’s Battle with a Killer Microbe
By Mary Heersink. New Horizon Press, 1996, 303 pgs.
Heersink describes her son’s experience dealing with the severe illness he developed after eating
an undercooked hamburger contaminated with drug-resistant E coli 0157. The child beats the
sickness, but not before several of his organs are threatened by the bacterium. Heersink, who is
not conﬁdent about the effectiveness of testing procedures for meat, has testiﬁed before Congress
about the matte
Parasite Rex: Inside the Bizarre World of Nature’s Most Dangerous Creatures
By Carl Zimmer. Free Press, 2000, 298 pgs.
Zimmer reviews the history of the study of parasites, starting with discoveries made in the
nineteenth century about their strange life cycles. He discusses how parasites travel from one
host to another, and the battle the immune system wages against them, concluding with a look at
the role of parasites in human medicine and agriculture.
The Coming Plague: Newly Emerging Diseases in a World Out of Balance
By Laurie Garrett. Farrar, Straus, and Giroux, 1994, 750 pgs.
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Garrett documents the history of global epidemics while introducing her reader to new,
increasingly threatening diseases. In this telling investigation, she explores the effects of social
development on ecosystems, suggesting that these disruptions may be the cause for the spread
and creation of infectious diseases. Garrett concludes with a sobering proposal, calling for the
creation of a global early warning system that would bolster detection in an effort to prevent the
spread of infectious diseases.
IMMUNOLOGY
Fatal Sequence: The Killer Within
This novel by Kevin Tracey, a neurosurgeon and immunologist, describes the case of a 1-yearold burn victim, Janice.
How the Immune System Works
By Lauren Sompayrac. Blackwell Publishers, 2003, 100 pgs. Second edition
In this overview of the body’s immune functions, Sompayrac avoids the intricacies of the
immune system and the exceptional phenomena that can sometimes occur and instead focuses on
the big picture, providing the lay reader with a basic foundation in immunology.
The Eradication of Smallpox: Edward Jenner and the First and Only Eradication of a
Human Infectious Disease
By Hervé Bazin. Academic Press, 2000, 246 pgs.
Bazin describes the history of smallpox, a disease that ravaged the world in the 1700s and 1800s,
and examines the life of Edward Jenner, who ﬁrst proposed ―
vaccination‖ with cowpox. He
follows the ﬁght against smallpox through its 1979 eradication and covers the debate about
whether to maintain the stocks of smallpox virus in the United States and Russia.
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Plague Time: How Stealth Infections Cause Cancers, Heart Disease, and Other Deadly
Ailments
By Paul W. Ewald. The Free Press, a division of Simon and Schuster, 2000, 288 pgs.
Ewald asserts that a wide variety of ailments, including breast cancer, diabetes, and
schizophrenia, are caused, at least in part, by microbes. Further, he says that there is strong
resistance to this idea within the medical community and that it is preventing progress in efforts
to combat these diseases. The book highlights the potential importance of a better understanding
of immunology as a ﬁeld.
My Adventure with Lupus: Living with a Chronic Illness
By Robert L. Yocum. Grifﬁn Publishing Group, 1995, 172 pgs.
Yocum recounts his own experience with lupus. Since there is no cure for the disease, which
inﬂames connective tissue in the body, living with lupus is a continuous battle. Yocum describes
how lupus develops and suggests how best to cope with it.
SARS: A Case Study in Emerging Infections
Edited by Angela R. McLean, Robert M. May, John Pattison, and Robin A. Weiss. Oxford
University Press, 2005, 133 pgs.
The editors use the SARS outbreak of 2002 as a model for examining worldwide response
capabilities in the face of infectious-disease epidemics. The authors look at issues of trans-global
travel and isolation of infected people in an increasingly integrated world. Highlighting many
global public health issues, the book offers a model for addressing future problems.
Multiple Sclerosis: The History of a Disease
By T. Jock Murray. Demos Medical Publishing, 2005, 580 pgs.
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Murray’s book outlining the history of multiple sclerosis is written for laypeople. It describes
early cases from the days before MS was a deﬁned disease and chronicles the development of the
various treatments in use today. The book provides an overview of the disease and its past.
Commotion in the Blood: Life, Death, and the Immune System
By Stephen S. Hall. Henry Holt, 1997, 544 pgs.
Hall traces the history of immune therapies for cancer, describing complex immunological
processes in simpler terms for the lay reader. He is critical of making too much of research
success and does not see a deﬁnite cure on the horizon.
At War Within: The Double-Edged Sword of Immunity
By William R. Clark. Oxford University Press, 1995, 276 pgs.
Highlighting several threats to public health, including tuberculosis, AIDS, and allergies, Clark
examines each in detail and describes the immune response. Among the varied reactions are
those that end up harming the body: so-called autoimmune responses. Clark also provides a basic
history of immunology.
Tao of Immunology: A Revolutionary New Understanding of Our Body’s Defenses
By Marc Lappé. Plenum Press, 1997, 317 pgs.
Lappé, a toxicologist, challenges the pop-culture approach of taking supplements to bolster the
immune system, arguing that too strong an immune system can be harmful. He cites the
numerous diseases in which the immune system attacks the body it is meant to protect.
Essentially the book argues that artiﬁcially manipulating the immune system does more damage
than good.
Inside AIDS: HIV Attacks the Immune System
By Conrad J. Storad. Lerner Publications Co., 1998, 96 pgs.
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The book (current through 1997) describes how HIV is transmitted, how it inﬁltrates the human
immune system, and its subsequent effect on the body. Storad focuses on the scientiﬁc and
microbial level rather than the public health level, though he does discuss methods for preventing
the spread of the disease. Storad also offers a history of AIDS, beginning in the early 1980s.
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Internet Resources
These are websites that may be of interest for further research and information about topics that
may come up in the course. I have compiled some of these from Biology by Campbell and online search engines.
General Resources
A comprehensive site covering signal transduction pathways, offered from Science, includes
articles, reviews and experimental protocols. http://stke.sciencemag.org/
A National Library of Medicine dataset of more than 9 million publications is the world’s most
comprehensive bibliographic database for biological and biomedical literatures.
American Academy of Family Physicians: www.aafp.org
American Association of Immunologists http://www.aai.org
American Association of Immunologists: www.aai.org
American Association of Veterinary Immunologists: cvm.missouri.edu/aavi
American Cancer Society, updated regularly http://www.cancer.org/docroot/home/index.asp
American Lung Association: www.lungusa.org
American Society for Histocompatibility & Immunogenetics (A National Research Council):
www.ashi-hla.org
Arthritis Foundation: www.arthritis.org
Associated with the Kuby Immunology Text www.whfreeman.com/kuby
Association of Medical Laboratory Immunologists: www.amli.org
Association of Medical School Microbiology and Immunology Chairs: www.amsmic.org
British Aerobiology Federation: www.pollenuk.co.uk/baf/BAF.html
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British Society for Immunology: immunology.org Department of Health (UK):
www.dh.gov.uk/Home/fs/en
Canadian Institutes of Health Research—Institute of Infection and Immunity: www.cihrirsc.gc.ca/e/13533.html
Canadian Society for Immunology: www.csi.ucalgary.ca/
Cells Alive sub-site has time-lapse video of cytotoxic T lymphocytes (CTLs) recognizing,
attacking, and killing a much larger influenza-infected target. http://www.cellsalive.com/ctl.htm
Centers for Disease Control and Prevention: www.cdc.gov
Clinical Immunology Society: www.clinimmsoc.org
Clinical Ligand Assay Society: www.clas.org
Comprehensive information about many types of cancer and good source of information about
cancer research and advances in cancer therapy http://www.oncolink.upenn.edu/
Department of Health and Human Services: www.hhs.gov
eMedicine.com: www.emedicine.com
Environmental Protection Agency: www.epa.gov
Every Child by Two offers useful information on childhood vaccination, including recommended
immunization schedules http://www.ecbt.org/
Federation of American Societies for Experimental Biology: www.faseb.org
Free software for visualizing molecular structures that can be run on Windows-based, Macintosh,
or Unix PCs, to view 3-D structures of many types of molecules, including proteins and nucleic
acids. http://www.umass.edu/microbio/rasmol/
Health Canada: www.hc-sc.gc.ca
Health Protection Agency: www.hpa.org.uk
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Home page for the National Institute for Arthritis and Musculoskeletal and skin Diseases
http://www.nih.gov/niams/
Home page for the National Institute for Diabetes and Digestive and Kidney Diseases
http://www.niddk.nih.gov/
Home page for the New England Biolabs, a molecular biology company, gives useful
information concerning restriction enzymes http://www.neb.com/
Home page for the World Health Organization, international organization that monitors
infectious diseases worldwide http://www.who.int/
Home page of Global Alliance for Vaccines and Immunization, a source of information about
vaccines in developing countries and worldwide efforts at disease eradication
http://www.VaccineAlliance.org/
http://www.ultranet.com~jkimball/BiologyPages/B/B_andTcells.html
Images of major inflammatory cells involved in acute and chronic inflammation, as well as
example of specific inflammatory diseases.http://cpmcnet.columbia.edu/dept/curricpathology/pathology/pathology/pathoatlas/GP_I_menu.html
Immune Deﬁciency Foundation: www.primaryimmune.org
ImmuneDisease.com: www.immunedisease.com
Immunization Action Coalition: www.immunize.org
Information about the global AIDS epidemic http://hivinsite.ucsf.edu/
Jeffrey Modell Foundation: www.jmfworld.com
Journal of Immunology: www.jimmunol.org
KidsHealth: www.kidshealth.org
MayoClinic.com: www.mayoclinic.com

188

Medinfo (UK): www.medinfo.co.uk
Molecular Biology web site, updated regularly
http://www.public.iastate.edu/~pedro/research_tools.html
Molecular Immunology Foundation: www.mifoundation.org
National Biological Information Infrastructure: www.nbii.gov
National Center for Biotechnology Information: www.ncbi.nlm.nih.gov
National Coalition for Adult Immunization: www.nfid.org/ncai
National Foundation for Infectious Diseases: www.nfid.org
National Heart, Lung and Blood Institute: www.nhlbi.nih.gov
National Human Genome Research Institute: www.genome.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases: www.niams.nih.gov
National Institute of Neurological Disorders and Stroke: www.ninds.nih.gov
National Library of Medicine: www.nlm.nih.gov
National Network for Immunization Information: www.immunizationinfo.org
National Primary Immunodeﬁciency Resource Center: npi.jmfworld.org
Primary Immunodeﬁciency Association: www.pia.org.uk
Society for Mucosal Immunology: www.socmucimm.org
The Animal Diversity Web (Taylor et al.) is based at the University of Michigan, comprehensive
database of animal classification as well as a source of information on animal natural history and
distribution. http://animaldiversity.ummz.umich.edu/site/index.html
The Antibodies: Structure and Sequence Web site summarizes useful information on antibody
structure and sequence. http://www.bioinf.org.uk/abs/
The Global Fund: www.theglobalfund.org/en
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The National Center for Infectious Diseases home page. Great site for monitoring emerging
diseases and many other links http://www.cdc.gov/ncidod/
The Online Mendelian Inheritance in Man Web site contains a sub-site that features 10 different
inherited diseases associated with defects in the TCR complex or associated proteins.
http://www.ncbi.nlm.nih.gov/Omim/
The SCID home page http://www.scid.net/
The site for the Lupus Foundation of America http://www.lupus.org/index.html
The University of Pittsburgh Center for Biosecurity Web site provides information about select
agents and emerging diseases that may pose a security threat http://www.upmc-biosecurity.org/
These sub-sites of John Kimball’s’ Biology Pages Web site provide a clear introduction to T-cell
biology and a good basic discussion of apoptosis
http://www.ultranet.com/~jkimball/BiologyPages/A/Apoptosis.html
United Scleroderma Foundation: www.scleroderma.com
World Health Organization: www.who.int/en
AIDS
See HIV.
Allergies and Asthma
Allergy & Asthma Network Mothers of Asthmatics: www.aanma.org/headquarters
Allergy Society of South Africa: www.allergysa.org
American Academy of Allergy, Asthma & Immunology: www.aaaai.org
American Lung Association: www.asthmacontrol.com
Asthma and Allergy Foundation of America: www.aafa.org
Asthma UK: www.asthma.org.uk

190

European Academy of Allergology and Clinical Immunology: www.eaaci.net/site/homepage.php
European Federation of Allergy and Airway Diseases: www.efanet.org
Global Initiative for Asthma: www.ginasthma.com
Hispanic American Allergy and Immunology Association: www.haama.org
Joint Council of Allergy, Asthma and Immunology: www.jcaai.org
Lung Association (Howe): www.lung.ca/asthma
My Asthma: www.myasthma.com
National Asthma Council (Australia): www.nationalasthma.org.au
National Institute of Allergy and Infectious Diseases: www.niaid.nih.gov
Texas Allergy, Asthma and Immunology Society: www.taai.org
World Allergy Organization: www.worldallergy.org
Amyotrophic lateral sclerosis (American Association for the Advancement of Science)
ALS Association: www.alsa.org/
ALS Society of Canada: www.als.ca/
Ataxia-Telangiectasia
A-T Children’s Project: www.atcp.org
Ataxia-Telangiectasia Society (UK): www.atsociety.org.uk
Autoimmune diseases
American Autoimmune Related Diseases Association: www.aarda.org
Bird Influenza
Agriculture Department—Animal Production and Health Division (Italy):
www.fao.org/ag/againfo/subjects/en/health/ diseases-cards/special_avian.html
Prevention of Avian Inﬂuenza (Hong Kong): www.info.gov.hk/info/ﬂu/eng
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Cancer
American Association for Cancer Research: www.aacr.org
American Cancer Society: www.cancer.org
Cancer Research and Prevention Foundation: www.preventcancer.org
Cancer Research UK: www.cancerresearchuk.org
Dana-Farber Cancer Institute: www.dfci.harvard.edu
Memorial Sloan-Kettering Cancer Center: www.mskcc.org/mskcc/html/44.cfm
National Cancer Institute: www.nci.nih.gov
Chronic granulomatous disease
Immune Deﬁciency Foundation: www.primaryimmune.org
Crohn’s disease
Crohn’s & Colitis Foundation of America: www.ccfa.org
Diabetes
American Diabetes Association: www.diabetes.org
Canadian Diabetes Association: www.diabetes.ca
Children with Diabetes: www.childrenwithdiabetes.com
Joslin Diabetes Center: www.joslin.org
Juvenile Diabetes Research Foundation International: www.jdf.org
Graft-versus-host disease
National Marrow Donor Program: www.marrow.org
Hepatitis A
Hepatitis Foundation International: www.hepﬁ.org
Hepatitis Neighborhood: www.hepatitisneighborhood.com

192

Hepatitis.org: www.hepatitis.org
Hepatitis Magazine: www.hepatitismag.com
HepNet (Canada): www.hepnet.com
Hepatitis C
See Hepatitis A.
Hepatitis C Information Center: www.hepatitis-central.com
Herpes
American Herpes Foundation: www.herpes-foundation.org
Herpes.com: www.herpes.com
HIV
Aegis-AIDS Education Global Information System: www.aegis.com
AIDSmap: www.aidsmap.com
HIV InSite: hivinsite.ucsf.edu
Joint United Nations Programme on HIV/AIDS: www.unaids.org/en/default.asp
The Body: www.thebody.com
Lyme disease
Lyme Disease Association: www.lymediseaseassociation.org
Lyme Disease Foundation: www.lyme.org
Lyme Info: www.lymeinfo.net
LymeNet: www.lymenet.org
Malaria
Africa Fighting Malaria: www.ﬁghtingmalaria.org
Malaria Foundation International: www.malaria.org
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Malaria Journal: www.malariajournal.com
Malaria Vaccine Initiative: www.malariavaccine.org
Measles
Measles Initiative: www.measlesinitiative.org
Multiple sclerosis
All About Multiple Sclerosis: www.mult-sclerosis.org
Consortium of Multiple Sclerosis Centers: www.mscare.org
MS Australia: www.msaustralia.org.au
Multiple Sclerosis Association of America: www.msaa.com
Multiple Sclerosis Foundation: www.msfacts.org
Multiple Sclerosis International Federation: www.msif.org
Multiple Sclerosis Resource Centre (UK): www.msrc.co.uk
Multiple Sclerosis Society of Canada: www.mssociety.ca
National Multiple Sclerosis Society: www.nmss.org
Rabies
Rabies.com: www.rabies.com
Respiratory syncytial virus (RSV)
RSV Info Center: www.rsvinfo.com
Rheumatoid arthritis
American College of Rheumatology: www.rheumatology.org
Arthritis Foundation: www.arthritis.org
Rotavirus
Rotavirus Vaccine Program: www.rotavirusvaccine.org
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SARS
SARSReference: www.sarsreference.com
Severe combined immunodeﬁciency disease (SCID) SCID.NET: www.scid.net
Sjögren’s syndrome
Sjögren’s Syndrome Foundation, Inc.: www.sjogrens.com
Systemic lupus erythematosus
Alliance for Lupus Research: www.lupusresearch.org
Lupus Foundation of America: www.lupus.org/
Toxic shock syndrome
Toxic Shock Syndrome Information Service: www.toxicshock.com
Tuberculosis
Tuberculosis.net: www.tuberculosis.net
Information on diseases not listed can usually be found on the general information or
government resources Web sites.
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Key Immunology Terms:
By From the Dana Sourcebook of Immunology, free access on-line (The Dana Foundation,
2005).
active immunity: usually long-lasting immunity that is acquired through the production of
antibodies and memory T cells within the organism in response to the presence of antigens.
adaptive immune system: also called the acquired immune system, this component of the
immune system comprises white blood cells, particularly lymphocytes. When it is presented with
a new microbe or vaccine, it may take days or weeks to respond or adapt, but the resultant
improved immune readiness, or ―
memory,‖ is sustained for long periods (years).
adenosine deaminase (ADA): an enzyme found in mammalian tissues that is capable of
catalyzing the process in which adenosine is split into inosine and ammonia. A deﬁciency can
cause problems with metabolic reactions in cells, which leads to the destruction of B and T cells.
ADA deﬁciency can lead to one form of severe combined immunodeﬁciency disease.
allergy: a misguided reaction by the immune system to harmless foreign substances.
antibody: a protein on the surface of B cells that is also secreted in large amounts into the blood
or lymph in response to an antigen, a component within an invader such as a bacterium, virus,
parasite, or transplanted organ. Antibodies neutralize the antigen, and thereby the invader, by
binding to it, often directing it toward a macrophage for destruction. Also called an
immunoglobulin.
antigen: a foreign substance (usually a protein or carbohydrate) capable of triggering an immune
response in an organism.
antiretroviral drugs: drugs that act against retroviruses (such as HIV ).
autoimmune disorders: conditions in which the body’s own immune system acts against it.
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autoreactive: describes immune cells that mount a response against the body’s own cells or
tissues.
B cell: a type of lymphocyte that produces antibodies, which bind to free-ﬂoating microbes
circulating in the blood so that they cannot infect other cells.
biochemicals: chemicals produced within living organisms. Many coordinate to ﬁght off
invasion in an immune response.
biological barriers: the body’s ﬁrst layer of protection against harmful microbes; skin is a prime
example.
blood-brain barrier: a tight layer of cells and tissue that separates the brain from the rest of the
body; a physical roadblock that normally keeps immune cells outside the brain.
blood-forming stem cells: immature cells in the bone marrow that multiply extensively and
produce red and white blood cells and platelets.
CD4+ helper T cells: T cells with CD4 receptors that respond to antigens on the surface of
speciﬁc molecules by secreting a certain type of cytokine that stimulates B cells and killer T
cells. Helper T cells are infected and killed by HIV; people who develop AIDS have no more
than one-ﬁfth the normal number of helper T cells.
central nervous system: the brain and spinal cord, to which sensory impulses are transmitted
and from which motor impulses emanate. The central nervous system supervises and coordinates
the activity of the entire nervous system and interacts with the immune system.
clones: copies that viruses make of themselves.
cytokine: a class of substance secreted by cells of the immune system to regulate immune cells.
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dendritic cell: an antigen-presenting immune cell that initiates the immune response by
activating lymphocytes and stimulating the secretion of cytokines. Dendritic cells also prevent
autoimmune reactions by instructing the T lymphocytes to be silent or tolerant to the body itself.
DNA (deoxyribonucleic acid): nucleic acid that carries the cell’s genetic information and is
capable of self-replication and the synthesis of RNA.
DNA vaccine: vaccines that often use ―
naked‖ DNA (DNA not associated with a cell or a virus)
with instructions for making protective antigens. When injected, the DNA is taken in by other
cells, which then produce protective antigens.
E. coli: a bacterium that is used in public health as an indicator of fecal pollution (as of water or
food) and in medicine and genetics as a research organism. E. coli occurs in various strains that
may live as harmless inhabitants of the human lower intestine or may produce a toxin causing
intestinal illness.
enzymes: complex proteins produced by living cells and that catalyze speciﬁc reactions from
biochemicals.
epidemic: an outbreak of disease that simultaneously affects an atypically large number of
individuals within a population, community, or region.
estrogen: a steroid hormone produced chieﬂy by the ovaries, responsible for promoting
development and maintenance of female secondary sex characteristics. Estrogen may play a role
in certain immune system diseases.
genetic engineering: deliberate alteration of genetic material by intervention in genetic
processes.
granulocyte: a type of phagocyte with cytoplasm that contains grain like particles.
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highly active antiretroviral therapy (HAART): a treatment to combat AIDS using several
antiretroviral drugs at the same time.
histamine: a compound found in mammalian tissues that causes stretching of capillaries,
contraction of smooth muscle, and stimulation of gastric acid secretions; released during allergic
reactions.
immune deﬁciency diseases (IDDs): diseases that result when one or more parts of the immune
system are missing or defective.
immunoglobulin E (IgE): a class of antibodies that function in allergic reactions.
immunosuppressive: describes a treatment that suppresses natural immune responses—for
example, chemotherapy for cancer.
inactivated vaccines: vaccines made by growing and purifying large numbers of the target
organism in the laboratory and then killing them with heat, radiation, or chemicals. The immune
system reacts to the dead microorganisms, producing immunity.
inﬂammation: a buildup of ﬂuid and cells that occurs as the immune system ﬁghts a hostile
invader.
innate immune system: component of the immune system that consists of a set of genetically
encoded responses to pathogens and does not change or adapt during the lifetime of the
organism. Innate immunity involves quickly mobilized defenses triggered by receptors that
recognize a broad spectrum of microbes; in contrast to adaptive immunity, it does not acquire
memory for an improved response during a second exposure to infection.
killer T cell: a type of lymphocyte that directly attacks and kills infected cells or other targets,
including tumor cells and even one’s own tissues. Killer cells are generated by the coordinated
action of dendritic cells and CD4+ helper T cells.
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knockout: term used in genetic engineering when a speciﬁc gene is deliberately removed in
order to create an organism unable to carry out the functions the gene codes for; knockouts are
used by immunologists to determine the functions of speciﬁc genes that encode immune proteins.
latency: the state or period in which a virus has invaded a host but is not actively multiplying,
and during which symptoms of the infection are not seen. ―
Microbial latency‖ means the
microbe is not multiplying, as occurs in some cells in HIV infection, while ―
clinical latency‖
means that the patient does not have symptoms of disease even though the virus is multiplying
and damaging the immune system. In HIV, clinical latency precedes the AIDS stage.
lymph nodes: small, rounded structures in the lymphatic system that contain disease-ﬁghting
white blood cells, especially lymphocytes, and ﬁlter out harmful microbes and toxins. Lymph
nodes may become enlarged when they are actively ﬁghting infection.
lymphocyte: a type of white blood cell involved in the human body’s immune system, of which
there are two broad categories, T cells and B cells. Lymphocytes are an integral part of the
body’s defenses because they are highly speciﬁc for antigens associated with microbes, tumor
cells, transplants, allergies, and tissues attacked in autoimmune diseases. The immune system
comprises clones of lymphocytes, each with a single speciﬁcity, and exposure to antigens leads
to clonal expansion, the acquisition of helper and killer functions, and formation of immune
memory.
lysozyme: an enzyme in saliva and tears that destroys bacteria.
macrophages: large phagocyte cells that remove harmful microbes from the body.
major histocompatibility complex (MHC) molecules: a group of molecules that help the
immune system distinguish between harmful and safe foreign substances in the body. Recent
research suggests some classes of MHC molecules also play an essential role in brain function.
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mast cells: large cells, found in connective tissues, that mediate allergic reactions. Mast cells
play an important protective role in wound healing and defend against pathogens.
memory B and T cells: B and T cells that remain in the body after the completion of an immune
response to ward off future attacks by the same microbe. Memory is imparted by the increased
size in the antigen-speciﬁc B or T cell clone, as well as improved function of individual cells
within the clone.
microglia: specialized immune cells, related to macrophages, that protect the central nervous
system.
molecular mimicry: an occurrence in many autoimmune disorders in which a microbe carries
antigens that resemble those on a particular organ, causing the immune system to attack the
body.
monoclonal antibodies: antibodies derived from a single cell and used against a speciﬁc antigen
such as a cancer cell. Rituxan and Herceptin are monoclonal antibodies used in the treatment of
lymphoma and breast cancer, respectively.
mutation: a process in which a microbe or organism undergoes a permanent change in
hereditary material. When viruses or bacteria mutate they are no longer recognized by the
immune system and become resistant to previously administered vaccines and drugs.
myelin: a white, fatty material that sheathes nerves and enhances the transmission of signals
between the brain and the body. In multiple sclerosis, an autoimmune disorder, immune cells
attack myelin, affecting the transmission of nerve signals.
pandemic: an outbreak of disease occurring over a wide geographical area and affecting an
exceptionally high proportion of the population.
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passive immunity: immunity acquired by the transfer of antibodies (as by injection of serum
from an individual with active immunity).
pathogen: a speciﬁc causative agent of disease, such as a bacterium or a virus.
penicillin: a mixture of nontoxic antibiotics produced by mold and used regularly to treat
harmful bacteria.
phagocyte: a cell such as a white blood cell that engulfs and consumes foreign material, such as
microorganisms.
plasma cell: an antibody-producing lymphocyte derived from a B cell upon reaction with a
speciﬁc antigen.
protease: an enzyme that catalyzes the splitting of proteins into smaller molecules. To treat
AIDS, scientists have designed drugs that interfere with protease made by the HIV virus, which
is essential to its replication.
reassortment: the constant state of ﬂux and rearrangement seen in the genes of viruses.
red blood cells: any of the hemoglobin-containing cells that carry oxygen to the tissues and are
responsible for the red color of vertebrate blood..
regulatory T cells (Treg cells): special T cells that regulate or suppress immune responses,
preventing autoimmunity for example.
replication: process by which an organism produces a copy of itself—for example, the way
microbes reproduce.
respiratory syncytial virus (RSV): a virus that forms masses, or syncytia, in tissue culture and
that is responsible for severe respiratory diseases.
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retrovirus: a type of RNA virus (such as HIV ) that reproduces by transcribing itself into DNA
(using reverse transcriptase). The resultant DNA inserts itself into a cell’s DNA and is
reproduced by the cell.
reverse transcriptase (RT): an enzyme that catalyzes the formation of DNA using RNA as a
template.
RNA (ribonucleic acid): a group of molecules similar in structure to a single strand of DNA.
The function of RNA is to carry the information from the DNA in the cell’s nucleus into the
body of the cell to assemble proteins.
rotavirus: a retrovirus with a double-layer protein shell and a wheel-like appearance.
Rotaviruses cause diarrhea, especially in infants.
stem cell transplants: a kind of passive immune therapy that transfers cells instead of
antibodies. Stem cells have the capacity to give rise to all elements of the immune system, such
as many types of lymphocytes and phagocytes.
steroids: a large family of chemical substances, comprising many hormones, body constituents,
and drugs; they are often immunosuppressive.
subunit vaccines: vaccines that contain only a part of the target microorganism.
synapses: specialized junctions at which cells of the nervous system signal to one another and to
nonneuronal cells, such as those of muscles and glands.
T cell: a type of lymphocyte that possesses highly speciﬁc cell-surface antigen receptors; types
include CD4+ helper T cells, regulatory T cells, and killer T cells.
tolerance: the capacity of the body to become less responsive to a substance or a physiological
insult. Tolerance to components of the self prevents or suppresses autoimmunity.
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toxoid vaccine: an inactivated and weakened version of the disease-causing toxin a microbe
produces; it is still capable of inducing the formation of antibodies when injected.
transgenic technology: technology used to deliberately alter the genome of an organism by the
transfer of a gene or genes from another species or breed.
two-photon microscopy: an imaging technique using high-powered laser microscopes to
examine immune response in the nervous system.
vaccine: killed microorganisms, weakened living organisms, fully virulent living organisms, or
subunit proteins of a microbe, administered to produce or artiﬁcially increase immunity to a
particular disease.
vector vaccines: vaccines made by inserting protective antigen genes into harmless bacteria or
viruses (vectors). As the vectors multiply in the body, they expose the immune system to
protective antigens, stimulating active immunity against the harmful organism.
white blood cells: any of the blood cells that are colorless, lack hemoglobin, and contain a
nucleus. They include the lymphocytes, dendritic cells, monocytes, neutrophils, eosinophils, and
basophiles; also called leukocytes
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Selected Diseases Related to the Immune System:
By From the Dana Sourcebook of Immunology, free on-line access
acquired immunodeﬁciency syndrome (AIDS): a disease of the immune system that is caused
by infection with human immunodeﬁciency virus (HIV), commonly transmitted in blood and
body secretions such as semen. People with AIDS are highly vulnerable to life-threatening
infections.
amyotrophic lateral sclerosis (ALS): a rare, fatal, progressive degenerative disease that affects
pyramidal motor neurons (responsible for all voluntary movements), characterized especially by
increasing and spreading muscular weakness. ALS, also called Lou Gehrig’s disease, usually
appears in middle age.
asthma: a condition often of allergic origin that is marked by labored breathing accompanied by
wheezing and a sense of constriction in the chest, and often by attacks of coughing or gasping.
athlete’s foot: a foot rash caused by a fungus.
autism: a mental disorder that appears at a young age and is characterized by self-absorption,
inability to interact socially, repetitive behavior, and language difficulty.
bird ﬂu: (also avian inﬂuenza); any of several highly variable diseases of domestic and wild
birds, caused by viruses and usually characterized by respiratory symptoms.
cancer: a malignant tumor of potentially unlimited growth that expands locally by invasion and
can spread throughout the body in a process called metastasis.
chicken pox: a contagious disease, usually in children, caused by a virus and marked by lowgrade fever and the formation of blister like spots; also called varicella.
chronic lung disease: one of a group of recurrent diseases of the lower respiratory tract.
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coronary artery disease: a condition that reduces the blood ﬂow through the coronary arteries
to the heart muscle; also called coronary disease, coronary heart disease.
cowpox: a mild disease in cows that is caused by a poxvirus and that protects against a related
virus, smallpox, when injected as a vaccine into humans.
Crohn’s disease: a disease of the small intestine that often spreads to the colon, part of the large
intestine. Crohn’s disease is characterized by diarrhea, cramping, and loss of appetite and weight,
with local abscesses and scarring.
diabetes: abnormal condition characterized by a lack of insulin or a resistance to insulin. The
excretion of excessive amounts of urine is an early symptom.
gonorrhea: a contagious inﬂammation of the genital mucous membrane caused by the
gonococcus bacterium.
hantavirus: any of a group of closely related viruses that cause a respiratory disease or fever
accompanied by leakage of plasma and red blood cells through the lining of blood vessels and by
the death of kidney tissue.
hepatitis A: a usually benign inﬂammation of the liver, caused by an RNA-containing virus that
does not persist in the blood serum. Hepatitis A is transmitted especially in food and water
contaminated with fecal matter.
hepatitis C: a disease that inﬂames the liver, caused by a single-stranded RNA-containing virus
and usually transmitted by exposure to blood or blood products. Hepatitis C leads eventually to
scarring in the liver and liver cancer.
herpes: inﬂammatory diseases of the skin caused by one of several herpes viruses and
characterized by clusters of blisters.
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human immunodeﬁciency virus (HIV): a retrovirus that infects and destroys CD4+ helper T
cells in the immune system, causing the marked reduction in their number and thus lowering
resistance to life-threatening infections that characterize AIDS.
Lyme disease: an acute inﬂammatory disease that is usually characterized initially by skin
lesions, fatigue, fever, and chills, and if left untreated may later manifest itself in cardiac and
neurological disorders, joint pain, and arthritis. Lyme disease is caused by a bacterium
transmitted by the bite of a tick.
malaria: a disease caused by the presence of the organism Plasmodium in human or other
vertebrate red blood cells, usually transmitted to humans by the bite of an infected female
mosquito that previously sucked blood from a person with malaria. The disease is characterized
by episodic severe chills, high fever, and exhaustion; it can be fatal.
measles: a contagious viral disease that begins with conjunctivitis (pinkeye), coughing, and spots
in the mouth. Measles is marked by the appearance on the third or fourth day of an eruption of
distinct red circular bumps that gradually diminish after another four days, and much less
frequently by serious inﬂammation of the brain (encephalitis).
mononucleosis: an infectious disease associated with the Epstein-Barr virus; characterized by
fever, swelling of lymph nodes, and an abnormal increase of single-nucleus white blood cells
(accounting for the preﬁx ―
mono-‖).
multiple sclerosis: a disease marked by patches of hardened tissue in the brain and on the spinal
cord that causes the destruction of the nerves’ protective myelin sheath. Partial or incomplete
paralysis and jerking muscle tremor can result.
mumps: a contagious disease caused by a paramyxovirus and marked by fever and swelling,
especially of the parotid glands.
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Parkinson’s disease: a chronic, progressive nervous system disease that usually appears later in
life and is linked to decreased dopamine production in the substantia nigra brain region.
Parkinson’s disease is marked by tremor and weakness of resting muscles and by a shuffling gait.
primary immune deﬁciency (PID) diseases: diseases caused by an inherited genetic defect that
interferes with the immune system’s normal development.
rabies: highly fatal infectious disease transmitted by the bite of infected animals, including dogs,
cats, foxes, raccoons, and bats, and caused by a virus in the central nervous system and the
salivary glands. The symptoms are characteristic of a profound disturbance of the nervous
system: excitement, aggressiveness, and madness, followed by paralysis and death.
rheumatoid arthritis: a usually chronic autoimmune disorder characterized especially by pain,
stiffness, inﬂammation, swelling, and sometimes destruction of joints.
rubella (German measles): a contagious viral disease that is milder than typical measles but is
damaging to the fetus when it occurs early in pregnancy.
scleroderma: a disease, usually slow to progress, characterized by ﬁbrous connective tissue in
the skin and, frequently, internal organs. Symptoms include sensitivity to cold and tightening and
thickening skin.
selective immunoglobulin A deﬁciency (selective IgA deﬁciency): a condition that results
when B lymphocytes, a type of white blood cell, do not mature properly and fail to produce
immunoglobulin A antibodies at the levels required. People with the condition can be healthy or
suffer recurrent lung, ear, and sinus infections.
severe acute respiratory syndrome (SARS): a severe form of pneumonia, caused by a virus,
that appeared in outbreaks in 2003.
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severe combined immunodeﬁciency disease (SCID): a rare, congenital disorder of the immune
system characterized by the inability of B cells and T cells to produce a normal complement of
antibodies; usually results in early death.
smallpox: a contagious disease characterized by fever, pus-ﬁlled bumps on the skin, separation
of dead tissue, and scar formation; caused by a poxvirus that is believed to exist now only in lab
cultures.
systemic lupus erythematosus: an inﬂammatory autoimmune disease of unknown cause that
leads to the production of autoantibodies, or antibodies that recognize and attack the body’s own
components. Occurring chieﬂy in women, it is characterized especially by fever, skin rash, and
arthritis; often by anemia, in which red blood cells are destroyed; by small hemorrhages in the
skin and mucous membranes; by inﬂammation of the pericardium (the sac around the heart); and
in serious cases by involvement of the kidneys and central nervous system.
toxic shock syndrome: a sometimes fatal disease characterized by fever, nausea, diarrhea, skin
redness, and shock. The syndrome is associated especially with the presence of the bacterium
Staphylococcus aureus, which produces a toxic protein, and occurs especially in menstruating
females using tampons.
tuberculosis: a highly variable disease caused by the tubercle bacterium or, rarely in the United
States, a related bacterium. Usually transmitted by inhalation of airborne bacteria, it affects the
lungs but may spread to other areas, especially the brain, from local lesions or by way of the
lymph or blood vessels. Tuberculosis is characterized by fever, coughing, difficulty in breathing,
and inﬂammation.
turista: also called traveler’s diarrhea; intestinal sickness typically caused by ingesting
microorganisms such as E. Coli.
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West Nile: disease caused by a virus spread chieﬂy by mosquitoes that causes an illness marked
by fever, headache, muscle ache, skin rash, and sometimes encephalitis or meningitis.
whooping cough: also called pertussis; an infectious disease especially of children that is caused
by a bacterium and is marked by a convulsive, spasmodic cough, sometimes followed by a shrill
intake of breath. Whooping cough is one of the targets of the diphtheria-pertussis-tetanus (DPT)
vaccine.
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Alignment with Utah State Performance Benchmarks with Standards:
The following are benchmarks, standards and objectives set out by the Utah State Board of
Education for secondary biology teachers. This Core was designed using the American Association
for the Advancement of Science’s Project 2061: Benchmarks For Science Literacy and the National
Academy of Science’s National Science Education Standards as guides to determine appropriate
content and skills. The Utah Science Home Page at http://www.usoe.k12.ut.us/curr/science is an
ongoing report of resources available and aligned to the Biology Core Curriculum.
* This professional development curriculum encompasses many of the items delineated from the
State Science Core but at a molecular and microbial level. When possible, the trainer should refer to
the State Core Standards and Objectives as he/she moves through the course with the teachers.
Emphasis in molecular biology and microbiology will not add more to the curriculum. Instead,
whenever the core refers to ―or
ganism‖ the trainer should point out that viruses, bacteria and host
cells of pathogens can just as easily be used to deal with state mandated objectives.
Benchmark 1: Ecosystems are shaped by interactions among living organisms and their physical
environment. Ecosystems change constantly, either staying in a state of dynamic balance or shifting to
a new state of balance. Matter cycles in ecosystems, and energy flows from outside sources through the
system. Humans are part of ecosystems and can deliberately or inadvertently alter an ecosystem.

STANDARD I: Students will understand that living organisms interact with one another and
their environment.
Objective 1: Summarize how energy flows through an ecosystem.
a. Arrange components of a food chain according to energy flow.
b. Compare the quantity of energy in the steps of an energy pyramid.
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c. Describe strategies used by organisms to balance the energy expended to obtain food to the energy
gained from the food.
d. Compare the relative energy output expended by an organism in obtaining food to the energy
gained from the food.
e. Research food production in various parts of the world.
Objective 2: Explain relationships between matter cycles and organisms.
a. Use diagrams to trace the movement of matter through a in a variety of biological communities and
ecosystems.
b. Explain how water is a limiting factor in various ecosystems.
c. Distinguish between inference and evidence in a newspaper, magazine, journal, or Internet article
that addresses an issue related to human impact on cycles of matter in an ecosystem and determine
the bias in the article.
d. Evaluate the impact of personal choices in relation to the cycling of matter within an ecosystem.
Objective 3: Describe how interactions among organisms and their environment help shape
ecosystems.
a. Categorize relationships among living things according to predator-prey, competition, and
symbiosis.
b. Formulate and test a hypothesis specific to the effect of changing one variable upon another in a
small ecosystem.
c. Use data to interpret interactions among biotic and abiotic factors (e.g., pH, temperature,
precipitation, populations, diversity) within an ecosystem.
d. Investigate an ecosystem using methods of science to gather quantitative and qualitative data that
describe the ecosystem in detail.
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Benchmark 2: Cells are the basic unit of life. All living things are composed of one or more cells that
come from preexisting cells. Cells perform a variety of functions necessary to maintain homeostasis
and life. The structure and function of a cell determines the cell's role in an organism. Living cells are
composed of chemical elements and molecules that form large, complex molecules. These molecules
form the basis for the structure and function of cells.

STANDARD II: Students will understand that all organisms are composed of one or more cells
that are made of molecules, come from preexisting cells, and perform life functions.
Objective 1: Describe the fundamental chemistry of living cells.
a. List the major chemical elements in cells (i.e., carbon, hydrogen, nitrogen, oxygen, phosphorous,
sulfur, trace elements).
b. Identify the function of the four major macromolecules.
c. Explain how the properties of water contribute to maintenance of cells and living organisms.
d. Explain the role of enzymes in cell chemistry.
Objective 2: Describe the flow of energy and matter in cellular function.
a. Distinguish between autotrophic and heterotrophic cells.
b. Illustrate the cycling of matter and the flow of energy through photosynthesis.
c. Measure the production of one or more of the products of either photosynthesis or respiration.
Objective 3: Investigate the structure and function of cells and cell parts.
a. Explain how cells divide from existing cells.
b. Describe cell theory and relate the nature of science to the development of cell theory.
c. Describe how the transport of materials in and out of cells enables cells to maintain homeostasis.
d. Describe the relationship between the organelles in a cell and the functions of that cell.
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e. Experiment with microorganisms and/or plants to investigate growth and reproduction.
Benchmark 3: Structure relates to function. Organs and organ systems function together to provide
homeostasis in organisms. The functioning of organs depends upon multiple organ systems.

STANDARD III: Students will understand the relationship between structure and function of
organs and organ systems.
Objective 1: Describe the structure and function of organs.
a. Diagram and label the structure of the primary components of representative organs in plants and
animals
b. Describe the function of various organs
c. Relate the structure of organs to the function of organs.
d. Compare the structure and function of organs in one organism to the structure and function of
organs in another organism.
e. Research and report on technological developments related to organs.
Objective 2: Describe the relationship between structure and function of organ systems in plants and
animals.
a. Relate the function of an organ to the function of an organ system.
b. Describe the structure and function of various organ systems (i.e., digestion, respiration,
circulation, protection and support, nervous) and how these systems contribute to homeostasis of
the organism.
c. Examine the relationships of organ systems within an organism and describe the relationship of
structure to function in the relationship.
d. Relate the tissues that make up organs to the structure and function of the organ.
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e. Compare the structure and function of organ systems in one organism to the structure and function
in another organism.
Benchmark 4: Information passed from parent to offspring is coded in DNA (deoxyribonucleic
acid) molecules. The fundamental DNA structure is the same for all living things; the sequence of
DNA differs between each organism and each species. Changes in the DNA sequence may alter
genetic expression. The genetic information in DNA provides the instructions for assembling
protein molecules in cells. The code used is virtually the same for all organisms. There are
predictable patterns of inheritance. Sexual reproduction increases the genetic variation of a species.
Asexual reproduction provides offspring that have the same genetic code as the parent.

STANDARD IV: Students will understand that genetic information coded in DNA is passed from
parents to offspring by sexual and asexual reproduction. The basic structure of DNA is the same
in all living things. Changes in DNA may alter genetic expression.
Objective 1: Compare sexual and asexual reproduction.
a. Explain the significance of meiosis and fertilization in genetic variation.
b. Compare the advantages/disadvantages of sexual and asexual reproduction to survival of species.
c. Formulate, defend, and support a perspective of a bioethical issue related to intentional or
unintentional chromosomal mutations.
Objective 2: Predict and interpret patterns of inheritance in sexually reproducing organisms.
a. Explain Mendel’s laws of segregation and independent assortment and their role in genetic
inheritance.
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b. Demonstrate possible results of recombination in sexually reproducing organisms using one or two
pairs of contrasting traits in the following crosses: dominance/recessive, incomplete dominance,
codominance, and sex-linked traits.
c. Relate Mendelian principles to modern-day practice of plant and animal breeding.
d. Analyze bioethical issues and consider the role of science in determining public policy.
Objective 3: Explain how the structure and replication of DNA are essential to heredity and protein
synthesis.
a. Use a model to describe the structure of DNA.
b. Explain the importance of DNA replication in cell reproduction.
c. Summarize how genetic information encoded in DNA provides instructions for assembling protein
molecules.
d. Describe how mutations may affect genetic expression and cite examples of mutagens.
e. Relate the historical events that lead to our present understanding of DNA to the cumulative nature
of science knowledge and technology.
f. Research, report, and debate genetic technologies that may improve the quality of life (e.g., genetic
engineering, cloning, gene splicing).
Benchmark 5: Evolution is central to modern science’s understanding of the living world. The basic
idea of biological evolution is that Earth’s present day species developed from earlier species.
Evolutionary processes allow some species to survive with little or no change, some to die out
altogether, and other species to change, giving rise to a greater diversity of species. Science
distinguishes itself from other ways of knowing and from other bodies of knowledge through the use of
empirical standards, logical arguments, and skepticism, as science strives for explanations of the world.
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STANDARD V: Students will understand that biological diversity is a result of evolutionary
processes.
Objective 1: Relate principles of evolution to biological diversity.
a. Describe the effects of environmental factors on natural selection.
b. Relate genetic variability to a species’ potential for adaptation to a changing environment.
c. Relate reproductive isolation to speciation.
d. Compare selective breeding to natural selection and relate the differences to agricultural practices.
Objective 2: Cite evidence for changes in populations over time and use concepts of evolution to
explain these changes.
a. Cite evidence that supports biological evolution over time (e.g., geologic and fossil records,
chemical mechanisms, and DNA structural similarities, homologous and vestigial structures).
b. Identify the role of mutation and recombination in evolution.
c. Relate the nature of science to the historical development of the theory of evolution.
d. Distinguish between observations and inferences in making interpretations related to evolution.
e. Review a scientific article and identify the research methods used to gather evidence that
documents the evolution of a species.
Objective 3: Classify organisms into a hierarchy of groups based on similarities that reflect their
evolutionary relationships.
a. Classify organisms using a classification tool such as a key or field guide.
b. Generalize criteria used for classification of organisms (e.g., dichotomy, structure, broad to
specific).
c. Explain how evolutionary relationships are related to classification systems.
Justify the ongoing changes to classification schemes used in biology.
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